| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYH1 MYH2 MYH4 MYH6 MYH8 MYH9 HIP1 MYH10 MYH13 MYO9A MARK3 HSPH1 CEP350 SPTBN5 STX1A DST ALMS1 BRCA1 CLU SYNE2 CGN MICAL3 DMD NLRP5 CACNA1C FKBP15 MYOT ANK3 CAMK2B SYNE1 KTN1 CAPZA1 ARFGEF2 ARFGEF1 RDX SIRT2 MACF1 RP1 CTNNA2 SCIN NEXN SMAD2 PHACTR1 | 6.22e-10 | 1099 | 276 | 43 | GO:0008092 |
| GeneOntologyMolecularFunction | actin binding | MYH1 MYH2 MYH4 MYH6 MYH8 MYH9 HIP1 MYH10 MYH13 MYO9A SPTBN5 DST SYNE2 CGN MICAL3 DMD FKBP15 MYOT CAMK2B SYNE1 CAPZA1 RDX MACF1 CTNNA2 SCIN NEXN PHACTR1 | 7.01e-10 | 479 | 276 | 27 | GO:0003779 |
| GeneOntologyMolecularFunction | microfilament motor activity | 1.86e-09 | 38 | 276 | 9 | GO:0000146 | |
| GeneOntologyMolecularFunction | actin filament binding | MYH1 MYH2 MYH4 MYH6 MYH8 MYH9 HIP1 MYH10 MYH13 MYO9A SPTBN5 SYNE1 CAPZA1 MACF1 CTNNA2 SCIN NEXN | 1.92e-08 | 227 | 276 | 17 | GO:0051015 |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | MYH9 SLK CDHR2 SCYL1 EVPL TENM2 ITGB7 NEO1 DST CGN KDR DMD DMP1 MYOT ANK3 IBSP KTN1 CAPZA1 RDX MICALL1 TENM3 DCHS1 MACF1 CTNNA2 NEXN HCFC1 | 2.85e-07 | 599 | 276 | 26 | GO:0050839 |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 1.09e-05 | 11 | 276 | 4 | GO:0098973 | |
| GeneOntologyMolecularFunction | protein kinase A binding | 1.47e-05 | 58 | 276 | 7 | GO:0051018 | |
| GeneOntologyMolecularFunction | cadherin binding | MYH9 SLK SCYL1 EVPL NEO1 CGN KDR ANK3 KTN1 CAPZA1 RDX MICALL1 DCHS1 MACF1 CTNNA2 HCFC1 | 2.17e-05 | 339 | 276 | 16 | GO:0045296 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 3.89e-05 | 118 | 276 | 9 | GO:0003774 | |
| GeneOntologyMolecularFunction | structural molecule activity | ERVK-6 MYH8 HIP1 EVPL POTEE SLIT2 DST DMD KRT78 MYOT ANK3 COL6A6 CILP DSPP KRT81 CAMK2B KRT83 POTEF KRT86 POM121L2 LMNB2 KRT87P ERVK-8 MACF1 CTNNA2 NUP93 POTEI NEXN | 4.67e-05 | 891 | 276 | 28 | GO:0005198 |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH1 MYH2 MYH4 MYH6 MYH8 MYH9 MYH10 MYH13 MYO9A ATAD5 SMC1A HSPH1 PEX1 ABCB4 CLU ATP11C RFC1 ATAD2 MLH3 HELZ2 ERCC6L2 MACF1 | 4.78e-05 | 614 | 276 | 22 | GO:0140657 |
| GeneOntologyMolecularFunction | vascular endothelial growth factor binding | 5.07e-05 | 6 | 276 | 3 | GO:0038085 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 8.29e-05 | 130 | 276 | 9 | GO:0005200 | |
| GeneOntologyMolecularFunction | calmodulin binding | MYH1 MYH2 MYH4 MYH6 MYH8 MYH9 MYH10 MYH13 CACNA1C CAMK2B UBR4 AKAP12 | 9.08e-05 | 230 | 276 | 12 | GO:0005516 |
| GeneOntologyMolecularFunction | DNA clamp unloader activity | 1.90e-04 | 2 | 276 | 2 | GO:0061860 | |
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | 3.05e-04 | 43 | 276 | 5 | GO:0030280 | |
| GeneOntologyMolecularFunction | protein kinase A regulatory subunit binding | 3.59e-04 | 25 | 276 | 4 | GO:0034237 | |
| GeneOntologyMolecularFunction | platelet-derived growth factor receptor activity | 5.66e-04 | 3 | 276 | 2 | GO:0005017 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 9.47e-04 | 32 | 276 | 4 | GO:0099186 | |
| GeneOntologyMolecularFunction | U4atac snRNA binding | 1.12e-03 | 4 | 276 | 2 | GO:0030622 | |
| GeneOntologyMolecularFunction | myosin binding | 1.16e-03 | 85 | 276 | 6 | GO:0017022 | |
| GeneOntologyMolecularFunction | chromatin binding | SOX9 NCOA3 SMC1A NAP1L2 SAFB BRCA1 SUPT5H KMT2A NELFE ZEB1 NSD2 CHAF1A CBFA2T3 ATAD2 ZFY NCOR1 SIRT2 MLH3 SMARCC1 HCFC1 SMAD2 | 1.51e-03 | 739 | 276 | 21 | GO:0003682 |
| GeneOntologyBiologicalProcess | endomembrane system organization | MYH2 MYH9 MYH10 KIAA0319L POLR2M CUL7 STX1B SPTBN5 STX1A CLU PIK3C3 CCDC47 SEC16A PEX5 UMOD ARHGAP21 CAVIN2 TOR1AIP2 FAT4 ANK3 CHMP1B SYNE1 UBR4 ARFGEF2 ARFGEF1 CHMP4BP1 LMNB2 MICALL1 SIRT2 NUP93 | 1.01e-08 | 672 | 278 | 30 | GO:0010256 |
| GeneOntologyBiologicalProcess | actin filament-based process | MYH2 MYH4 MYH6 MYH8 MYH9 HIP1 MYH10 FRMPD4 PDGFRA PDGFRB SPTBN5 POTEE SLIT2 ALMS1 SYNE2 MICAL3 HAX1 PREX1 NLRP5 AKAP6 CACNA1C POTEF BAG4 CAPZA1 ARFGEF1 RDX LATS1 ARHGAP12 CTNNA2 POTEI SCIN PHACTR1 | 7.84e-07 | 912 | 278 | 32 | GO:0030029 |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex assembly | SOX9 MYH9 RIOK3 DNAJC6 STX1B SPTBN5 SLIT2 STX1A CLU SEC16A PEX5 HAX1 PREX1 BAG4 CAPZA1 ARFGEF1 RDX ICE1 SIRT2 LATS1 SCIN HCFC1 | 9.04e-07 | 489 | 278 | 22 | GO:0043254 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | MYH6 MYH9 HIP1 SLK MYH10 PDGFRA PDGFRB SPTBN5 SLIT2 ALMS1 CLU MICAL3 HAX1 PREX1 NLRP5 KRT78 KRT81 KRT83 KRT86 BAG4 CAPZA1 ARFGEF1 RDX KRT87P LATS1 ARHGAP12 SMN1 RP1 CTNNA2 SCIN PCM1 PHACTR1 | 2.19e-06 | 957 | 278 | 32 | GO:0097435 |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex assembly | SOX9 MYH9 RIOK3 SPTBN5 SLIT2 CLU PEX5 CAPZA1 ARFGEF1 RDX SIRT2 SCIN | 4.20e-06 | 173 | 278 | 12 | GO:0031333 |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | SOX9 MYH9 SLK RIOK3 CHGA DNAJC6 TENM2 STX1B SPICE1 SPTBN5 SLIT2 STX1A ALMS1 BRCA1 CLU SYNE2 SEC16A PEX5 KDR HAX1 PREX1 CHMP1B SYNE1 BAG4 CAPZA1 ARFGEF1 RDX CHMP4BP1 ICE1 SIRT2 LATS1 RESF1 MACF1 RP1 SCIN HCFC1 | 4.71e-06 | 1189 | 278 | 36 | GO:0044087 |
| GeneOntologyBiologicalProcess | microtubule-based process | MYH9 SLK SMC1A HSPH1 KIAA0319L PEX1 CUL7 SPICE1 CEP350 CABYR DST ALMS1 BRCA1 RSPH1 SYNE2 CGN PKD1 ARHGAP21 NLRP5 ANK3 CHMP1B KTN1 CHMP4BP1 NCOR1 IFT52 MACF1 SMN1 RP1 RPGR CFAP61 SPAG17 PCM1 USP33 | 6.59e-06 | 1058 | 278 | 33 | GO:0007017 |
| GeneOntologyBiologicalProcess | regulation of actin filament polymerization | MYH9 SPTBN5 SLIT2 HAX1 PREX1 BAG4 CAPZA1 ARFGEF1 RDX LATS1 SCIN | 9.06e-06 | 156 | 278 | 11 | GO:0030833 |
| GeneOntologyBiologicalProcess | protein-containing complex disassembly | MYH9 DNAJC6 SPTBN5 PIK3C3 PEX5 MICAL3 CHMP1B CAPZA1 RDX CHMP4BP1 ATAD2 SMARCC1 SMN1 RP1 SCIN | 1.05e-05 | 291 | 278 | 15 | GO:0032984 |
| GeneOntologyBiologicalProcess | regulation of organelle organization | MYH9 PDGFRA PDGFRB HSPH1 STOX1 CUL7 SPICE1 SPTBN5 SLIT2 ALMS1 BRCA1 CLU SYNE2 PKD1 SEC16A KDR HAX1 PREX1 VDAC1 ANAPC4 CHMP1B CAMK2B SYNE1 BAG4 CAPZA1 ARFGEF1 RDX CHMP4BP1 ZFY SIRT2 LATS1 RESF1 FBXO43 SMARCC1 RP1 CTNNA2 EIF4G3 SCIN | 1.16e-05 | 1342 | 278 | 38 | GO:0033043 |
| GeneOntologyBiologicalProcess | nucleus localization | 2.61e-05 | 44 | 278 | 6 | GO:0051647 | |
| GeneOntologyBiologicalProcess | regulation of actin polymerization or depolymerization | MYH9 SPTBN5 SLIT2 HAX1 PREX1 BAG4 CAPZA1 ARFGEF1 RDX LATS1 SCIN | 2.96e-05 | 177 | 278 | 11 | GO:0008064 |
| GeneOntologyBiologicalProcess | organelle localization | MYH9 MYH10 PEX1 UNC13D POLR2M CHGA STX1B SPICE1 STX1A SYNE2 PKD1 SEC16A DMD ARHGAP21 TRAPPC9 NLRP5 CHMP1B SYNE1 CHMP4BP1 LMNB2 CHAMP1 RAB44 SIRT2 PCM1 | 3.14e-05 | 703 | 278 | 24 | GO:0051640 |
| GeneOntologyBiologicalProcess | regulation of actin filament length | MYH9 SPTBN5 SLIT2 HAX1 PREX1 BAG4 CAPZA1 ARFGEF1 RDX LATS1 SCIN | 3.46e-05 | 180 | 278 | 11 | GO:0030832 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | MYH6 MYH9 HIP1 MYH10 FRMPD4 PDGFRA PDGFRB SPTBN5 POTEE SLIT2 ALMS1 MICAL3 HAX1 PREX1 NLRP5 POTEF BAG4 CAPZA1 ARFGEF1 RDX LATS1 ARHGAP12 CTNNA2 POTEI SCIN PHACTR1 | 3.58e-05 | 803 | 278 | 26 | GO:0030036 |
| GeneOntologyBiologicalProcess | muscle filament sliding | 3.92e-05 | 15 | 278 | 4 | GO:0030049 | |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | MYH9 PDGFRA PDGFRB HSPH1 SPTBN5 SLIT2 ALMS1 BRCA1 PKD1 HAX1 PREX1 CHMP1B BAG4 CAPZA1 ARFGEF1 RDX CHMP4BP1 LATS1 RP1 CTNNA2 SCIN | 4.21e-05 | 579 | 278 | 21 | GO:0051493 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | MYH9 SLK SMC1A HSPH1 CUL7 SPICE1 CEP350 DST ALMS1 BRCA1 RSPH1 SYNE2 CGN PKD1 NLRP5 ANK3 CHMP1B CHMP4BP1 NCOR1 SMN1 RP1 SPAG17 PCM1 USP33 | 4.59e-05 | 720 | 278 | 24 | GO:0000226 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | CDHR2 PKD1 PCDH10 FAT4 MYOT DSC1 PCDHGB5 PCDHA13 TENM3 DCHS1 NEXN | 4.90e-05 | 187 | 278 | 11 | GO:0007156 |
| GeneOntologyBiologicalProcess | actin polymerization or depolymerization | MYH9 SPTBN5 SLIT2 MICAL3 HAX1 PREX1 BAG4 CAPZA1 ARFGEF1 RDX LATS1 SCIN | 5.11e-05 | 222 | 278 | 12 | GO:0008154 |
| GeneOntologyBiologicalProcess | positive regulation of isotype switching | 5.47e-05 | 31 | 278 | 5 | GO:0045830 | |
| GeneOntologyBiologicalProcess | postsynaptic actin cytoskeleton organization | 5.47e-05 | 31 | 278 | 5 | GO:0098974 | |
| GeneOntologyBiologicalProcess | intracellular transport | ERVK-6 SYNRG GRIPAP1 MYH10 PEX1 DNAJC6 STX1B SPTBN5 STX1A DST ALMS1 BRCA1 CLU PIK3C3 SYNE2 PKD1 SEC16A PEX5 UMOD ARHGAP21 TRAPPC9 PLEKHA8 CASC3 ANK3 CHMP1B SYNE1 RDX NDFIP2 POM121L2 CHMP4BP1 ICE1 LMNB2 MICALL1 IFT52 RPGR NUP93 SEC63 SPAG17 PCM1 | 5.58e-05 | 1496 | 278 | 39 | GO:0046907 |
| GeneOntologyBiologicalProcess | actin filament polymerization | MYH9 SPTBN5 SLIT2 HAX1 PREX1 BAG4 CAPZA1 ARFGEF1 RDX LATS1 SCIN | 5.66e-05 | 190 | 278 | 11 | GO:0030041 |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 5.84e-05 | 99 | 278 | 8 | GO:0045104 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 6.28e-05 | 100 | 278 | 8 | GO:0045103 | |
| GeneOntologyBiologicalProcess | actin filament organization | MYH9 HIP1 MYH10 SPTBN5 SLIT2 ALMS1 MICAL3 HAX1 PREX1 NLRP5 BAG4 CAPZA1 ARFGEF1 RDX LATS1 ARHGAP12 CTNNA2 SCIN PHACTR1 | 6.71e-05 | 509 | 278 | 19 | GO:0007015 |
| GeneOntologyBiologicalProcess | negative regulation of actin filament polymerization | 6.80e-05 | 75 | 278 | 7 | GO:0030837 | |
| GeneOntologyBiologicalProcess | protein localization to organelle | SOX9 MARK3 PEX1 CHGA DDIT3 PGR CEP350 TAF8 BRCA1 CLU PIK3C3 CCDC47 SEC16A PEX5 UMOD HAX1 TOR1AIP2 SYNE1 BAG4 RDX POM121L2 LMNB2 CHAMP1 MICALL1 ANKRD13A LATS1 MACF1 NUP93 SEC63 PCM1 TP53BP1 | 7.47e-05 | 1091 | 278 | 31 | GO:0033365 |
| GeneOntologyBiologicalProcess | actin-myosin filament sliding | 8.51e-05 | 18 | 278 | 4 | GO:0033275 | |
| GeneOntologyBiologicalProcess | chromatin organization | SOX9 NCOA3 PHF20 NAP1L2 GTF3C4 TASOR2 SAFB BRCA1 SUPT5H APOBEC2 KMT2A NSD2 CHAF1A LMNB2 ATAD2 MIER1 ZFY NCOR1 RIF1 SIRT2 RESF1 BAZ1A PAXIP1 ERCC6L2 SMARCC1 HCFC1 TP53BP1 | 8.54e-05 | 896 | 278 | 27 | GO:0006325 |
| GeneOntologyBiologicalProcess | nuclear migration | 8.67e-05 | 34 | 278 | 5 | GO:0007097 | |
| GeneOntologyBiologicalProcess | plasma membrane repair | 8.67e-05 | 34 | 278 | 5 | GO:0001778 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | MYH10 MYO9A UNC5B CUL7 TENM2 POTEE SLIT2 NEK3 NEO1 DST CLU KDR DMD MYOT ANK3 CAMK2B POTEF SYNE1 MACF1 SMN1 CTNNA2 POTEI NEXN USP33 PHACTR1 | 9.30e-05 | 802 | 278 | 25 | GO:0048812 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | CDHR2 MCAM TENM2 PKD1 UMOD PCDH10 FAT4 MYOT DSC1 PCDHGB5 PCDHA13 TENM3 DCHS1 NEXN | 9.63e-05 | 313 | 278 | 14 | GO:0098742 |
| GeneOntologyBiologicalProcess | postsynaptic cytoskeleton organization | 1.00e-04 | 35 | 278 | 5 | GO:0099188 | |
| GeneOntologyBiologicalProcess | regulation of actin filament-based process | MYH9 PDGFRA PDGFRB SPTBN5 SLIT2 ALMS1 HAX1 PREX1 AKAP6 CACNA1C BAG4 CAPZA1 ARFGEF1 RDX LATS1 CTNNA2 SCIN | 1.02e-04 | 438 | 278 | 17 | GO:0032970 |
| GeneOntologyBiologicalProcess | protein-containing complex localization | GRIPAP1 HIP1 STX1B AKAP6 SYNE1 RALGAPB RDX LMNB2 SIRT2 IFT52 RPGR SPAG17 PCM1 | 1.10e-04 | 278 | 278 | 13 | GO:0031503 |
| GeneOntologyBiologicalProcess | calcium-ion regulated exocytosis | 1.20e-04 | 82 | 278 | 7 | GO:0017156 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | MYH10 MYO9A UNC5B CUL7 TENM2 POTEE SLIT2 NEK3 NEO1 DST CLU KDR DMD MYOT ANK3 CAMK2B POTEF SYNE1 MACF1 SMN1 CTNNA2 POTEI NEXN USP33 PHACTR1 | 1.29e-04 | 819 | 278 | 25 | GO:0120039 |
| GeneOntologyBiologicalProcess | mesenchymal cell proliferation | 1.41e-04 | 59 | 278 | 6 | GO:0010463 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | MYH10 MYO9A UNC5B CUL7 TENM2 POTEE SLIT2 NEK3 NEO1 DST CLU KDR DMD MYOT ANK3 CAMK2B POTEF SYNE1 MACF1 SMN1 CTNNA2 POTEI NEXN USP33 PHACTR1 | 1.47e-04 | 826 | 278 | 25 | GO:0048858 |
| GeneOntologyBiologicalProcess | protein depolymerization | 1.50e-04 | 144 | 278 | 9 | GO:0051261 | |
| GeneOntologyBiologicalProcess | establishment of organelle localization | MYH9 MYH10 UNC13D CHGA SPICE1 SYNE2 PKD1 SEC16A ARHGAP21 TRAPPC9 NLRP5 CHMP1B SYNE1 CHMP4BP1 LMNB2 CHAMP1 RAB44 SIRT2 PCM1 | 1.67e-04 | 546 | 278 | 19 | GO:0051656 |
| GeneOntologyBiologicalProcess | DNA clamp unloading | 1.81e-04 | 2 | 278 | 2 | GO:0090618 | |
| GeneOntologyBiologicalProcess | cortical granule exocytosis | 1.81e-04 | 2 | 278 | 2 | GO:0060471 | |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | RALGAPA1 PDGFRB MYO9A FAM13B SLIT2 PREX1 ARHGAP21 RALGAPB ARFGEF2 ARFGEF1 RDX ARFGEF3 ARHGAP12 ARHGAP45 | 1.84e-04 | 333 | 278 | 14 | GO:0051056 |
| GeneOntologyBiologicalProcess | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | SOX9 HIP1 PDGFRA PDGFRB UNC5B STOX1 KDR HAX1 BAG4 ARFGEF1 MTDH | 1.84e-04 | 217 | 278 | 11 | GO:0051897 |
| GeneOntologyBiologicalProcess | chromatin remodeling | SOX9 NCOA3 NAP1L2 GTF3C4 TASOR2 BRCA1 SUPT5H APOBEC2 KMT2A NSD2 CHAF1A LMNB2 ATAD2 MIER1 ZFY RIF1 SIRT2 RESF1 BAZ1A PAXIP1 ERCC6L2 SMARCC1 HCFC1 | 1.89e-04 | 741 | 278 | 23 | GO:0006338 |
| GeneOntologyBiologicalProcess | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 2.03e-04 | 63 | 278 | 6 | GO:0007157 | |
| GeneOntologyBiologicalProcess | heart valve morphogenesis | 2.03e-04 | 63 | 278 | 6 | GO:0003179 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | SOX9 NCOA3 PHF20 NAP1L2 GTF3C4 TASOR2 TAF8 SAFB BRCA1 SUPT5H APOBEC2 KMT2A NSD2 CHAF1A LMNB2 ATAD2 MIER1 ZFY NCOR1 RIF1 SIRT2 RESF1 BAZ1A PAXIP1 ERCC6L2 SMARCC1 HCFC1 TP53BP1 | 2.12e-04 | 999 | 278 | 28 | GO:0071824 |
| GeneOntologyBiologicalProcess | maintenance of location in cell | POLR2M DDIT3 PGR ITPR2 TAF8 DMD ARHGAP21 AKAP6 CACNA1C ANK3 SYNE1 SCIN | 2.19e-04 | 259 | 278 | 12 | GO:0051651 |
| GeneOntologyBiologicalProcess | negative regulation of protein polymerization | 2.31e-04 | 91 | 278 | 7 | GO:0032272 | |
| GeneOntologyBiologicalProcess | regulation of actin filament organization | MYH9 SPTBN5 SLIT2 ALMS1 HAX1 PREX1 BAG4 CAPZA1 ARFGEF1 RDX LATS1 CTNNA2 SCIN | 2.32e-04 | 300 | 278 | 13 | GO:0110053 |
| GeneOntologyBiologicalProcess | actin filament-based movement | 2.37e-04 | 153 | 278 | 9 | GO:0030048 | |
| GeneOntologyBiologicalProcess | regulation of actin cytoskeleton organization | MYH9 PDGFRA PDGFRB SPTBN5 SLIT2 ALMS1 HAX1 PREX1 BAG4 CAPZA1 ARFGEF1 RDX LATS1 CTNNA2 SCIN | 2.42e-04 | 384 | 278 | 15 | GO:0032956 |
| GeneOntologyBiologicalProcess | regulation of isotype switching | 2.43e-04 | 42 | 278 | 5 | GO:0045191 | |
| GeneOntologyBiologicalProcess | plasma membrane organization | MYH2 MYH9 MYH10 CLU CAVIN2 FAT4 ANK3 CHMP1B CHMP4BP1 MICALL1 | 2.45e-04 | 188 | 278 | 10 | GO:0007009 |
| GeneOntologyBiologicalProcess | cell cycle process | SOX9 MYH9 MYH10 PDGFRB ATAD5 SMC1A RIOK3 STOX1 CUL7 SPICE1 FANCD2 ALMS1 BRCA1 PIK3C3 PKD1 ANAPC4 NLRP5 ANK3 CHMP1B CAMK2B RDX CHMP4BP1 CHAMP1 ZFY NCOR1 SIRT2 MLH3 LATS1 PAXIP1 FBXO43 SMARCC1 CLSPN EIF4G3 PCM1 TP53BP1 USP33 | 2.54e-04 | 1441 | 278 | 36 | GO:0022402 |
| GeneOntologyBiologicalProcess | actin filament depolymerization | 2.62e-04 | 66 | 278 | 6 | GO:0030042 | |
| GeneOntologyBiologicalProcess | positive regulation of gene expression | SOX4 SOX9 ERVK-6 NCOA3 MYH9 ATAD5 MRPS27 RIOK3 STOX1 DDIT3 PGR DEFA5 MELTF NOD1 BRCA1 CLU APOBEC2 KMT2A C5 AKAP6 ANK3 NSD2 ARFGEF2 RDX LARP1B ATAD2 AKAP12 RIF1 CD80 PAXIP1 SMN1 EIF4G3 HCFC1 TP53BP1 SMAD2 PHACTR1 | 2.72e-04 | 1446 | 278 | 36 | GO:0010628 |
| GeneOntologyBiologicalProcess | membrane organization | MYH2 MYH9 MYH10 KIAA0319L STX1B ABCB4 STX1A CLU CCDC47 SEC16A PEX5 UMOD ATP11C TRAPPC9 CAVIN2 PLEKHA8 TOR1AIP2 FAT4 ANK3 CHMP1B CHMP4BP1 LMNB2 MICALL1 SIRT2 ARHGAP12 NUP93 | 2.86e-04 | 914 | 278 | 26 | GO:0061024 |
| GeneOntologyBiologicalProcess | neuron projection development | MYH10 MYO9A UNC5B CUL7 TENM2 STX1B POTEE SLIT2 NEK3 NEO1 DST ALMS1 CLU KDR DMD PREX1 FAT4 MYOT ANK3 CAMK2B POTEF SYNE1 ARFGEF1 FRYL MICALL1 TENM3 MACF1 SMN1 CTNNA2 POTEI NEXN USP33 PHACTR1 | 2.87e-04 | 1285 | 278 | 33 | GO:0031175 |
| GeneOntologyBiologicalProcess | negative regulation of cytoskeleton organization | 3.15e-04 | 194 | 278 | 10 | GO:0051494 | |
| GeneOntologyBiologicalProcess | regulation of protein polymerization | MYH9 SPTBN5 SLIT2 HAX1 PREX1 BAG4 CAPZA1 ARFGEF1 RDX LATS1 SCIN | 3.15e-04 | 231 | 278 | 11 | GO:0032271 |
| GeneOntologyBiologicalProcess | regulation of meiotic nuclear division | 3.37e-04 | 45 | 278 | 5 | GO:0040020 | |
| GeneOntologyBiologicalProcess | neuron development | MYH10 MYO9A UNC5B SCYL1 CUL7 TENM2 STX1B POTEE SLIT2 NEK3 NEO1 DST ALMS1 CLU KDR DMD PREX1 FAT4 MYOT ANK3 CAMK2B POTEF SYNE1 ARFGEF1 FRYL MICALL1 TENM3 MACF1 SMN1 RP1 RPGR CTNNA2 POTEI NEXN USP33 PHACTR1 | 3.39e-04 | 1463 | 278 | 36 | GO:0048666 |
| GeneOntologyBiologicalProcess | regulation of establishment of protein localization | SOX4 GRIPAP1 MYH9 MYH10 CHGA RSC1A1 FNDC1 STX1A NEO1 BRCA1 LYPLA1 UMOD HAX1 CACNA1C ANK3 NSD2 BAG4 NDFIP2 ICE1 HCFC1 PCM1 | 3.43e-04 | 674 | 278 | 21 | GO:0070201 |
| GeneOntologyBiologicalProcess | negative regulation of supramolecular fiber organization | 3.56e-04 | 197 | 278 | 10 | GO:1902904 | |
| GeneOntologyBiologicalProcess | Golgi to plasma membrane transport | 3.62e-04 | 70 | 278 | 6 | GO:0006893 | |
| GeneOntologyBiologicalProcess | regulation of mesenchymal stem cell differentiation | 3.69e-04 | 11 | 278 | 3 | GO:2000739 | |
| GeneOntologyBiologicalProcess | branching morphogenesis of an epithelial tube | 3.70e-04 | 198 | 278 | 10 | GO:0048754 | |
| GeneOntologyBiologicalProcess | actin filament capping | 3.74e-04 | 46 | 278 | 5 | GO:0051693 | |
| GeneOntologyBiologicalProcess | regulation of synapse structural plasticity | 4.87e-04 | 12 | 278 | 3 | GO:0051823 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | SOX9 PDGFRB ATAD5 STOX1 CUL7 SPICE1 FANCD2 ALMS1 BRCA1 PIK3C3 PKD1 ANAPC4 CHMP1B CAMK2B RDX CHMP4BP1 ZFY SIRT2 PAXIP1 FBXO43 SMARCC1 CLSPN EIF4G3 TP53BP1 | 5.02e-04 | 845 | 278 | 24 | GO:0010564 |
| GeneOntologyBiologicalProcess | metanephric glomerulus morphogenesis | 5.38e-04 | 3 | 278 | 2 | GO:0072275 | |
| GeneOntologyBiologicalProcess | metanephric glomerular capillary formation | 5.38e-04 | 3 | 278 | 2 | GO:0072277 | |
| GeneOntologyBiologicalProcess | metanephric glomerulus vasculature morphogenesis | 5.38e-04 | 3 | 278 | 2 | GO:0072276 | |
| GeneOntologyBiologicalProcess | VEGF-activated platelet-derived growth factor receptor signaling pathway | 5.38e-04 | 3 | 278 | 2 | GO:0038086 | |
| GeneOntologyBiologicalProcess | positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway | 5.38e-04 | 3 | 278 | 2 | GO:0038091 | |
| GeneOntologyBiologicalProcess | actin filament bundle distribution | 5.38e-04 | 3 | 278 | 2 | GO:0070650 | |
| GeneOntologyBiologicalProcess | vesicle-mediated transport to the plasma membrane | GRIPAP1 RSC1A1 STX1B SEC16A LYPLA1 ANK3 ARFGEF2 MICALL1 MACF1 | 5.60e-04 | 172 | 278 | 9 | GO:0098876 |
| GeneOntologyBiologicalProcess | establishment of protein localization to plasma membrane | 5.64e-04 | 76 | 278 | 6 | GO:0061951 | |
| GeneOntologyBiologicalProcess | negative regulation of mesenchymal cell apoptotic process | 6.27e-04 | 13 | 278 | 3 | GO:2001054 | |
| GeneOntologyBiologicalProcess | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | SOX9 HIP1 PDGFRA PDGFRB UNC5B STOX1 DDIT3 KDR HAX1 BAG4 ARFGEF1 NCOR1 MTDH | 6.43e-04 | 334 | 278 | 13 | GO:0051896 |
| GeneOntologyBiologicalProcess | heart valve development | 6.48e-04 | 78 | 278 | 6 | GO:0003170 | |
| GeneOntologyBiologicalProcess | negative regulation of actin filament depolymerization | 6.65e-04 | 52 | 278 | 5 | GO:0030835 | |
| GeneOntologyBiologicalProcess | regulation of cellular component size | MYH9 CDHR2 SPTBN5 SLIT2 CLCN6 HAX1 PREX1 SLC12A6 BAG4 CAPZA1 ARFGEF1 RDX LATS1 MACF1 SCIN | 7.14e-04 | 426 | 278 | 15 | GO:0032535 |
| GeneOntologyBiologicalProcess | phosphatidylinositol 3-kinase/protein kinase B signal transduction | SOX9 HIP1 PDGFRA PDGFRB UNC5B STOX1 DDIT3 PIK3C3 KDR HAX1 BAG4 ARFGEF1 NCOR1 MTDH | 7.27e-04 | 382 | 278 | 14 | GO:0043491 |
| GeneOntologyBiologicalProcess | epithelium development | SOX4 SOX9 NCOA3 PDGFRA CDHR2 MYO9A EVPL STOX1 CUL7 ITPK1 PGR SLIT2 ALMS1 CGN PKD1 UMOD KDR DMD KDF1 FNDC3B FAT4 KRT78 ZEB1 DSPP KRT81 KRT83 KRT86 RDX KRT87P NCOR1 LATS1 IFT52 ARHGAP12 DCHS1 SMAD2 | 7.36e-04 | 1469 | 278 | 35 | GO:0060429 |
| GeneOntologyBiologicalProcess | organ growth | SOX9 MYH6 MYH10 PDGFRA PDGFRB KDR AKAP6 CACNA1C DSPP LATS1 SMAD2 | 7.45e-04 | 256 | 278 | 11 | GO:0035265 |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | SOX4 SOX9 NCOA3 CDHR2 MYO9A EVPL CUL7 PGR CGN KDR DMD KDF1 FNDC3B FAT4 KRT78 ZEB1 DSPP KRT81 KRT83 KRT86 RDX KRT87P LATS1 SMAD2 | 7.54e-04 | 870 | 278 | 24 | GO:0030855 |
| GeneOntologyBiologicalProcess | cell morphogenesis | MYH9 MYH10 MYO9A UNC5B CUL7 TENM2 POTEE SLIT2 NEK3 NEO1 DST CLU CGN KDR DMD MYOT ANK3 CAMK2B POTEF SYNE1 RDX FRYL LATS1 MACF1 SMN1 CTNNA2 POTEI NEXN USP33 PHACTR1 | 7.80e-04 | 1194 | 278 | 30 | GO:0000902 |
| GeneOntologyBiologicalProcess | mesenchymal stem cell differentiation | 7.90e-04 | 14 | 278 | 3 | GO:0072497 | |
| GeneOntologyBiologicalProcess | regulation of meiotic cell cycle | 8.44e-04 | 82 | 278 | 6 | GO:0051445 | |
| GeneOntologyBiologicalProcess | positive regulation of immunoglobulin mediated immune response | 9.35e-04 | 56 | 278 | 5 | GO:0002891 | |
| GeneOntologyBiologicalProcess | positive regulation of B cell mediated immunity | 9.35e-04 | 56 | 278 | 5 | GO:0002714 | |
| GeneOntologyBiologicalProcess | regulation of supramolecular fiber organization | MYH9 SPTBN5 SLIT2 ALMS1 CLU HAX1 PREX1 BAG4 CAPZA1 ARFGEF1 RDX LATS1 RP1 CTNNA2 SCIN | 9.45e-04 | 438 | 278 | 15 | GO:1902903 |
| GeneOntologyBiologicalProcess | egg activation | 9.77e-04 | 15 | 278 | 3 | GO:0007343 | |
| GeneOntologyCellularComponent | myosin filament | 8.09e-10 | 25 | 279 | 8 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin II complex | 2.25e-09 | 28 | 279 | 8 | GO:0016460 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH1 MYH2 MYH4 MYH6 MYH8 MYH9 HIP1 MYH10 MYH13 MYO9A POLR2M SPTBN5 POTEE STX1A DST CGN HAX1 ARHGAP21 FKBP15 MYOT POTEF CAPZA1 RDX MACF1 CTNNA2 POTEI SCIN NEXN | 4.22e-09 | 576 | 279 | 28 | GO:0015629 |
| GeneOntologyCellularComponent | myosin complex | 5.39e-09 | 59 | 279 | 10 | GO:0016459 | |
| GeneOntologyCellularComponent | cell cortex | MYH2 MYH9 HIP1 MYH10 POLR2M STOX1 ITPR2 SPTBN5 DST MICAL3 HAX1 KDF1 NLRP5 POTEF CAPZA1 RDX FRYL AKAP12 MACF1 CTNNA2 SCIN | 3.10e-08 | 371 | 279 | 21 | GO:0005938 |
| GeneOntologyCellularComponent | muscle myosin complex | 3.83e-08 | 16 | 279 | 6 | GO:0005859 | |
| GeneOntologyCellularComponent | supramolecular fiber | MYH1 MYH2 MYH4 MYH6 MYH8 MYH9 MYH10 MYH13 MYO9A HSPH1 EVPL POLR2M POTEE DST RSPH1 SYNE2 DMD CACNA1C KRT78 MYOT ANK3 CHMP1B KRT81 KRT83 POTEF SYNE1 KRT86 ARFGEF2 CHMP4BP1 LMNB2 KRT87P SIRT2 MACF1 SMN1 RP1 POTEI SPAG17 NEXN | 4.36e-07 | 1179 | 279 | 38 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | MYH1 MYH2 MYH4 MYH6 MYH8 MYH9 MYH10 MYH13 MYO9A HSPH1 EVPL POLR2M POTEE DST RSPH1 SYNE2 DMD CACNA1C KRT78 MYOT ANK3 CHMP1B KRT81 KRT83 POTEF SYNE1 KRT86 ARFGEF2 CHMP4BP1 LMNB2 KRT87P SIRT2 MACF1 SMN1 RP1 POTEI SPAG17 NEXN | 5.15e-07 | 1187 | 279 | 38 | GO:0099081 |
| GeneOntologyCellularComponent | myofibril | MYH1 MYH2 MYH4 MYH6 MYH8 MYH13 POLR2M DST SYNE2 DMD CACNA1C MYOT ANK3 SYNE1 SMN1 NEXN | 8.94e-07 | 273 | 279 | 16 | GO:0030016 |
| GeneOntologyCellularComponent | anchoring junction | MYH1 MYH2 MYH9 PDGFRB CDHR2 MCAM EVPL POLR2M TENM2 FRMD4B ITGB7 ABCB4 FNDC1 DST SYNE2 CGN NHS KDR DMD KDF1 ARHGAP21 AKAP6 DSC1 ANK3 CAPZA1 RDX AKAP12 SIRT2 CTNNA2 SCIN NEXN MTDH USP33 | 9.54e-07 | 976 | 279 | 33 | GO:0070161 |
| GeneOntologyCellularComponent | sarcomere | MYH1 MYH2 MYH4 MYH6 MYH8 POLR2M DST SYNE2 DMD CACNA1C MYOT ANK3 SYNE1 SMN1 NEXN | 1.40e-06 | 249 | 279 | 15 | GO:0030017 |
| GeneOntologyCellularComponent | contractile muscle fiber | MYH1 MYH2 MYH4 MYH6 MYH8 MYH13 POLR2M DST SYNE2 DMD CACNA1C MYOT ANK3 SYNE1 SMN1 NEXN | 1.97e-06 | 290 | 279 | 16 | GO:0043292 |
| GeneOntologyCellularComponent | axon | GRIPAP1 MYH10 PDGFRA MYO9A TENM2 STX1B PGR ITPR2 POTEE SLIT2 NEK3 STX1A NEO1 DST CLU DMD PREX1 SLC12A6 CACNA1C FKBP15 MYOT ANK3 POTEF SIRT2 TENM3 SMN1 CTNNA2 POTEI NEXN HCFC1 | 3.36e-06 | 891 | 279 | 30 | GO:0030424 |
| GeneOntologyCellularComponent | nuclear envelope | PHF20 POLR2M STX1A DST SYNE2 LYPLA1 HAX1 AKAP6 TOR1AIP2 CASC3 CHMP1B SYNE1 PARP8 POM121L2 CHMP4BP1 LMNB2 RIF1 FAM169A NUP93 MTDH PCM1 | 2.25e-05 | 560 | 279 | 21 | GO:0005635 |
| GeneOntologyCellularComponent | spindle | MYH9 MYH10 SMC1A STX1B SPICE1 CEP350 ALMS1 RSPH1 UMOD MICAL3 CHMP1B CAMK2B CHMP4BP1 CHAMP1 NCOR1 RIF1 SIRT2 LATS1 | 6.86e-05 | 471 | 279 | 18 | GO:0005819 |
| GeneOntologyCellularComponent | nuclear membrane | PHF20 STX1A SYNE2 LYPLA1 HAX1 AKAP6 TOR1AIP2 CASC3 SYNE1 LMNB2 RIF1 FAM169A NUP93 MTDH PCM1 | 7.66e-05 | 349 | 279 | 15 | GO:0031965 |
| GeneOntologyCellularComponent | I band | 8.16e-05 | 166 | 279 | 10 | GO:0031674 | |
| GeneOntologyCellularComponent | cell-cell junction | MYH1 MYH2 MYH9 EVPL TENM2 FRMD4B ABCB4 FNDC1 DST CGN NHS AKAP6 DSC1 ANK3 CAPZA1 RDX SIRT2 CTNNA2 NEXN MTDH | 1.44e-04 | 591 | 279 | 20 | GO:0005911 |
| GeneOntologyCellularComponent | apical part of cell | TRPM6 MYH9 PDGFRB CDHR2 ITPK1 ABCB4 SPTBN5 NOD1 UMOD NHS HAX1 NLRP5 SLC12A6 FAT4 RDX CEP164 DCHS1 MTDH PCM1 SLC4A11 | 1.47e-04 | 592 | 279 | 20 | GO:0045177 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | PRPF31 NCOA3 MYH9 ERCC5 PHF20 POLR2M CUL7 DDIT3 CACTIN TAF8 BRCA1 SUPT5H SYNE2 KMT2A ANAPC4 NELFE CASC3 CHMP1B ICE2 SYNE1 ARFGEF1 GEMIN5 POM121L2 CHMP4BP1 ICE1 TSSC4 NCOR1 SIRT2 BAZ1A UTP4 PAXIP1 SMARCC1 NUP93 HCFC1 SMAD2 | 1.88e-04 | 1377 | 279 | 35 | GO:0140513 |
| GeneOntologyCellularComponent | Z disc | 2.00e-04 | 151 | 279 | 9 | GO:0030018 | |
| GeneOntologyCellularComponent | midbody | MYH10 DEFA5 SAFB PIK3C3 MICAL3 CHMP1B SYNE1 RDX CHMP4BP1 SIRT2 LATS1 | 2.06e-04 | 222 | 279 | 11 | GO:0030496 |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | EVPL PJA2 DST SYNE2 DMD KRT78 KRT81 KRT83 KRT86 LMNB2 KRT87P MACF1 | 2.31e-04 | 263 | 279 | 12 | GO:0045111 |
| GeneOntologyCellularComponent | centrosome | SCYL1 STOX1 CUL7 STX1B SPICE1 CEP350 PJA2 ALMS1 BRCA1 CAMK2B UBR4 ARFGEF2 ECPAS CEP164 SIRT2 LATS1 IFT52 PPP4R2 ERCC6L2 RPGR NUP93 PCM1 USP33 | 2.86e-04 | 770 | 279 | 23 | GO:0005813 |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 3.23e-04 | 45 | 279 | 5 | GO:1902562 | |
| GeneOntologyCellularComponent | myosin II filament | 5.28e-04 | 3 | 279 | 2 | GO:0097513 | |
| GeneOntologyCellularComponent | Elg1 RFC-like complex | 5.28e-04 | 3 | 279 | 2 | GO:0031391 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | NCOA3 SYNRG SLK CHGA CUL7 TAF8 DST CLU SEC16A KCNS1 DMD PREX1 AKAP6 CASC3 PTGES2 SYNE1 ARFGEF2 AGGF1 ARFGEF1 NDFIP2 ANKRD13A NCOR1 SIRT2 MTDH USP33 | 7.86e-04 | 934 | 279 | 25 | GO:0048471 |
| GeneOntologyCellularComponent | MLL1 complex | 8.32e-04 | 32 | 279 | 4 | GO:0071339 | |
| GeneOntologyCellularComponent | sarcoplasm | 8.54e-04 | 114 | 279 | 7 | GO:0016528 | |
| GeneOntologyCellularComponent | MLL1/2 complex | 9.37e-04 | 33 | 279 | 4 | GO:0044665 | |
| GeneOntologyCellularComponent | intermediate filament | 9.91e-04 | 227 | 279 | 10 | GO:0005882 | |
| GeneOntologyCellularComponent | brush border | 1.02e-03 | 152 | 279 | 8 | GO:0005903 | |
| GeneOntologyCellularComponent | histone locus body | 1.05e-03 | 4 | 279 | 2 | GO:0035363 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 1.16e-03 | 88 | 279 | 6 | GO:0016529 | |
| GeneOntologyCellularComponent | microtubule organizing center | SCYL1 STOX1 CUL7 STX1B SPICE1 CEP350 PJA2 ALMS1 BRCA1 CAMK2B UBR4 ARFGEF2 ECPAS CEP164 SIRT2 LATS1 IFT52 RESF1 PPP4R2 ERCC6L2 RPGR NUP93 PCM1 USP33 | 1.39e-03 | 919 | 279 | 24 | GO:0005815 |
| GeneOntologyCellularComponent | cortical actin cytoskeleton | 1.55e-03 | 93 | 279 | 6 | GO:0030864 | |
| GeneOntologyCellularComponent | cortical cytoskeleton | 1.75e-03 | 129 | 279 | 7 | GO:0030863 | |
| GeneOntologyCellularComponent | nuclear periphery | 2.15e-03 | 171 | 279 | 8 | GO:0034399 | |
| GeneOntologyCellularComponent | site of polarized growth | 2.22e-03 | 253 | 279 | 10 | GO:0030427 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | MYH9 MYO9A HSPH1 EVPL POTEE DST RSPH1 DMD KRT78 CHMP1B KRT81 KRT83 POTEF KRT86 ARFGEF2 CHMP4BP1 LMNB2 KRT87P SIRT2 MACF1 RP1 POTEI SPAG17 | 2.27e-03 | 899 | 279 | 23 | GO:0099513 |
| GeneOntologyCellularComponent | cortical granule | 2.57e-03 | 6 | 279 | 2 | GO:0060473 | |
| GeneOntologyCellularComponent | condensed chromosome | SMC1A FANCD2 BRCA1 RSPH1 CHMP1B CHMP4BP1 CHAMP1 RIF1 MLH3 SMARCC1 TP53BP1 | 2.91e-03 | 307 | 279 | 11 | GO:0000793 |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 3.01e-03 | 45 | 279 | 4 | GO:0033017 | |
| GeneOntologyCellularComponent | cell leading edge | MYH9 SLK MYH10 PDGFRB FRMD4B DST SYNE2 NHS HAX1 DMD KDF1 RDX MACF1 CTNNA2 ARHGAP45 | 3.10e-03 | 500 | 279 | 15 | GO:0031252 |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 3.16e-03 | 223 | 279 | 9 | GO:0098862 | |
| GeneOntologyCellularComponent | methyltransferase complex | 3.29e-03 | 108 | 279 | 6 | GO:0034708 | |
| GeneOntologyCellularComponent | histone methyltransferase complex | 3.30e-03 | 75 | 279 | 5 | GO:0035097 | |
| GeneOntologyCellularComponent | DNA repair complex | 3.42e-03 | 23 | 279 | 3 | GO:1990391 | |
| GeneOntologyCellularComponent | actomyosin contractile ring | 3.57e-03 | 7 | 279 | 2 | GO:0005826 | |
| GeneOntologyCellularComponent | photoreceptor connecting cilium | 3.81e-03 | 48 | 279 | 4 | GO:0032391 | |
| Domain | Myosin_tail_1 | 1.08e-12 | 18 | 271 | 9 | PF01576 | |
| Domain | Myosin_tail | 1.08e-12 | 18 | 271 | 9 | IPR002928 | |
| Domain | Myosin_N | 1.04e-11 | 15 | 271 | 8 | IPR004009 | |
| Domain | Myosin_N | 1.04e-11 | 15 | 271 | 8 | PF02736 | |
| Domain | Myosin-like_IQ_dom | 1.17e-10 | 19 | 271 | 8 | IPR027401 | |
| Domain | - | 1.17e-10 | 19 | 271 | 8 | 4.10.270.10 | |
| Domain | MYOSIN_MOTOR | 2.82e-09 | 38 | 271 | 9 | PS51456 | |
| Domain | Myosin_head_motor_dom | 2.82e-09 | 38 | 271 | 9 | IPR001609 | |
| Domain | Myosin_head | 2.82e-09 | 38 | 271 | 9 | PF00063 | |
| Domain | MYSc | 2.82e-09 | 38 | 271 | 9 | SM00242 | |
| Domain | SPEC | 1.38e-08 | 32 | 271 | 8 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.38e-08 | 32 | 271 | 8 | IPR018159 | |
| Domain | Spectrin_repeat | 1.49e-07 | 29 | 271 | 7 | IPR002017 | |
| Domain | CH | 3.92e-07 | 65 | 271 | 9 | SM00033 | |
| Domain | Spectrin | 7.24e-07 | 23 | 271 | 6 | PF00435 | |
| Domain | ACTININ_2 | 7.24e-07 | 23 | 271 | 6 | PS00020 | |
| Domain | ACTININ_1 | 7.24e-07 | 23 | 271 | 6 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 7.24e-07 | 23 | 271 | 6 | IPR001589 | |
| Domain | CH | 7.49e-07 | 70 | 271 | 9 | PF00307 | |
| Domain | IQ | 8.47e-07 | 71 | 271 | 9 | PF00612 | |
| Domain | - | 8.47e-07 | 71 | 271 | 9 | 1.10.418.10 | |
| Domain | CH | 1.08e-06 | 73 | 271 | 9 | PS50021 | |
| Domain | CH-domain | 1.36e-06 | 75 | 271 | 9 | IPR001715 | |
| Domain | ARM-type_fold | RALGAPA1 HIP1 SCYL1 CUL7 ITPR2 PIK3C3 TARBP1 UBR4 ARFGEF2 ARFGEF1 FRYL ECPAS RSPRY1 ARFGEF3 RIF1 THADA STKLD1 EIF4G3 | 2.49e-06 | 339 | 271 | 18 | IPR016024 |
| Domain | IQ | 2.62e-06 | 81 | 271 | 9 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 6.32e-06 | 90 | 271 | 9 | IPR000048 | |
| Domain | IQ | 8.29e-06 | 93 | 271 | 9 | PS50096 | |
| Domain | DCB_dom | 1.20e-05 | 4 | 271 | 3 | IPR032629 | |
| Domain | DCB | 1.20e-05 | 4 | 271 | 3 | PF16213 | |
| Domain | Sec7_C | 1.20e-05 | 4 | 271 | 3 | IPR015403 | |
| Domain | DUF1981 | 1.20e-05 | 4 | 271 | 3 | PF09324 | |
| Domain | BRCT_dom | 4.63e-05 | 28 | 271 | 5 | IPR001357 | |
| Domain | - | 5.85e-05 | 6 | 271 | 3 | 3.90.1290.10 | |
| Domain | ANK | POTEB3 POTEB2 POTEE GABPB2 POTEB ANK3 POTEF POTEG POTED POTEC ANKRD13A POTEM POTEI | 8.12e-05 | 251 | 271 | 13 | SM00248 |
| Domain | ANK_REPEAT | POTEB3 POTEB2 POTEE GABPB2 POTEB ANK3 POTEF POTEG POTED POTEC ANKRD13A POTEM POTEI | 8.80e-05 | 253 | 271 | 13 | PS50088 |
| Domain | ANK_REP_REGION | POTEB3 POTEB2 POTEE GABPB2 POTEB ANK3 POTEF POTEG POTED POTEC ANKRD13A POTEM POTEI | 9.15e-05 | 254 | 271 | 13 | PS50297 |
| Domain | Plectin | 1.01e-04 | 7 | 271 | 3 | PF00681 | |
| Domain | DUF3585 | 1.01e-04 | 7 | 271 | 3 | IPR022735 | |
| Domain | DUF3585 | 1.01e-04 | 7 | 271 | 3 | PF12130 | |
| Domain | Plectin_repeat | 1.01e-04 | 7 | 271 | 3 | IPR001101 | |
| Domain | PLEC | 1.01e-04 | 7 | 271 | 3 | SM00250 | |
| Domain | Ankyrin_rpt | POTEB3 POTEB2 POTEE GABPB2 POTEB ANK3 POTEF POTEG POTED POTEC ANKRD13A POTEM POTEI | 1.25e-04 | 262 | 271 | 13 | IPR002110 |
| Domain | BRCT | 1.42e-04 | 19 | 271 | 4 | PF00533 | |
| Domain | Tyr_kinase_rcpt_3_CS | 1.60e-04 | 8 | 271 | 3 | IPR001824 | |
| Domain | RECEPTOR_TYR_KIN_III | 1.60e-04 | 8 | 271 | 3 | PS00240 | |
| Domain | STX1A/1B | 2.10e-04 | 2 | 271 | 2 | IPR028669 | |
| Domain | BRCT | 2.58e-04 | 22 | 271 | 4 | SM00292 | |
| Domain | - | 3.09e-04 | 23 | 271 | 4 | 3.40.50.10190 | |
| Domain | Ankyrin_rpt-contain_dom | POTEB3 POTEB2 POTEE GABPB2 POTEB ANK3 POTEF POTEG POTEC ANKRD13A POTEM POTEI | 3.54e-04 | 254 | 271 | 12 | IPR020683 |
| Domain | Keratin_2_head | 3.66e-04 | 24 | 271 | 4 | IPR032444 | |
| Domain | Keratin_2_head | 3.66e-04 | 24 | 271 | 4 | PF16208 | |
| Domain | BRCT | 5.04e-04 | 26 | 271 | 4 | PS50172 | |
| Domain | Keratin_II | 5.04e-04 | 26 | 271 | 4 | IPR003054 | |
| Domain | Ank | POTEE GABPB2 POTEB ANK3 POTEF POTEG POTED POTEC ANKRD13A POTEM POTEI | 5.20e-04 | 228 | 271 | 11 | PF00023 |
| Domain | Rhs_assc_core | 6.23e-04 | 3 | 271 | 2 | IPR022385 | |
| Domain | Kinase-like_dom | TRPM6 SLK PDGFRA PDGFRB MARK3 SCYL1 RIOK3 NEK3 DST PIK3C3 KDR DMD MAP3K19 CAMK2B LATS1 SMARCC1 MACF1 STKLD1 | 9.99e-04 | 542 | 271 | 18 | IPR011009 |
| Domain | - | POTEB3 POTEB2 POTEE GABPB2 ANK3 POTEF POTEG POTEC ANKRD13A POTEM POTEI | 1.04e-03 | 248 | 271 | 11 | 1.25.40.20 |
| Domain | Cadherin_CS | 1.06e-03 | 109 | 271 | 7 | IPR020894 | |
| Domain | Ank_2 | POTEB3 POTEB2 POTEE GABPB2 ANK3 POTEF POTEG POTEC POTEM POTEI | 1.22e-03 | 215 | 271 | 10 | PF12796 |
| Domain | Tox-GHH_dom | 1.23e-03 | 4 | 271 | 2 | IPR028916 | |
| Domain | KASH | 1.23e-03 | 4 | 271 | 2 | PS51049 | |
| Domain | Tox-GHH | 1.23e-03 | 4 | 271 | 2 | PF15636 | |
| Domain | KASH | 1.23e-03 | 4 | 271 | 2 | PF10541 | |
| Domain | Ten_N | 1.23e-03 | 4 | 271 | 2 | PF06484 | |
| Domain | Sec7_N | 1.23e-03 | 4 | 271 | 2 | PF12783 | |
| Domain | TENEURIN_N | 1.23e-03 | 4 | 271 | 2 | PS51361 | |
| Domain | KASH | 1.23e-03 | 4 | 271 | 2 | IPR012315 | |
| Domain | KASH | 1.23e-03 | 4 | 271 | 2 | SM01249 | |
| Domain | Ten_N | 1.23e-03 | 4 | 271 | 2 | IPR009471 | |
| Domain | Sec7_N | 1.23e-03 | 4 | 271 | 2 | IPR032691 | |
| Domain | CADHERIN_1 | 1.31e-03 | 113 | 271 | 7 | PS00232 | |
| Domain | Cadherin | 1.31e-03 | 113 | 271 | 7 | PF00028 | |
| Domain | - | 1.38e-03 | 114 | 271 | 7 | 2.60.40.60 | |
| Domain | CADHERIN_2 | 1.38e-03 | 114 | 271 | 7 | PS50268 | |
| Domain | CA | 1.45e-03 | 115 | 271 | 7 | SM00112 | |
| Domain | SEC7 | 1.47e-03 | 16 | 271 | 3 | PS50190 | |
| Domain | Sec7_dom | 1.47e-03 | 16 | 271 | 3 | IPR000904 | |
| Domain | Actin_CS | 1.47e-03 | 16 | 271 | 3 | IPR004001 | |
| Domain | Sec7 | 1.47e-03 | 16 | 271 | 3 | SM00222 | |
| Domain | Cadherin-like | 1.52e-03 | 116 | 271 | 7 | IPR015919 | |
| Domain | Cadherin | 1.68e-03 | 118 | 271 | 7 | IPR002126 | |
| Domain | CarboxyPept-like_regulatory | 1.77e-03 | 17 | 271 | 3 | IPR008969 | |
| Domain | ACTINS_2 | 1.77e-03 | 17 | 271 | 3 | PS00432 | |
| Domain | YD | 2.04e-03 | 5 | 271 | 2 | IPR006530 | |
| Domain | ARM-like | SCYL1 CUL7 TARBP1 ARFGEF2 ARFGEF1 FRYL ECPAS ATAD2 RSPRY1 RIF1 STKLD1 | 2.04e-03 | 270 | 271 | 11 | IPR011989 |
| Domain | RhoGAP | 2.04e-03 | 62 | 271 | 5 | SM00324 | |
| Domain | Rib_L2_dom2 | 2.10e-03 | 18 | 271 | 3 | IPR014722 | |
| Domain | Actin/actin-like_CS | 2.10e-03 | 18 | 271 | 3 | IPR020902 | |
| Domain | - | 2.10e-03 | 18 | 271 | 3 | 2.30.30.30 | |
| Domain | RhoGAP | 2.19e-03 | 63 | 271 | 5 | PF00620 | |
| Domain | Intermediate_filament_CS | 2.19e-03 | 63 | 271 | 5 | IPR018039 | |
| Domain | RhoGAP_dom | 2.35e-03 | 64 | 271 | 5 | IPR000198 | |
| Domain | - | 2.35e-03 | 64 | 271 | 5 | 1.10.555.10 | |
| Domain | RHOGAP | 2.35e-03 | 64 | 271 | 5 | PS50238 | |
| Domain | ACTINS_ACT_LIKE | 2.46e-03 | 19 | 271 | 3 | PS01132 | |
| Domain | GAR | 3.03e-03 | 6 | 271 | 2 | PS51460 | |
| Domain | REJ | 3.03e-03 | 6 | 271 | 2 | PF02010 | |
| Domain | GAS_dom | 3.03e-03 | 6 | 271 | 2 | IPR003108 | |
| Domain | GAS2 | 3.03e-03 | 6 | 271 | 2 | PF02187 | |
| Domain | PKD/REJ-like | 3.03e-03 | 6 | 271 | 2 | IPR002859 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 5.32e-09 | 70 | 207 | 11 | M12294 | |
| Pathway | KEGG_TIGHT_JUNCTION | 2.47e-05 | 132 | 207 | 10 | M11355 | |
| Pathway | REACTOME_RHOF_GTPASE_CYCLE | 3.15e-05 | 42 | 207 | 6 | M41821 | |
| Pubmed | MYH1 MYH2 MYH4 MYH6 MYH8 MYH9 MYH10 ERCC5 MYH13 HSPH1 STOX1 TASOR2 ABCB4 POTEE SAFB DST BRCA1 CCDC47 SYNE2 KMT2A ATP11C KDR DMD PREX1 ARHGAP21 CAVIN2 SLC12A6 CACNA1C PCDHGB5 NSD2 CAMK2B POTEF SYNE1 CHAF1A PARP8 KTN1 UBR4 CAPZA1 RDX LMNB2 NCOR1 LATS1 BAZ1A ARHGAP12 FAM169A SMARCC1 MACF1 POTEI EIF4G3 SPAG17 MTDH SLC4A11 | 1.32e-19 | 1442 | 283 | 52 | 35575683 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | SYNRG MYH9 SLK MYH10 ATAD5 HSPH1 ZMYM2 PFAS GTF3C4 SAFB DST ALMS1 SEC16A KMT2A ARHGAP21 VDAC1 ANAPC4 NELFE EHBP1 FKBP15 DSC1 KTN1 CAPZA1 GEMIN5 RDX ICE1 RFC1 CHAMP1 AKAP12 RIF1 SIRT2 BAZ1A UTP4 FAM169A MACF1 ELF2 EIF4G3 SCIN MTDH HCFC1 PCM1 TP53BP1 | 2.50e-19 | 934 | 283 | 42 | 33916271 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RALGAPA1 PRPF31 SYNRG HIVEP1 PDGFRA MYO9A MARK3 MDM4 SPICE1 CEP350 PJA2 DST ALMS1 PIK3C3 SYNE2 CGN SEC16A KMT2A NHS ARHGAP21 TRAPPC9 NELFE EHBP1 CASC3 KRT78 POTEF PARP8 RALGAPB FRYL LARP1B RFX7 MICALL1 ARFGEF3 LATS1 RESF1 MACF1 NUP93 EIF4G3 EDRF1 PCM1 | 6.24e-19 | 861 | 283 | 40 | 36931259 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NCOA3 SYNRG CAAP1 HIVEP1 ERCC5 SMC1A ZMYM2 GTF3C4 SPICE1 FANCD2 CACTIN SAFB SEC16A KMT2A MICAL3 VDAC1 NELFE ZEB1 CHAF1A RALGAPB ARFGEF2 GEMIN5 RFC1 TSSC4 RFX7 ECPAS ATAD2 CHAMP1 MIER1 MICALL1 NCOR1 RIF1 LATS1 HELZ2 SMARCC1 ELF2 PCM1 TP53BP1 | 8.06e-19 | 774 | 283 | 38 | 15302935 |
| Pubmed | MYH9 MYH10 PFAS CUL7 TASOR2 DST SUPT5H SYNE2 CGN SEC16A KMT2A VDAC1 PTCD3 NSD2 UBR4 GEMIN5 FRYL LMNB2 RFC1 ECPAS ATAD2 RIF1 UTP4 HELZ2 SMARCC1 MACF1 NUP93 EIF4G3 HCFC1 PCM1 TP53BP1 | 4.04e-15 | 653 | 283 | 31 | 22586326 | |
| Pubmed | GRIPAP1 MYH9 MYH13 KIAA0319L SCYL1 MCAM TASOR2 CEP350 NEO1 DST BRCA1 SEC16A PEX5 RELL1 PCDH10 ARHGAP21 PLEKHA8 PTCD3 FAT4 ANK3 ARFGEF2 ARFGEF1 AKAP12 ARFGEF3 NCOR1 RIF1 THADA TENM3 RPGR CLSPN EIF4G3 MTDH PCM1 | 1.18e-14 | 777 | 283 | 33 | 35844135 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TRPM6 PRPF31 MYH9 SLK MYH10 HIVEP1 PDGFRB SMC1A HSPH1 MRPS27 PFAS FANCD2 SAFB CCDC47 SUPT5H HAX1 QARS1 VDAC1 PTCD3 DSC1 NSD2 CAMK2B SYNE1 CHAF1A KTN1 UBR4 CAPZA1 GEMIN5 RDX NDFIP2 LMNB2 RFC1 ECPAS ATAD2 RIF1 THADA TRMT6 BAZ1A UTP4 SMARCC1 NUP93 SEC63 MTDH HCFC1 | 2.98e-14 | 1425 | 283 | 44 | 30948266 |
| Pubmed | NCOA3 MYH9 SLK MYH10 ZMYM2 DNAJC6 TMEM132B TENM2 SPICE1 DST ZNF394 CLU SYNE2 SEC16A PEX5 ARHGAP21 CASC3 FKBP15 ZEB1 ANK3 CAMK2B SYNE1 KTN1 UBR4 RDX LMNB2 AKAP12 NCOR1 DCHS1 SMARCC1 MACF1 CTNNA2 PCM1 TP53BP1 PHACTR1 | 1.69e-13 | 963 | 283 | 35 | 28671696 | |
| Pubmed | RALGAPA1 MYH9 MYO9A MARK3 UNC5B SMC1A HSPH1 SPICE1 DST CCDC47 SEC16A MICAL3 QARS1 ARHGAP21 VDAC1 EHBP1 ANK3 ICE2 KTN1 CAPZA1 RDX ECPAS AKAP12 MICALL1 LATS1 ARHGAP12 MACF1 SEC63 EIF4G3 HCFC1 | 2.18e-13 | 708 | 283 | 30 | 39231216 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | SYNRG GRIPAP1 HIVEP1 MYO9A ZMYM2 RIOK3 PFAS CUL7 MDM4 POTEE ALMS1 SUPT5H SEC16A CAMK2B CAPZA1 ARFGEF3 NCOR1 SIRT2 RESF1 PPP4R2 UTP4 MACF1 POTEI CLSPN SCIN PCM1 TP53BP1 | 5.73e-13 | 588 | 283 | 27 | 38580884 |
| Pubmed | RALGAPA1 NR2C2 ATAD5 MARK3 UNC5B HSPH1 MRPS27 PFAS DNAJC6 SPICE1 ITPR2 PJA2 CACTIN NEO1 DNAJC28 CLU CCDC47 SYNE2 RELL1 HAX1 PTCD3 TOR1AIP2 ANK3 SYNE1 KTN1 UBR4 BAG4 RALGAPB LMNB2 AKAP12 MICALL1 FAM204A THADA UTP4 MACF1 SEC63 EIF4G3 MTDH EDRF1 PCM1 TP53BP1 USP33 | 2.25e-12 | 1487 | 283 | 42 | 33957083 | |
| Pubmed | SOX4 SOX9 NCOA3 NR2C2 SLK MYH10 HIVEP1 ATAD5 SMC1A HSPH1 MRPS27 ZMYM2 CUL7 TAF8 DST ALMS1 BRCA1 SYNE2 SEC16A KMT2A QARS1 TRAPPC9 VDAC1 PTCD3 ZEB1 CNOT10 UBR4 RFC1 RFX7 MIER1 NCOR1 RIF1 RESF1 PAXIP1 SMARCC1 SMN1 ELF2 NUP93 HCFC1 PCM1 TP53BP1 | 2.60e-12 | 1429 | 283 | 41 | 35140242 | |
| Pubmed | RALGAPA1 MYH6 MYH9 SLK MYH10 MYO9A MARK3 HSPH1 DNAJC6 STX1B ITPR2 SAFB DST CLCN6 CLU SEC16A KMT2A MICAL3 HAX1 DMD ARHGAP21 TRAPPC9 VDAC1 PTCD3 SLC12A6 KRT78 ANK3 CAMK2B SYNE1 KTN1 CAPZA1 ARFGEF2 GEMIN5 RDX BCAS1 SIRT2 MACF1 CTNNA2 EIF4G3 MTDH PCM1 | 2.72e-12 | 1431 | 283 | 41 | 37142655 | |
| Pubmed | RALGAPA1 GRIPAP1 KIAA0319L MCAM PEX1 ITPR2 NEO1 DST CCDC47 SYNE2 SEC16A TOR1AIP2 SLC12A6 FKBP15 KTN1 ARFGEF2 ARFGEF1 AKAP12 ARFGEF3 SEC63 SCIN MTDH SMAD2 USP33 | 5.51e-12 | 504 | 283 | 24 | 34432599 | |
| Pubmed | SECISBP2L CAAP1 MYH9 MYH10 MYH13 MARK3 HSPH1 MRPS27 GTF3C4 CEP350 CACTIN CCDC47 CGN SEC16A KMT2A C5 HAX1 QARS1 VDAC1 PTCD3 NELFE CASC3 KTN1 RDX LARP1B RFC1 TSSC4 RIF1 TRMT6 BAZ1A HELZ2 SMARCC1 SMN1 CTNNA2 NUP93 SEC63 MTDH HCFC1 PCM1 | 1.22e-11 | 1371 | 283 | 39 | 36244648 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | SOX9 PRPF31 NR2C2 HIVEP1 ATAD5 SMC1A ZMYM2 GTF3C4 CACTIN BRCA1 KMT2A NSD2 CHAF1A RFC1 ATAD2 CHAMP1 MIER1 RIF1 TRMT6 BAZ1A UTP4 FAM169A SMARCC1 ELF2 HCFC1 | 4.56e-11 | 608 | 283 | 25 | 36089195 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | PRPF31 NR2C2 CAAP1 ZNF777 HIVEP1 ATAD5 SMC1A ZMYM2 TASOR2 SAFB BRCA1 SEC16A KMT2A VDAC1 ANAPC4 NELFE NSD2 CHAF1A KTN1 ICE1 RFC1 CHAMP1 NCOR1 RIF1 BAZ1A SMARCC1 ELF2 MTDH HCFC1 PCM1 TP53BP1 | 7.49e-11 | 954 | 283 | 31 | 36373674 |
| Pubmed | SECISBP2L GRIPAP1 SMC1A HSPH1 MRPS27 PFAS CUL7 CEP350 ALMS1 CGN MICAL3 PREX1 TRAPPC9 EHBP1 KTN1 RSPRY1 THADA UTP4 HELZ2 FAM169A MACF1 SCIN | 1.50e-10 | 493 | 283 | 22 | 15368895 | |
| Pubmed | GRIPAP1 MYH9 SLK MYH10 SCYL1 EVPL SAFB DST CGN SEC16A MICAL3 CAVIN2 PTCD3 KTN1 LMNB2 AKAP12 MACF1 NUP93 TP53BP1 | 1.71e-10 | 360 | 283 | 19 | 33111431 | |
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 2.05e-10 | 6 | 283 | 5 | 10077619 | |
| Pubmed | 2.05e-10 | 6 | 283 | 5 | 17171436 | ||
| Pubmed | SYNRG MYO9A PFAS CEP350 DST ALMS1 SEC16A PEX5 NHS MICAL3 ARHGAP21 LARP1B ARFGEF3 MACF1 PCM1 | 2.22e-10 | 209 | 283 | 15 | 36779422 | |
| Pubmed | NCOA3 NR2C2 MYH9 HIVEP1 ZMYM2 GTF3C4 DST ALMS1 SEC16A ARHGAP21 EHBP1 ZEB1 UBR4 GEMIN5 ICE1 ECPAS CHAMP1 NCOR1 RESF1 PCM1 | 3.15e-10 | 418 | 283 | 20 | 34709266 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | PRPF31 SYNRG CAAP1 SLK ATAD5 HSPH1 CEP350 SLIT2 BRCA1 QARS1 NELFE FNDC3B KRT78 CNOT10 ICE2 KTN1 CAPZA1 GEMIN5 LARP1B AKAP12 MICALL1 UTP4 SMARCC1 MACF1 EIF4G3 MTDH | 3.41e-10 | 724 | 283 | 26 | 36232890 |
| Pubmed | MARK3 UNC5B MCAM DST SEC16A NHS MICAL3 RELL1 DMD ARHGAP21 TOR1AIP2 EHBP1 SLC12A6 ANK3 RALGAPB AKAP12 TENM3 MACF1 SEC63 SMAD2 | 3.56e-10 | 421 | 283 | 20 | 36976175 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | PRPF31 MYH10 SMC1A SCYL1 ZMYM2 ITPR2 KMT2A NELFE UBR4 ARFGEF1 ECPAS CHAMP1 NCOR1 RIF1 PAXIP1 SMN1 HCFC1 TP53BP1 | 5.22e-10 | 341 | 283 | 18 | 32971831 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | MYH10 SCYL1 MRPS27 PEX1 CUL7 ITPR2 FANCD2 SPTBN5 POTEE DST DNAJC28 ALMS1 CCDC47 SYNE2 SEC16A PEX5 HAX1 VDAC1 PTCD3 TOR1AIP2 EHBP1 CASC3 PTGES2 SYNE1 KTN1 UBR4 LMNB2 LARP1B ARFGEF3 THADA SIRT2 TRMT6 UTP4 ARHGAP12 FAM169A SEC63 MTDH USP33 | 5.76e-10 | 1496 | 283 | 38 | 32877691 |
| Pubmed | PRPF31 CAAP1 HIP1 ATAD5 MARK3 HSPH1 MRPS27 ZMYM2 POTEE TAF8 DST BRCA1 CCDC47 KMT2A PREX1 PTCD3 FNDC3B CASC3 NSD2 CNOT10 SYNE1 CHAF1A KTN1 RALGAPB GEMIN5 ICE1 ATAD2 CEP164 RIF1 BAZ1A UTP4 HELZ2 MACF1 SMN1 CTNNA2 SEC63 EIF4G3 EDRF1 | 5.87e-10 | 1497 | 283 | 38 | 31527615 | |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | PRPF31 UNC5B MRPS27 PEX1 CUL7 GTF3C4 SPICE1 CEP350 PJA2 CLCN6 SEC16A KMT2A HAX1 ANAPC4 PTCD3 TOR1AIP2 DSC1 CILP UBR4 AKAP12 SMARCC1 CTNNA2 CLSPN PCM1 | 6.95e-10 | 639 | 283 | 24 | 23443559 |
| Pubmed | 7.14e-10 | 7 | 283 | 5 | 35210422 | ||
| Pubmed | 7.14e-10 | 7 | 283 | 5 | 15276201 | ||
| Pubmed | 7.14e-10 | 7 | 283 | 5 | 16819597 | ||
| Pubmed | MYH2 HIP1 MYH10 MARK3 HSPH1 MRPS27 ITPR2 FANCD2 DST CLU CCDC47 MICB SYNE2 KMT2A MICAL3 HAX1 QARS1 TRAPPC9 VDAC1 PTCD3 KTN1 UBR4 CAPZA1 GEMIN5 RFC1 ECPAS ARFGEF3 ANKRD13A THADA IGKC CTNNA2 NUP93 SEC63 NEXN MTDH HCFC1 PCM1 | 7.28e-10 | 1440 | 283 | 37 | 30833792 | |
| Pubmed | RALGAPA1 MYH10 ATAD5 MCAM PFAS CUL7 SPICE1 ITPR2 CEP350 FANCD2 CACTIN CCDC47 SUPT5H SYNE2 CGN SEC16A NHS MICAL3 RELL1 HAX1 DMD TOR1AIP2 ANK3 NSD2 RALGAPB NCOR1 RIF1 MTMR7 PPP4R2 NUP93 SCIN | 7.51e-10 | 1049 | 283 | 31 | 27880917 | |
| Pubmed | RALGAPA1 MARK3 SMC1A CUL7 GTF3C4 SPICE1 DST ALMS1 CGN SEC16A QARS1 TRAPPC9 FKBP15 CNOT10 PARP8 RALGAPB FRYL ECPAS LATS1 PCM1 | 9.67e-10 | 446 | 283 | 20 | 24255178 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | PRPF31 MYH2 MYH4 MYH9 SLK MYH10 HIVEP1 MARK3 SMC1A PFAS PJA2 SAFB BRCA1 TARBP1 NELFE TOR1AIP2 DSC1 KRT81 CNOT10 KTN1 CAPZA1 AGGF1 RDX ICE1 NUP93 EIF4G3 MTDH HCFC1 TP53BP1 USP33 | 1.14e-09 | 1005 | 283 | 30 | 19615732 |
| Pubmed | SOX9 PDGFRB SMC1A HSPH1 KIAA0319L NAP1L2 ZMYM2 FRMD4B GTF3C4 CEP350 STX1A DST RSPH1 CLU SUPT5H PKD1 QARS1 PREX1 TARBP1 ARHGAP21 AKAP6 PTGES2 MCHR1 ANK3 KRT83 SYNE1 UBR4 ARFGEF2 RDX MACF1 EIF4G3 PCM1 SMAD2 USP33 | 1.82e-09 | 1285 | 283 | 34 | 35914814 | |
| Pubmed | 1.89e-09 | 8 | 283 | 5 | 12475935 | ||
| Pubmed | RALGAPA1 PRPF31 GRIPAP1 FRMD4B GTF3C4 ITPR2 CEP350 NEO1 ALMS1 CCDC47 SEC16A PEX5 CASC3 FKBP15 ICE2 CHAF1A KTN1 NDFIP2 ICE1 LMNB2 SEC63 CLSPN HCFC1 PCM1 USP33 | 2.16e-09 | 733 | 283 | 25 | 34672954 | |
| Pubmed | CAAP1 C5orf22 ATAD5 PEX1 CUL7 FANCD2 SLIT2 PJA2 CACTIN TAF8 ALMS1 BRCA1 CLU SEC16A PEX5 HAX1 ANAPC4 PTCD3 TOR1AIP2 NSD2 CHAF1A BAG4 CHAMP1 THADA MLH3 RESF1 SMARCC1 MACF1 CLSPN PCM1 SLC4A11 | 3.25e-09 | 1116 | 283 | 31 | 31753913 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | SECISBP2L SOX4 PRPF31 NCOA3 GRIPAP1 SMC1A SCYL1 GTF3C4 SLIT2 SUPT5H CGN SEC16A QARS1 TRAPPC9 VDAC1 TOR1AIP2 EHBP1 FKBP15 ANK3 CNOT10 CAMK2B KTN1 CAPZA1 RSPRY1 AKAP12 MICALL1 ANKRD13A RIF1 THADA IFT52 PPP4R2 RPGR EDRF1 TP53BP1 | 3.65e-09 | 1321 | 283 | 34 | 27173435 |
| Pubmed | SLK ATAD5 SPICE1 CEP350 DST ALMS1 BRCA1 SEC16A KMT2A MICAL3 VDAC1 PTCD3 NSD2 CNOT10 CHAF1A RFC1 ATAD2 MIER1 PAXIP1 FAM169A ELF2 EDRF1 PCM1 | 4.25e-09 | 645 | 283 | 23 | 25281560 | |
| Pubmed | 4.29e-09 | 4 | 283 | 4 | 10388558 | ||
| Pubmed | 4.29e-09 | 4 | 283 | 4 | 11023856 | ||
| Pubmed | 53BP1 mediates productive and mutagenic DNA repair through distinct phosphoprotein interactions. | 4.29e-09 | 4 | 283 | 4 | 23727112 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | MYH1 MYH2 MYH4 MYH6 MYH8 MYH9 MYH10 MYH13 HSPH1 PJA2 SEC16A HAX1 QARS1 PTCD3 DSC1 UBR4 CAPZA1 RDX LMNB2 AKAP12 ANKRD13A THADA TP53BP1 | 4.50e-09 | 647 | 283 | 23 | 26618866 |
| Pubmed | SYNRG GRIPAP1 MYH9 MYH10 FRMPD4 MRPS27 TENM2 STX1B PJA2 STX1A NEO1 SAFB CLU HAX1 VDAC1 PTCD3 EHBP1 FKBP15 ANK3 CAMK2B KTN1 UBR4 ARFGEF3 FAM169A MACF1 CTNNA2 EIF4G3 MTDH PCM1 TP53BP1 PHACTR1 | 5.22e-09 | 1139 | 283 | 31 | 36417873 | |
| Pubmed | SOX9 PRPF31 NCOA3 MYH9 ATAD5 SMC1A GTF3C4 FANCD2 CACTIN SAFB SUPT5H KMT2A NELFE FKBP15 NSD2 CHAF1A UBR4 GEMIN5 LMNB2 RFC1 ECPAS CHAMP1 NCOR1 RIF1 BAZ1A PPP4R2 SMARCC1 NUP93 HCFC1 | 5.69e-09 | 1014 | 283 | 29 | 32416067 | |
| Pubmed | PRPF31 MYH9 FANCD2 PJA2 CLU CCDC47 SEC16A HAX1 QARS1 VDAC1 UBR4 CAPZA1 ARFGEF1 GEMIN5 ECPAS AKAP12 ANKRD13A RIF1 THADA ARHGAP12 SMN1 NUP93 SEC63 | 6.00e-09 | 657 | 283 | 23 | 36180527 | |
| Pubmed | MYH8 HIVEP1 SMC1A RIOK3 NEO1 DST ALMS1 SYNE2 ARHGAP21 AKAP6 SLC12A6 FNDC3B MYOT SYNE1 KTN1 RDX AKAP12 NCOR1 MACF1 SMAD2 | 6.09e-09 | 497 | 283 | 20 | 23414517 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | MYH2 MYH4 MYH9 MYH10 MARK3 SMC1A RIOK3 PFAS CACTIN PIK3C3 CCDC47 CGN PREX1 VDAC1 PTCD3 NELFE KRT78 CNOT10 CAMK2B CHAF1A UBR4 CAPZA1 FRYL BCAS1 ECPAS MICALL1 SIRT2 PPP4R2 IGKC SMARCC1 NUP93 SEC63 EIF4G3 | 6.54e-09 | 1284 | 283 | 33 | 17353931 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | PRPF31 MYH9 MYH10 MYO9A SMC1A HSPH1 RIOK3 PFAS GTF3C4 SAFB DST CCDC47 SEC16A QARS1 PTCD3 FNDC3B DSC1 KTN1 UBR4 CAPZA1 GEMIN5 LMNB2 RFC1 TSSC4 ATAD2 RIF1 BAZ1A UTP4 IGKC SMARCC1 MACF1 NUP93 NEXN TP53BP1 | 6.61e-09 | 1353 | 283 | 34 | 29467282 |
| Pubmed | SLK MYH10 FRMPD4 MARK3 DNAJC6 TENM2 PJA2 SEC16A MICAL3 PCDH10 ARHGAP21 FKBP15 SYNE1 RALGAPB ARFGEF3 TENM3 MACF1 USP33 | 8.42e-09 | 407 | 283 | 18 | 12693553 | |
| Pubmed | PRPF31 NR2C2 MYH9 MYH10 SMC1A MRPS27 PLEKHS1 EVPL GTF3C4 SAFB KMT2A HAX1 QARS1 CAVIN2 TOR1AIP2 KTN1 CAPZA1 RFC1 ATAD2 ZFY NCOR1 RIF1 BAZ1A SMN1 NUP93 MTDH | 8.86e-09 | 847 | 283 | 26 | 35850772 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | MYH9 SLK MARK3 SCYL1 EVPL DST CGN NHS RELL1 KDF1 ARHGAP21 EHBP1 ANK3 KTN1 CAPZA1 RDX MICALL1 TENM3 MACF1 CTNNA2 HCFC1 | 1.01e-08 | 565 | 283 | 21 | 25468996 |
| Pubmed | NCOA3 MYH2 HIVEP1 ATAD5 MRPS27 ZMYM2 CEP350 CCDC47 SYNE2 C5 PREX1 TARBP1 CAVIN2 TOR1AIP2 FAT4 KTN1 UBR4 RFC1 NCOR1 PAXIP1 SMARCC1 ARHGAP45 | 1.70e-08 | 638 | 283 | 22 | 31182584 | |
| Pubmed | MYH9 SMC1A SCYL1 PEX1 PFAS SYNE2 SEC16A ZSCAN2 DMD ARHGAP21 VDAC1 MAP3K19 PPP1R21 FAT4 DSC1 SYNE1 CAPZA1 LMNB2 ECPAS DCHS1 SMARCC1 NUP93 SEC63 MTDH | 1.72e-08 | 754 | 283 | 24 | 35906200 | |
| Pubmed | 1.84e-08 | 22 | 283 | 6 | 24301466 | ||
| Pubmed | Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development. | 2.13e-08 | 5 | 283 | 4 | 12919077 | |
| Pubmed | Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro. | 2.13e-08 | 5 | 283 | 4 | 3829126 | |
| Pubmed | Detection of Gene and Protein Expression in Mouse Embryos and Tissue Sections. | 2.13e-08 | 5 | 283 | 4 | 30737693 | |
| Pubmed | 2.13e-08 | 5 | 283 | 4 | 38244928 | ||
| Pubmed | 2.13e-08 | 5 | 283 | 4 | 6196357 | ||
| Pubmed | Characterization of a 300 kbp region of human DNA containing the type II hair keratin gene domain. | 2.60e-08 | 12 | 283 | 5 | 10692104 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | PRPF31 NR2C2 MYH9 PHF20 ATAD5 SMC1A ZMYM2 GTF3C4 CACTIN SAFB DST BRCA1 SUPT5H KMT2A NSD2 CHAF1A KTN1 LMNB2 RFC1 RFX7 CHAMP1 MIER1 NCOR1 RIF1 BAZ1A UTP4 PAXIP1 SMARCC1 ELF2 NUP93 MTDH HCFC1 | 2.77e-08 | 1294 | 283 | 32 | 30804502 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | PRPF31 MYH13 HSPH1 MRPS27 GTF3C4 KMT2A MICAL3 QARS1 ARHGAP21 ANAPC4 CACNA1C DPYD ANK3 COL6A6 KTN1 ECPAS ERCC6L2 RP1 HCFC1 | 3.32e-08 | 497 | 283 | 19 | 36774506 |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | PRPF31 MYH1 MYH2 MYH6 MYH8 SLK ERCC5 MYH13 MARK3 HSPH1 SCYL1 PEX1 CUL7 GTF3C4 ITPR2 NEK3 DST CLU KMT2A HAX1 ARHGAP21 ANAPC4 FKBP15 CAMK2B LATS1 CLSPN | 3.73e-08 | 910 | 283 | 26 | 36736316 |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | POLR2M GTF3C4 CEP350 CABYR SAFB ALMS1 BRCA1 CLU CCDC47 SUPT5H MICAL3 VDAC1 ANAPC4 CAPZA1 AGGF1 GEMIN5 CHAMP1 PAXIP1 SMN1 NUP93 EIF4G3 TP53BP1 | 4.02e-08 | 670 | 283 | 22 | 22990118 |
| Pubmed | MYO9A SMC1A ZMYM2 FAM13B POTEE PJA2 CCDC47 CGN SEC16A KMT2A HAX1 DMD PREX1 ARHGAP21 VDAC1 KRT81 KRT86 RDX LMNB2 ECPAS RIF1 UTP4 ARHGAP12 SMARCC1 SMN1 NUP93 | 4.24e-08 | 916 | 283 | 26 | 32203420 | |
| Pubmed | SOX4 MYH8 MYH9 MYH10 PDGFRA MARK3 HSPH1 UNC13D PFAS FAM186B FANCD2 SAFB NOD1 SEC16A KMT2A NHS CAVIN2 VDAC1 NELFE ICE2 CHAF1A UBR4 RALGAPB PCDHA13 ATAD2 PAXIP1 FAM169A SMARCC1 ELF2 SEC63 CLSPN PCM1 | 4.93e-08 | 1327 | 283 | 32 | 32694731 | |
| Pubmed | PRPF31 SPTBN5 DST ALMS1 SYNE2 PKD1 DMD POTEF SYNE1 LMNB2 TENM3 CTNNA2 | 5.02e-08 | 187 | 283 | 12 | 26460568 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | RALGAPA1 PRPF31 MYH9 MYH10 PDGFRA SMC1A HSPH1 ZMYM2 SAFB SUPT5H QARS1 VDAC1 PTCD3 NELFE DSC1 CHAF1A LMNB2 RFC1 ATAD2 CHAMP1 RIF1 UTP4 SMARCC1 SEC63 CLSPN HCFC1 TP53BP1 | 5.08e-08 | 989 | 283 | 27 | 36424410 |
| Pubmed | NCOA3 NR2C2 HIVEP1 ZMYM2 GTF3C4 TAF8 KMT2A NELFE CHAMP1 NCOR1 PAXIP1 SMARCC1 ELF2 HCFC1 | 5.14e-08 | 268 | 283 | 14 | 33640491 | |
| Pubmed | MYH9 SLK HSPH1 SCYL1 MCAM DST CCDC47 SYNE2 SEC16A TOR1AIP2 EHBP1 KTN1 RDX LMNB2 AKAP12 SEC63 MTDH HCFC1 PCM1 USP33 | 5.52e-08 | 568 | 283 | 20 | 37774976 | |
| Pubmed | SLK DST CCDC47 SYNE2 SEC16A TOR1AIP2 EHBP1 KTN1 GEMIN5 AKAP12 SEC63 MTDH | 6.34e-08 | 191 | 283 | 12 | 31177093 | |
| Pubmed | 6.36e-08 | 6 | 283 | 4 | 1728586 | ||
| Pubmed | Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development. | 6.36e-08 | 6 | 283 | 4 | 10588881 | |
| Pubmed | MYH10 HSPH1 CUL7 GTF3C4 DST BRCA1 SUPT5H ARHGAP21 CAVIN2 ANAPC4 PTCD3 DSC1 ANK3 UBR4 ECPAS IGKC SMARCC1 MACF1 CTNNA2 MTDH PCM1 | 7.14e-08 | 634 | 283 | 21 | 34591612 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 7.26e-08 | 123 | 283 | 10 | 26912792 | |
| Pubmed | 9.62e-08 | 96 | 283 | 9 | 23580065 | ||
| Pubmed | Identification of a novel actin isoform in hepatocellular carcinoma. | 9.67e-08 | 15 | 283 | 5 | 16824795 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | NR2C2 CAAP1 MYH9 MYH10 GTF3C4 CACTIN SUPT5H NELFE RFC1 CHAMP1 NCOR1 RIF1 MTDH HCFC1 | 1.01e-07 | 283 | 283 | 14 | 30585729 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | PRPF31 SMC1A CUL7 ITPR2 CEP350 SLIT2 SAFB DST SUPT5H SYNE2 CGN SEC16A PEX5 QARS1 KRT78 SYNE1 KRT86 CAPZA1 LMNB2 RIF1 BAZ1A UTP4 MACF1 NUP93 SCIN MTDH PCM1 | 1.02e-07 | 1024 | 283 | 27 | 24711643 |
| Pubmed | MYH9 MYH10 HIVEP1 MYO9A ZMYM2 EVPL FAM13B CEP350 DST DMD EHBP1 ANK3 SYNE1 CHAF1A KTN1 RIF1 LATS1 MACF1 | 1.23e-07 | 486 | 283 | 18 | 20936779 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | SECISBP2L PRPF31 NCOA3 SYNRG SCYL1 RIOK3 POLR2M FRMD4B SPICE1 CEP350 PJA2 SEC16A PEX5 HAX1 DMD ARHGAP21 ANAPC4 EHBP1 CASC3 FKBP15 ANKRD13A SIRT2 UTP4 ARHGAP12 PAXIP1 SMN1 CLSPN | 1.34e-07 | 1038 | 283 | 27 | 26673895 |
| Pubmed | Comprehensive analysis of keratin gene clusters in humans and rodents. | 1.40e-07 | 16 | 283 | 5 | 15085952 | |
| Pubmed | SYNRG SLK GTF3C4 ALMS1 CGN SEC16A KMT2A NELFE ANK3 KTN1 CAPZA1 GEMIN5 CHAMP1 NCOR1 LATS1 SMARCC1 HCFC1 PCM1 TP53BP1 | 1.56e-07 | 549 | 283 | 19 | 38280479 | |
| Pubmed | MYH9 MYH10 SMC1A HSPH1 ALMS1 BRCA1 SEC16A QARS1 CAPZA1 ARFGEF2 ARFGEF1 GEMIN5 ECPAS AKAP12 SMARCC1 NUP93 HCFC1 TP53BP1 | 1.57e-07 | 494 | 283 | 18 | 26831064 | |
| Pubmed | NCOA3 MYH9 HSPH1 ZMYM2 SAFB SEC16A NHS NELFE CHAF1A GEMIN5 RFC1 CHAMP1 NCOR1 RIF1 EIF4G3 HCFC1 PCM1 TP53BP1 | 2.04e-07 | 503 | 283 | 18 | 16964243 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | PRPF31 MYH9 SLK MYH10 ERCC5 SMC1A HSPH1 MRPS27 PFAS CCDC47 SYNE2 SEC16A HAX1 QARS1 TARBP1 VDAC1 PTCD3 NELFE KTN1 UBR4 CAPZA1 GEMIN5 RDX RFC1 TSSC4 CHAMP1 RIF1 IGKC SMARCC1 MACF1 MTDH HCFC1 | 2.09e-07 | 1415 | 283 | 32 | 28515276 |
| Pubmed | Interaction network of human early embryonic transcription factors. | NCOA3 NR2C2 HIVEP1 ZMYM2 ALMS1 SEC16A KMT2A ZEB1 RFX7 NCOR1 RESF1 BAZ1A PAXIP1 SMARCC1 ELF2 | 2.33e-07 | 351 | 283 | 15 | 38297188 |
| Pubmed | A Tcf4-positive mesodermal population provides a prepattern for vertebrate limb muscle patterning. | 2.93e-07 | 8 | 283 | 4 | 14667415 | |
| Pubmed | 2.93e-07 | 8 | 283 | 4 | 3864153 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | GRIPAP1 MYH9 HIP1 SLK MYH10 HSPH1 PFAS SAFB CCDC47 SUPT5H SYNE2 SEC16A QARS1 KRT78 DSC1 KTN1 UBR4 CAPZA1 ARFGEF1 GEMIN5 FRYL RFC1 ECPAS CHAMP1 AKAP12 ANKRD13A SMARCC1 NUP93 NEXN HCFC1 TP53BP1 | 3.09e-07 | 1367 | 283 | 31 | 32687490 |
| Pubmed | SMC1A DST ALMS1 CLCN6 SYNE2 SEC16A PREX1 AKAP6 SYNE1 RALGAPB HELZ2 MACF1 | 3.74e-07 | 225 | 283 | 12 | 12168954 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | MYH9 SMC1A ZMYM2 GTF3C4 TASOR2 POTEE POTEF KTN1 RFC1 SMARCC1 POTEI HCFC1 TP53BP1 | 4.11e-07 | 271 | 283 | 13 | 32433965 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SOX4 SYNRG HIP1 KIAA0319L PFAS ITPR2 DST PKD1 SEC16A MICAL3 PREX1 ARHGAP21 TRAPPC9 NSD2 UBR4 ARFGEF2 GEMIN5 FRYL ICE1 LMNB2 MICALL1 NCOR1 THADA SIRT2 PAXIP1 HELZ2 HCFC1 | 4.55e-07 | 1105 | 283 | 27 | 35748872 |
| Pubmed | MYH10 HIVEP1 MCAM ZMYM2 DST SUPT5H PKD1 QARS1 ANK3 KRT81 UBR4 ARFGEF2 ANKRD13A NCOR1 TENM3 BAZ1A PAXIP1 MACF1 SMAD2 | 4.77e-07 | 591 | 283 | 19 | 15231748 | |
| Pubmed | 5.24e-07 | 9 | 283 | 4 | 16364570 | ||
| Pubmed | 5.33e-07 | 3 | 283 | 3 | 23146028 | ||
| Interaction | NAA40 interactions | SYNRG NR2C2 MYH9 SLK MYH10 ATAD5 HSPH1 ZMYM2 PFAS GTF3C4 SAFB DST ALMS1 SEC16A KMT2A KDF1 ARHGAP21 VDAC1 ANAPC4 NELFE EHBP1 FKBP15 DSC1 KTN1 CAPZA1 GEMIN5 RDX ICE1 RFC1 CHAMP1 AKAP12 RIF1 SIRT2 BAZ1A UTP4 FAM169A MACF1 ELF2 EIF4G3 SCIN MTDH HCFC1 PCM1 TP53BP1 | 4.46e-12 | 978 | 279 | 44 | int:NAA40 |
| Interaction | NUP43 interactions | NR2C2 HIVEP1 ERCC5 SMC1A ZMYM2 CCDC168 CUL7 TASOR2 FANCD2 CACTIN SAFB DST BRCA1 SYNE2 KMT2A VDAC1 ANAPC4 DSC1 NSD2 CAMK2B ICE1 RFC1 ATAD2 CHAMP1 NCOR1 RIF1 RESF1 BAZ1A FAM169A SMARCC1 ELF2 NUP93 EIF4G3 HCFC1 | 1.02e-11 | 625 | 279 | 34 | int:NUP43 |
| Interaction | RAB5A interactions | PRPF31 NR2C2 GRIPAP1 HIVEP1 MARK3 UNC5B MCAM PFAS FANCD2 NEO1 DST PIK3C3 CCDC47 SYNE2 SEC16A KDR HAX1 QARS1 VDAC1 TOR1AIP2 PPP1R21 EHBP1 SLC12A6 KTN1 UBR4 AKAP12 ARFGEF3 NCOR1 ARHGAP12 MACF1 SMN1 SEC63 MTDH USP33 | 2.67e-10 | 706 | 279 | 34 | int:RAB5A |
| Interaction | H2BC8 interactions | PRPF31 NR2C2 MYH9 ERCC5 ATAD5 ZMYM2 GTF3C4 POTEE CACTIN BRCA1 CCDC47 SUPT5H SEC16A KMT2A VDAC1 ZEB1 NSD2 CHAF1A RFC1 ATAD2 CHAMP1 MIER1 RIF1 TRMT6 BAZ1A FAM169A SMARCC1 ELF2 | 9.22e-09 | 576 | 279 | 28 | int:H2BC8 |
| Interaction | YWHAG interactions | RALGAPA1 SYNRG SLK MYH10 HIVEP1 MYO9A MARK3 HSPH1 CUL7 MDM4 FAM13B SPICE1 CEP350 FANCD2 PJA2 DST ALMS1 PIK3C3 SYNE2 CGN SEC16A KMT2A NHS KDR ARHGAP21 TRAPPC9 NELFE EHBP1 CASC3 POTEF CHAF1A PARP8 RALGAPB FRYL LARP1B RFX7 MICALL1 LATS1 BAZ1A MACF1 EIF4G3 EDRF1 PCM1 | 2.88e-08 | 1248 | 279 | 43 | int:YWHAG |
| Interaction | KDM1A interactions | NCOA3 NR2C2 GRIPAP1 MYH9 HIVEP1 ZMYM2 DNAJC6 GTF3C4 SPICE1 CEP350 FANCD2 DST ALMS1 BRCA1 GABPB2 CLU SUPT5H SEC16A ARHGAP21 EHBP1 ZEB1 NSD2 CHAF1A UBR4 GEMIN5 ICE1 CBFA2T3 ECPAS CHAMP1 FAM204A NCOR1 RESF1 SMARCC1 SMN1 PCM1 TP53BP1 | 3.40e-08 | 941 | 279 | 36 | int:KDM1A |
| Interaction | PCNT interactions | NAP1L2 DNAJC6 SPICE1 CEP350 DST ALMS1 HAX1 ARHGAP21 AKAP6 SYNE1 RDX LATS1 UTP4 MACF1 EIF4G3 PCM1 TP53BP1 | 4.76e-08 | 241 | 279 | 17 | int:PCNT |
| Interaction | SIRT7 interactions | MYH9 MYH10 PFAS CUL7 TASOR2 DST SUPT5H SYNE2 CGN SEC16A KMT2A VDAC1 PTCD3 NSD2 UBR4 GEMIN5 FRYL LMNB2 RFC1 ECPAS ATAD2 RIF1 UTP4 HELZ2 SMARCC1 MACF1 NUP93 EIF4G3 HCFC1 PCM1 TP53BP1 | 5.03e-08 | 744 | 279 | 31 | int:SIRT7 |
| Interaction | KCNA3 interactions | RALGAPA1 MYH9 MYO9A MARK3 UNC5B SMC1A HSPH1 SPICE1 DST CCDC47 CGN SEC16A KMT2A MICAL3 QARS1 ARHGAP21 VDAC1 NLRP5 EHBP1 ANK3 ICE2 KTN1 CAPZA1 RDX ECPAS AKAP12 MICALL1 LATS1 ARHGAP12 MACF1 RP1 SEC63 EIF4G3 HCFC1 | 5.24e-08 | 871 | 279 | 34 | int:KCNA3 |
| Interaction | YWHAH interactions | RALGAPA1 NCOA3 SYNRG HIVEP1 MYO9A MARK3 HSPH1 MDM4 CEP350 FANCD2 PJA2 DST ALMS1 PIK3C3 SYNE2 CGN SEC16A KMT2A NHS ARHGAP21 TRAPPC9 NELFE EHBP1 CASC3 KRT78 POTEF PARP8 RALGAPB FRYL LARP1B RFX7 MICALL1 ARFGEF3 LATS1 RESF1 MACF1 EIF4G3 EDRF1 PCM1 | 6.88e-08 | 1102 | 279 | 39 | int:YWHAH |
| Interaction | STX6 interactions | RALGAPA1 SYNRG GRIPAP1 HIP1 MARK3 UNC5B KIAA0319L STX1A DST CCDC47 SEC16A ARHGAP21 TRAPPC9 EHBP1 SLC12A6 ANK3 KTN1 RALGAPB ARFGEF2 ARFGEF1 AKAP12 MICALL1 MACF1 | 7.81e-08 | 448 | 279 | 23 | int:STX6 |
| Interaction | HDAC1 interactions | MYH1 MYH2 MYH4 NR2C2 MYH8 MYH9 MYH10 HIVEP1 SMC1A HSPH1 ZMYM2 DNAJC6 DDIT3 FANCD2 DST ALMS1 BRCA1 CCDC47 SYNE2 KMT2A ARHGAP21 EHBP1 ZEB1 NSD2 CHAF1A UBR4 ARFGEF1 GEMIN5 RFC1 CBFA2T3 ECPAS MIER1 NCOR1 BAZ1A SMARCC1 SMN1 HCFC1 PCM1 SMAD2 | 7.93e-08 | 1108 | 279 | 39 | int:HDAC1 |
| Interaction | BRCA1 interactions | NCOA3 MYH9 MYH10 HIVEP1 ERCC5 PDGFRA SMC1A HSPH1 POLR2M GTF3C4 PGR CEP350 FANCD2 CABYR DST ALMS1 BRCA1 SUPT5H SEC16A PEX5 QARS1 ARHGAP21 ANAPC4 NSD2 CHAF1A UBR4 CAPZA1 ARFGEF2 ARFGEF1 GEMIN5 RDX RFC1 ECPAS AKAP12 RIF1 UTP4 SMARCC1 NUP93 CLSPN HCFC1 TP53BP1 SMAD2 | 8.38e-08 | 1249 | 279 | 42 | int:BRCA1 |
| Interaction | H3C3 interactions | SOX9 PRPF31 NR2C2 HIVEP1 ATAD5 SMC1A ZMYM2 GTF3C4 CACTIN BRCA1 KMT2A NSD2 CHAF1A RFC1 ATAD2 CHAMP1 MIER1 RIF1 TRMT6 BAZ1A UTP4 FAM169A SMARCC1 ELF2 | 1.17e-07 | 495 | 279 | 24 | int:H3C3 |
| Interaction | YWHAZ interactions | RALGAPA1 PRPF31 SYNRG NR2C2 MYH9 SLK MYH10 HIVEP1 MYO9A MARK3 SMC1A PFAS CUL7 MDM4 FAM13B FANCD2 DST BRCA1 PIK3C3 SYNE2 CGN KMT2A NHS ARHGAP21 VDAC1 NELFE FNDC3B KRT78 DSC1 COL6A6 CAMK2B POTEF CHAF1A PARP8 RALGAPB FRYL MICALL1 NCOR1 LATS1 IGKC MACF1 PCM1 TP53BP1 | 1.37e-07 | 1319 | 279 | 43 | int:YWHAZ |
| Interaction | TERF2IP interactions | HIVEP1 ERCC5 ATAD5 ZMYM2 GTF3C4 TASOR2 CACTIN BRCA1 SUPT5H KMT2A ANAPC4 NELFE ZEB1 NSD2 CHAF1A RFC1 TSSC4 CHAMP1 NCOR1 RIF1 TRMT6 SMARCC1 ELF2 CLSPN HCFC1 | 2.30e-07 | 552 | 279 | 25 | int:TERF2IP |
| Interaction | RAB9A interactions | RALGAPA1 GRIPAP1 MARK3 SMC1A MCAM CUL7 ITPR2 FANCD2 DST PIK3C3 CCDC47 SYNE2 SEC16A TOR1AIP2 EHBP1 FKBP15 KTN1 RALGAPB ARFGEF2 ARFGEF1 ECPAS MICALL1 ARFGEF3 NUP93 SEC63 MTDH | 2.60e-07 | 595 | 279 | 26 | int:RAB9A |
| Interaction | SMC5 interactions | PRPF31 MYH1 MYH4 NR2C2 CAAP1 ZNF777 MYH9 HIVEP1 ATAD5 SMC1A ZMYM2 TASOR2 SAFB BRCA1 SEC16A KMT2A VDAC1 ANAPC4 NELFE NSD2 CHAF1A KTN1 ICE1 RFC1 CHAMP1 NCOR1 RIF1 BAZ1A SMARCC1 SMN1 ELF2 MTDH HCFC1 PCM1 TP53BP1 | 4.51e-07 | 1000 | 279 | 35 | int:SMC5 |
| Interaction | STX7 interactions | RALGAPA1 SYNRG GRIPAP1 HIP1 MARK3 UNC5B MCAM STX1A DST CCDC47 SYNE2 MICAL3 RELL1 ARHGAP21 TOR1AIP2 EHBP1 SLC12A6 ANK3 ICE2 KTN1 RALGAPB ARFGEF2 AKAP12 MICALL1 ARFGEF3 SEC63 MTDH | 5.38e-07 | 659 | 279 | 27 | int:STX7 |
| Interaction | POTEC interactions | 5.77e-07 | 13 | 279 | 5 | int:POTEC | |
| Interaction | GSK3A interactions | SYNRG NR2C2 MYO9A MARK3 PFAS SPICE1 CEP350 DEFA5 DST ALMS1 SEC16A PEX5 NHS MICAL3 ARHGAP21 PARP8 LARP1B RFX7 ARFGEF3 MACF1 PCM1 SMAD2 | 5.86e-07 | 464 | 279 | 22 | int:GSK3A |
| Interaction | PFN1 interactions | SYNRG NR2C2 MYH9 MYO9A CUL7 CEP350 FANCD2 ALMS1 BRCA1 SYNE2 SEC16A MICAL3 QARS1 ARHGAP21 VDAC1 NELFE KTN1 RALGAPB RDX THADA MACF1 SCIN TP53BP1 | 7.42e-07 | 509 | 279 | 23 | int:PFN1 |
| Interaction | MEN1 interactions | PRPF31 MYH9 MYH10 PHF20 SMC1A SCYL1 MRPS27 ZMYM2 GTF3C4 ITPR2 FANCD2 SAFB KMT2A QARS1 CAVIN2 NELFE KTN1 UBR4 CAPZA1 ARFGEF1 RFC1 ECPAS ATAD2 CHAMP1 ZFY NCOR1 RIF1 BAZ1A PAXIP1 SMN1 NUP93 MTDH HCFC1 TP53BP1 SMAD2 | 8.73e-07 | 1029 | 279 | 35 | int:MEN1 |
| Interaction | CDC42 interactions | RALGAPA1 MYH10 MYO9A MARK3 UNC5B SCYL1 MCAM RIOK3 FAM13B ITPR2 FANCD2 CCDC47 SYNE2 CGN LYPLA1 RELL1 PREX1 ARHGAP21 VDAC1 MAP3K19 TOR1AIP2 EHBP1 FNDC3B FAT4 ANK3 SYNE1 KTN1 RALGAPB CAPZA1 NDFIP2 FRYL LMNB2 ECPAS AKAP12 MICALL1 ARFGEF3 THADA TENM3 SCIN MTDH PCM1 | 1.03e-06 | 1323 | 279 | 41 | int:CDC42 |
| Interaction | H3C1 interactions | NR2C2 MYH9 MYH10 PHF20 ATAD5 SMC1A MRPS27 ZMYM2 GTF3C4 FANCD2 CACTIN KMT2A TARBP1 PTCD3 PTGES2 FAT4 ANK3 NSD2 SYNE1 CHAF1A UBR4 RFC1 TSSC4 ATAD2 CHAMP1 NCOR1 RIF1 SIRT2 BAZ1A PAXIP1 ELF2 TP53BP1 | 1.07e-06 | 901 | 279 | 32 | int:H3C1 |
| Interaction | MDC1 interactions | ATAD5 SMC1A CUL7 FANCD2 BRCA1 CLU KDR MICAL3 CAVIN2 VDAC1 ANAPC4 NSD2 CAPZA1 ICE1 CHAMP1 RIF1 PAXIP1 SMARCC1 SMN1 TP53BP1 | 1.45e-06 | 414 | 279 | 20 | int:MDC1 |
| Interaction | TRIM33 interactions | NCOA3 MYH9 SLK MYH10 HSPH1 ZMYM2 PFAS PJA2 BRCA1 RSPH1 PEX5 QARS1 ANAPC4 KTN1 CBFA2T3 CHAMP1 NCOR1 RESF1 SMARCC1 TP53BP1 SMAD2 | 1.53e-06 | 453 | 279 | 21 | int:TRIM33 |
| Interaction | RHOA interactions | RALGAPA1 SLK MYO9A MARK3 UNC5B KIAA0319L MCAM TENM2 ITPR2 FANCD2 PIK3C3 CCDC47 SYNE2 NHS RELL1 PREX1 ARHGAP21 TOR1AIP2 EHBP1 FAT4 ANK3 KTN1 RALGAPB NDFIP2 FRYL LMNB2 ATAD2 AKAP12 MICALL1 TENM3 BAZ1A MACF1 RPGR CTNNA2 SEC63 MTDH SMAD2 USP33 | 1.58e-06 | 1199 | 279 | 38 | int:RHOA |
| Interaction | RAB35 interactions | RALGAPA1 GRIPAP1 MARK3 UNC5B MCAM SPICE1 FANCD2 DST CCDC47 SYNE2 MICAL3 RELL1 ARHGAP21 EHBP1 SLC12A6 ANK3 ARFGEF2 AKAP12 MICALL1 ARFGEF3 LATS1 SLC6A5 MACF1 SEC63 | 1.62e-06 | 573 | 279 | 24 | int:RAB35 |
| Interaction | RCOR1 interactions | GRIPAP1 MYH9 MYH10 HIVEP1 ZMYM2 DNAJC6 DST ALMS1 SEC16A ARHGAP21 EHBP1 UBR4 GEMIN5 ICE1 ECPAS MIER1 NCOR1 RESF1 FAM169A SMARCC1 PCM1 TP53BP1 | 1.65e-06 | 494 | 279 | 22 | int:RCOR1 |
| Interaction | YWHAQ interactions | RALGAPA1 PRPF31 NCOA3 MYH2 SYNRG MYH9 SLK MYH13 MYO9A MARK3 HSPH1 MRPS27 CUL7 MDM4 CEP350 FANCD2 DST BRCA1 PIK3C3 CGN KMT2A NHS HAX1 ARHGAP21 NELFE POTEF CHAF1A PARP8 FRYL LARP1B RFC1 RFX7 LATS1 BAZ1A MACF1 PCM1 | 2.14e-06 | 1118 | 279 | 36 | int:YWHAQ |
| Interaction | PPIA interactions | PRPF31 NR2C2 MYH9 CUL7 FAM186B TMEM132B FANCD2 SAFB DST SUPT5H SEC16A DMD ARHGAP21 VDAC1 ANAPC4 NELFE ANK3 NSD2 KRT83 RFC1 ECPAS CHAMP1 RIF1 TRMT6 BAZ1A UTP4 PAXIP1 MACF1 NEXN HCFC1 TP53BP1 | 2.28e-06 | 888 | 279 | 31 | int:PPIA |
| Interaction | STX4 interactions | GRIPAP1 MARK3 UNC5B MCAM STX1B STX1A NEO1 CCDC47 SYNE2 SEC16A MICAL3 TOR1AIP2 EHBP1 SLC12A6 ANK3 SYNE1 KTN1 SEC63 MTDH USP33 | 2.41e-06 | 428 | 279 | 20 | int:STX4 |
| Interaction | PLEC interactions | NR2C2 MYH9 HIP1 SLK MYO9A CUL7 FANCD2 DST BRCA1 RSPH1 SYNE2 PEX5 QARS1 KRT78 ANK3 NSD2 LATS1 FBXO43 MACF1 MTDH | 2.59e-06 | 430 | 279 | 20 | int:PLEC |
| Interaction | CFTR interactions | MYH1 MYH2 MYH4 MYH6 MYH8 MYH9 HIP1 MYH10 MYH13 PDGFRA HSPH1 MRPS27 ITGB7 PJA2 MELTF STX1A NOD1 CGN PKD1 SEC16A NHS HAX1 DMD QARS1 MAP3K19 PTCD3 AKAP6 PPP1R21 KRT78 DSC1 KRT81 KRT86 UBR4 CAPZA1 RDX LMNB2 BCAS1 AKAP12 ANKRD13A THADA IGKC MACF1 TP53BP1 | 2.94e-06 | 1480 | 279 | 43 | int:CFTR |
| Interaction | CBX3 interactions | NR2C2 ATAD5 ZMYM2 CUL7 GTF3C4 FANCD2 CACTIN BRCA1 SUPT5H KMT2A VDAC1 NELFE ZEB1 NSD2 CHAF1A RFC1 ATAD2 CHAMP1 NCOR1 RIF1 MACF1 ELF2 NUP93 CLSPN TP53BP1 | 3.97e-06 | 646 | 279 | 25 | int:CBX3 |
| Interaction | ITGB3 interactions | MYH9 MYH10 PDGFRA PDGFRB HSPH1 MCAM PFAS SUPT5H KDR UBR4 HCFC1 TP53BP1 | 4.60e-06 | 170 | 279 | 12 | int:ITGB3 |
| Interaction | XRCC6 interactions | NR2C2 CAAP1 MYH9 MYH10 SMC1A CUL7 GTF3C4 PGR FANCD2 CACTIN BRCA1 CLU SUPT5H KMT2A VDAC1 NELFE ZEB1 DSC1 NSD2 CHAF1A ICE1 RFC1 CHAMP1 NCOR1 RIF1 BAZ1A PAXIP1 MTDH HCFC1 TP53BP1 SMAD2 | 5.59e-06 | 928 | 279 | 31 | int:XRCC6 |
| Interaction | TERF2 interactions | RALGAPA1 MYH9 MYH10 MARK3 HSPH1 POTEE DST BRCA1 SUPT5H SYNE2 SEC16A DMD SYNE1 CHAMP1 MACF1 PCM1 TP53BP1 | 5.77e-06 | 340 | 279 | 17 | int:TERF2 |
| Interaction | CENPA interactions | PRPF31 HIVEP1 ERCC5 ATAD5 MRPS27 GTF3C4 CACTIN CCDC47 KMT2A NSD2 CHAF1A RFC1 ECPAS ATAD2 BAZ1A SMARCC1 ELF2 HCFC1 | 5.79e-06 | 377 | 279 | 18 | int:CENPA |
| Interaction | GJD3 interactions | HIP1 MARK3 UNC5B KIAA0319L SCYL1 MCAM ITPR2 DST CCDC47 SYNE2 SEC16A RELL1 TOR1AIP2 EHBP1 SYNE1 KTN1 ARFGEF1 SEC63 MTDH USP33 | 5.84e-06 | 454 | 279 | 20 | int:GJD3 |
| Interaction | MYH6 interactions | 6.25e-06 | 94 | 279 | 9 | int:MYH6 | |
| Interaction | RSPH6A interactions | 6.48e-06 | 34 | 279 | 6 | int:RSPH6A | |
| Interaction | MCM2 interactions | SOX4 MYH1 MYH2 MYH4 NR2C2 MYH6 MYH8 MYH9 MYO9A SMC1A HSPH1 SCYL1 GTF3C4 FANCD2 DST BRCA1 CLU SEC16A KMT2A DMD QARS1 KDF1 FKBP15 DSC1 ANK3 SYNE1 CHAF1A UBR4 BAG4 CAPZA1 PPP4R2 MACF1 CTNNA2 CLSPN | 6.97e-06 | 1081 | 279 | 34 | int:MCM2 |
| Interaction | CTNNA1 interactions | MARK3 HSPH1 MCAM CUL7 CEP350 FANCD2 BRCA1 CGN PKD1 NHS DMD ARHGAP21 ANK3 CHAF1A SIRT2 MACF1 CTNNA2 | 7.54e-06 | 347 | 279 | 17 | int:CTNNA1 |
| Interaction | KCTD13 interactions | RALGAPA1 MYH6 MYH9 SLK MYH10 MYO9A MARK3 HSPH1 DNAJC6 STX1B ITPR2 PJA2 DST CLCN6 CLU SEC16A KMT2A MICAL3 HAX1 DMD ARHGAP21 TRAPPC9 VDAC1 PTCD3 SLC12A6 ANK3 CAMK2B SYNE1 KTN1 CAPZA1 ARFGEF2 GEMIN5 RDX BCAS1 SIRT2 MACF1 CTNNA2 EIF4G3 MTDH PCM1 | 9.15e-06 | 1394 | 279 | 40 | int:KCTD13 |
| Interaction | CDH1 interactions | MYH9 SLK MARK3 SCYL1 EVPL ITGB7 FANCD2 DST BRCA1 CGN PKD1 NHS RELL1 KDF1 ARHGAP21 EHBP1 ZEB1 ANK3 CHAF1A KTN1 CAPZA1 RDX MICALL1 TENM3 MACF1 CTNNA2 HCFC1 | 9.42e-06 | 768 | 279 | 27 | int:CDH1 |
| Interaction | KRT19 interactions | NR2C2 SPICE1 CEP350 FANCD2 ALMS1 DMD KRT78 KRT81 CNOT10 KRT83 KRT86 KTN1 CEP164 SIRT2 PCM1 | 9.89e-06 | 282 | 279 | 15 | int:KRT19 |
| Interaction | EZR interactions | MYH13 MARK3 HSPH1 MCAM CUL7 GTF3C4 FANCD2 DST BRCA1 RSPH1 SEC16A ARHGAP21 TRAPPC9 VDAC1 EHBP1 ANK3 RDX AKAP12 SIRT2 FBXO43 MACF1 EIF4G3 | 1.00e-05 | 553 | 279 | 22 | int:EZR |
| Interaction | POTED interactions | 1.04e-05 | 4 | 279 | 3 | int:POTED | |
| Interaction | GAN interactions | PRPF31 SPTBN5 TAF8 DST ALMS1 SYNE2 PKD1 DMD POTEF SYNE1 RDX LMNB2 TENM3 CTNNA2 | 1.26e-05 | 253 | 279 | 14 | int:GAN |
| Interaction | LATS1 interactions | PRPF31 MYH1 MYH2 MYH4 MYH6 MYH8 MYH13 SPICE1 CEP350 PJA2 ALMS1 CGN SEC16A HAX1 KRT78 RIF1 LATS1 SMARCC1 PCM1 | 1.33e-05 | 440 | 279 | 19 | int:LATS1 |
| Interaction | APEX1 interactions | RALGAPA1 PRPF31 MYH9 HIVEP1 ERCC5 MYO9A ATAD5 MARK3 PFAS MDM4 SLIT2 CACTIN STX1A SAFB BRCA1 SUPT5H PKD1 KMT2A QARS1 ZEB1 NSD2 CHAF1A PARP8 KTN1 RFC1 CHAMP1 RIF1 THADA LATS1 BAZ1A FAM169A SMARCC1 ELF2 RPGR EIF4G3 PCM1 TP53BP1 | 1.50e-05 | 1271 | 279 | 37 | int:APEX1 |
| Interaction | EMD interactions | NR2C2 MYH9 SCYL1 CUL7 ITPR2 FANCD2 STX1A CCDC47 SYNE2 SEC16A KDR HAX1 VDAC1 TOR1AIP2 EHBP1 ZEB1 SYNE1 KTN1 LMNB2 NCOR1 LATS1 PAXIP1 FAM169A SMARCC1 SEC63 MTDH USP33 | 1.52e-05 | 789 | 279 | 27 | int:EMD |
| Interaction | H3-3A interactions | SOX9 PRPF31 NR2C2 MYH9 HIVEP1 PDGFRA ATAD5 SMC1A ZMYM2 GTF3C4 FANCD2 CACTIN BRCA1 KMT2A NSD2 CHAF1A RFC1 TSSC4 ATAD2 CHAMP1 RIF1 TRMT6 BAZ1A SMARCC1 ELF2 HCFC1 | 1.73e-05 | 749 | 279 | 26 | int:H3-3A |
| Interaction | CLEC4D interactions | MYH9 MYH10 KIAA0319L SLIT2 SAFB CCDC47 SYNE2 SEC16A VDAC1 PCDHGB5 KTN1 UBR4 LMNB2 NUP93 | 1.78e-05 | 261 | 279 | 14 | int:CLEC4D |
| Interaction | DNAJA1 interactions | MYH9 MYH10 HIVEP1 HSPH1 MRPS27 CUL7 PGR FANCD2 SAFB BRCA1 HAX1 QARS1 KDF1 NELFE MIER1 THADA PPP4R2 PAXIP1 SMARCC1 RPGR EDRF1 | 1.85e-05 | 533 | 279 | 21 | int:DNAJA1 |
| Interaction | S100A2 interactions | ATAD5 HSPH1 MRPS27 POLR2M SPICE1 CEP350 MICAL3 QARS1 ARHGAP21 EHBP1 SYNE1 GEMIN5 RDX MTMR7 LATS1 RESF1 PAXIP1 PCM1 | 1.92e-05 | 412 | 279 | 18 | int:S100A2 |
| Interaction | EED interactions | NR2C2 MYH9 HIP1 MYH10 SMC1A HSPH1 SCYL1 PEX1 ZMYM2 CUL7 ITGB7 GTF3C4 TASOR2 FANCD2 SAFB BRCA1 SUPT5H CGN LYPLA1 VWC2L VDAC1 NSD2 UBR4 CAPZA1 GEMIN5 LMNB2 ATAD2 NCOR1 RIF1 THADA SIRT2 BAZ1A IGKC SMARCC1 MACF1 NUP93 NEXN HCFC1 PCM1 TP53BP1 | 2.10e-05 | 1445 | 279 | 40 | int:EED |
| Interaction | FBXO22 interactions | PRPF31 MYH13 HSPH1 MRPS27 GTF3C4 KMT2A MICAL3 QARS1 ARHGAP21 ANAPC4 CACNA1C DPYD ANK3 COL6A6 KTN1 ECPAS NCOR1 ERCC6L2 RP1 HCFC1 TP53BP1 | 2.24e-05 | 540 | 279 | 21 | int:FBXO22 |
| Interaction | SLC25A46 interactions | SCYL1 ITPR2 CCDC47 SYNE2 SEC16A HAX1 VDAC1 TOR1AIP2 EHBP1 KTN1 LMNB2 SEC63 MTDH USP33 | 2.30e-05 | 267 | 279 | 14 | int:SLC25A46 |
| Interaction | TMPO interactions | NR2C2 MYH9 MYH10 HSPH1 MCAM CUL7 FANCD2 NEK3 CLU CCDC47 SYNE2 SEC16A QARS1 TOR1AIP2 NSD2 CHMP1B KTN1 LMNB2 PAXIP1 FAM169A FBXO43 SMN1 SEC63 MTDH TP53BP1 USP33 | 2.32e-05 | 762 | 279 | 26 | int:TMPO |
| Interaction | RHOF interactions | HIP1 PDGFRB MARK3 UNC5B MCAM POTEE CCDC47 RELL1 ARHGAP21 TOR1AIP2 EHBP1 FAT4 ANK3 RALGAPB ARFGEF2 RDX LMNB2 ECPAS ATAD2 AKAP12 MICALL1 ARHGAP12 FAM169A MACF1 | 2.39e-05 | 673 | 279 | 24 | int:RHOF |
| Interaction | EPHA2 interactions | PDGFRA PDGFRB MARK3 UNC5B MCAM MDM4 FANCD2 DST SEC16A NHS MICAL3 RELL1 DMD ARHGAP21 TOR1AIP2 EHBP1 SLC12A6 ANK3 RALGAPB AKAP12 MICALL1 TENM3 MACF1 SEC63 SMAD2 | 2.45e-05 | 719 | 279 | 25 | int:EPHA2 |
| Interaction | TNIK interactions | MCAM ZMYM2 IL20RA DST CLU SYNE2 ARHGAP21 FKBP15 ANK3 CAMK2B SYNE1 LMNB2 DCHS1 MACF1 CTNNA2 PCM1 TP53BP1 | 2.52e-05 | 381 | 279 | 17 | int:TNIK |
| Interaction | USP15 interactions | SOX4 PRPF31 MYH2 SYNRG MYH4 MYH9 MYH10 SMC1A ZMYM2 GTF3C4 PGR FANCD2 ANK3 KRT81 GEMIN5 LATS1 PPP4R2 SMARCC1 SMN1 SMAD2 USP33 | 2.64e-05 | 546 | 279 | 21 | int:USP15 |
| Interaction | WWTR1 interactions | SYNRG SLK ALMS1 CGN SEC16A KMT2A ZEB1 ANK3 KTN1 CAPZA1 GEMIN5 NCOR1 LATS1 SMARCC1 HCFC1 PCM1 TP53BP1 SMAD2 | 2.64e-05 | 422 | 279 | 18 | int:WWTR1 |
| Interaction | RHOG interactions | RALGAPA1 NR2C2 GRIPAP1 MARK3 KIAA0319L MCAM MRPS27 FANCD2 RSPH1 CCDC47 SYNE2 RELL1 HAX1 ARHGAP21 PTCD3 TOR1AIP2 EHBP1 SLC12A6 ANK3 KTN1 RALGAPB NDFIP2 LMNB2 AKAP12 MICALL1 ARFGEF3 FAM169A MACF1 MTDH | 2.73e-05 | 910 | 279 | 29 | int:RHOG |
| Interaction | GSK3B interactions | SOX9 NCOA3 SYNRG MYH9 MYO9A HSPH1 PELI3 MRPS27 PFAS SPICE1 CEP350 DEFA5 CABYR DST ALMS1 SEC16A PEX5 NHS MICAL3 HAX1 QARS1 ARHGAP21 CAPZA1 LARP1B ARFGEF3 MACF1 CLSPN PCM1 | 3.05e-05 | 868 | 279 | 28 | int:GSK3B |
| Interaction | ATG16L1 interactions | CAAP1 GRIPAP1 HIP1 SMC1A UNC13D PFAS CCDC168 SPICE1 ITPR2 CEP350 CACTIN SAFB NOD1 PIK3C3 CCDC47 PKD1 PEX5 VDAC1 NELFE FKBP15 ANK3 CNOT10 KTN1 CAPZA1 GEMIN5 TSSC4 ARFGEF3 THADA HELZ2 SMARCC1 NUP93 ARHGAP45 HCFC1 PCM1 | 3.05e-05 | 1161 | 279 | 34 | int:ATG16L1 |
| Interaction | YWHAB interactions | RALGAPA1 PRPF31 SYNRG SLK HIVEP1 MYO9A MARK3 HSPH1 CUL7 MDM4 CEP350 FANCD2 DST CGN KMT2A NHS ARHGAP21 NELFE CASC3 CAMK2B POTEF CHAF1A PARP8 RALGAPB CAPZA1 FRYL RFX7 MICALL1 LATS1 MACF1 PCM1 | 3.15e-05 | 1014 | 279 | 31 | int:YWHAB |
| Interaction | SSRP1 interactions | PRPF31 NR2C2 CUL7 SPICE1 FANCD2 SAFB BRCA1 SUPT5H KMT2A CAVIN2 VDAC1 NELFE CHMP1B CHAF1A GEMIN5 RFC1 CEP164 NCOR1 RIF1 SMARCC1 NUP93 CLSPN MTDH HCFC1 | 3.18e-05 | 685 | 279 | 24 | int:SSRP1 |
| Interaction | ANPEP interactions | RALGAPA1 MCAM CUL7 CLU CCDC47 SYNE2 VDAC1 KTN1 UBR4 AKAP12 MTDH | 3.22e-05 | 174 | 279 | 11 | int:ANPEP |
| Interaction | CAPZA2 interactions | NR2C2 MYH9 MYH10 CUL7 ITPR2 FANCD2 DST CGN SEC16A LYPLA1 MICAL3 ARHGAP21 CNOT10 KTN1 CAPZA1 MICALL1 MACF1 NEXN | 3.38e-05 | 430 | 279 | 18 | int:CAPZA2 |
| Interaction | IFITM1 interactions | RALGAPA1 GRIPAP1 MYH9 MYH10 KIAA0319L SLIT2 SEC16A PCDH10 TRAPPC9 VDAC1 PPP1R21 EHBP1 FKBP15 UBR4 LMNB2 ARFGEF3 | 3.86e-05 | 355 | 279 | 16 | int:IFITM1 |
| Interaction | ARL14 interactions | 4.21e-05 | 119 | 279 | 9 | int:ARL14 | |
| Interaction | RYK interactions | KIAA0319L NEO1 DST CLU MICB PCDH10 FAT4 ANK3 PCDHGB5 DCHS1 CTNNA2 NUP93 | 4.22e-05 | 212 | 279 | 12 | int:RYK |
| Interaction | PRKAG2 interactions | 4.26e-05 | 68 | 279 | 7 | int:PRKAG2 | |
| Interaction | RAB7A interactions | SECISBP2L RALGAPA1 GRIPAP1 KIAA0319L MCAM PEX1 CUL7 ITPR2 FANCD2 NEO1 DST CCDC47 SYNE2 SEC16A VDAC1 TOR1AIP2 SLC12A6 FKBP15 KTN1 ARFGEF2 ARFGEF1 AKAP12 ARFGEF3 SEC63 SCIN MTDH SMAD2 USP33 | 4.37e-05 | 886 | 279 | 28 | int:RAB7A |
| Interaction | TMT1A interactions | NR2C2 CCDC168 ITPR2 CCDC47 SYNE2 SEC16A MICAL3 TOR1AIP2 EHBP1 SYNE1 KTN1 LMNB2 FAM169A SEC63 MTDH USP33 | 4.42e-05 | 359 | 279 | 16 | int:TMT1A |
| Interaction | ITPRID2 interactions | 4.49e-05 | 120 | 279 | 9 | int:ITPRID2 | |
| Interaction | SBDS interactions | MYH1 MYH2 MYH4 MYH8 MYH13 NAP1L2 SPTBN5 BRCA1 PTGES2 KTN1 CHAMP1 | 4.62e-05 | 181 | 279 | 11 | int:SBDS |
| Interaction | KRT8 interactions | MYH1 GRIPAP1 MYH9 SPICE1 CEP350 FANCD2 PJA2 ALMS1 PKD1 SEC16A PEX5 DMD ARHGAP21 UBR4 ARFGEF1 THADA SIRT2 NUP93 | 4.69e-05 | 441 | 279 | 18 | int:KRT8 |
| Interaction | ASF1A interactions | NR2C2 HIVEP1 ATAD5 TASOR2 BRCA1 KMT2A CHAF1A NCOR1 RIF1 SMARCC1 ELF2 CLSPN HCFC1 | 4.70e-05 | 249 | 279 | 13 | int:ASF1A |
| Interaction | SP110 interactions | 5.12e-05 | 122 | 279 | 9 | int:SP110 | |
| Interaction | SLC39A3 interactions | 5.15e-05 | 70 | 279 | 7 | int:SLC39A3 | |
| Interaction | RHOD interactions | RALGAPA1 SLK MARK3 KIAA0319L MCAM CCDC47 SYNE2 RELL1 ARHGAP21 EHBP1 ANK3 KTN1 RALGAPB LMNB2 AKAP12 MICALL1 ARHGAP12 MACF1 SEC63 MTDH SMAD2 | 5.17e-05 | 572 | 279 | 21 | int:RHOD |
| Interaction | LATS2 interactions | PDGFRA MCAM CUL7 MDM4 GTF3C4 SPICE1 ALMS1 CGN SEC16A HAX1 ECPAS LATS1 PCM1 SMAD2 | 5.45e-05 | 289 | 279 | 14 | int:LATS2 |
| Interaction | RAC3 interactions | RALGAPA1 MARK3 UNC5B MCAM CCDC47 NHS MICAL3 RELL1 PCDH10 ARHGAP21 EHBP1 FAT4 KTN1 RALGAPB NDFIP2 FRYL LMNB2 AKAP12 MICALL1 TENM3 MACF1 MTDH | 5.54e-05 | 619 | 279 | 22 | int:RAC3 |
| Interaction | NPM1 interactions | NR2C2 MYH10 HIVEP1 MCAM MRPS27 CUL7 GTF3C4 FANCD2 SLIT2 BRCA1 SYNE2 KMT2A KDR QARS1 CAVIN2 VDAC1 PTCD3 NELFE CASC3 ZEB1 ANK3 NSD2 CNOT10 CHAF1A KTN1 GEMIN5 RDX RFC1 AKAP12 UTP4 SMN1 RP1 RPGR MTDH | 5.99e-05 | 1201 | 279 | 34 | int:NPM1 |
| Interaction | MYOM1 interactions | 6.21e-05 | 31 | 279 | 5 | int:MYOM1 | |
| Interaction | ACTA1 interactions | NCOA3 MYH9 CUL7 FANCD2 POTEE DST DMD CHMP1B POTEF RDX LATS1 MACF1 POTEI SCIN NEXN PHACTR1 | 6.52e-05 | 371 | 279 | 16 | int:ACTA1 |
| Interaction | LYN interactions | NR2C2 MYH9 FRMPD4 MARK3 UNC5B MCAM FANCD2 DST KMT2A MICAL3 RELL1 DMD ARHGAP21 EHBP1 SLC12A6 ANK3 NSD2 CNOT10 RDX NDFIP2 AKAP12 MICALL1 ARHGAP12 MACF1 | 6.95e-05 | 720 | 279 | 24 | int:LYN |
| Interaction | RAC2 interactions | NR2C2 PDGFRB MARK3 KIAA0319L MCAM FANCD2 POTEE DST CCDC47 SYNE2 NHS RELL1 ARHGAP21 TOR1AIP2 EHBP1 KTN1 ARFGEF2 RDX LMNB2 AKAP12 TENM3 MACF1 MTDH | 6.95e-05 | 674 | 279 | 23 | int:RAC2 |
| Interaction | NCOA3 interactions | SOX9 NCOA3 MYH9 PGR BRCA1 NSD2 ATAD2 NCOR1 SIRT2 SMARCC1 TP53BP1 SMAD2 | 7.17e-05 | 224 | 279 | 12 | int:NCOA3 |
| Interaction | RAB4A interactions | RALGAPA1 SYNRG GRIPAP1 HSPH1 KIAA0319L MCAM DST PIK3C3 CCDC47 SYNE2 TOR1AIP2 EHBP1 SLC12A6 SYNE1 KTN1 RALGAPB ARFGEF2 ARFGEF1 | 7.40e-05 | 457 | 279 | 18 | int:RAB4A |
| Interaction | STXBP1 interactions | HSPH1 MCAM STX1B SPICE1 STX1A HAX1 PREX1 UBR4 MACF1 EIF4G3 MTDH | 7.52e-05 | 191 | 279 | 11 | int:STXBP1 |
| Interaction | B3GAT1 interactions | HIP1 MARK3 UNC5B ITPR2 NEO1 CCDC47 SYNE2 SEC16A TOR1AIP2 EHBP1 KTN1 ARFGEF1 LMNB2 ECPAS SEC63 MTDH | 7.87e-05 | 377 | 279 | 16 | int:B3GAT1 |
| Interaction | TPTE interactions | 7.91e-05 | 129 | 279 | 9 | int:TPTE | |
| Interaction | ABTB2 interactions | 8.11e-05 | 101 | 279 | 8 | int:ABTB2 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 8.91e-16 | 13 | 190 | 9 | 685 | |
| GeneFamily | Myosin heavy chains | 7.75e-13 | 15 | 190 | 8 | 1098 | |
| GeneFamily | Ankyrin repeat domain containing | POTEB2 POTEE GABPB2 POTEB ANK3 POTEF POTEG POTED POTEC ANKRD13A POTEM POTEI | 1.00e-05 | 242 | 190 | 12 | 403 |
| GeneFamily | SIBLING family | 1.12e-05 | 5 | 190 | 3 | 1279 | |
| GeneFamily | EF-hand domain containing|Plakins | 6.15e-05 | 8 | 190 | 3 | 939 | |
| GeneFamily | Keratins, type II | 1.72e-04 | 27 | 190 | 4 | 609 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 2.28e-04 | 29 | 190 | 4 | 396 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 6.50e-04 | 4 | 190 | 2 | 1252 | |
| GeneFamily | Cadherin related | 6.97e-04 | 17 | 190 | 3 | 24 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.59e-03 | 161 | 190 | 7 | 593 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 1.87e-03 | 50 | 190 | 4 | 721 | |
| GeneFamily | AAA ATPases | 2.32e-03 | 53 | 190 | 4 | 413 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | SLK MYH10 ERCC5 MYO9A HSPH1 FAM13B TASOR2 ITPR2 CEP350 PJA2 BRCA1 CCDC47 SYNE2 ICE2 KTN1 AGGF1 ARFGEF1 RDX RFC1 ATAD2 RIF1 RESF1 BAZ1A PPP4R2 RPGR SEC63 MTDH ZNF654 PCM1 | 1.06e-10 | 656 | 278 | 29 | M18979 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SECISBP2L SOX9 NCOA3 SLK HIVEP1 PHF20 MARK3 ZMYM2 CEP350 SLIT2 PJA2 DST BRCA1 PIK3C3 SYNE2 MICAL3 DMD EHBP1 DPYD ZEB1 ARFGEF1 RDX FRYL RIF1 BAZ1A ARHGAP12 FAM169A MACF1 RPGR EIF4G3 TP53BP1 | 2.97e-09 | 856 | 278 | 31 | M4500 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | RALGAPA1 SMC1A CEP350 BRCA1 ZEB1 NSD2 FRYL RFX7 ATAD2 NCOR1 RIF1 MACF1 HCFC1 PCM1 | 8.75e-09 | 180 | 278 | 14 | M8239 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | NCOA3 SLK HIVEP1 MARK3 ZMYM2 CEP350 PJA2 DST BRCA1 PIK3C3 MICAL3 EHBP1 DPYD ARFGEF1 FRYL BAZ1A ARHGAP12 FAM169A RPGR EIF4G3 | 1.52e-07 | 466 | 278 | 20 | M13522 |
| Coexpression | LAKE_ADULT_KIDNEY_C29_UNKNOWN_NOVEL_PT_CFH_POS_SUBPOPULATION_S2 | 3.36e-07 | 86 | 278 | 9 | M39248 | |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_B | POTEB3 GRIPAP1 SLK POTEB2 ITPK1 POTEE DST ALMS1 LYPLA1 POTEB CNOT10 POTEF POTEG POTEC FAM204A NCOR1 RIF1 MLH3 POTEM UTP4 ARHGAP12 POTEI | 3.38e-07 | 584 | 278 | 22 | MM1080 |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 8.80e-07 | 155 | 278 | 11 | M39246 | |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | SLK SMC1A NAP1L2 RIOK3 POLR2M TASOR2 CEP350 PJA2 KTN1 RALGAPB ARFGEF2 AGGF1 RDX ECPAS NCOR1 MACF1 SEC63 SMAD2 | 8.93e-07 | 429 | 278 | 18 | M29 |
| Coexpression | GAL_LEUKEMIC_STEM_CELL_UP | 1.33e-06 | 130 | 278 | 10 | M17428 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | RALGAPA1 NCOA3 SYNRG MYH9 SLK PHF20 MARK3 UNC13D MDM4 FAM13B ITGB7 ITPR2 CEP350 MICB KMT2A PREX1 ZEB1 SYNE1 PARP8 KTN1 UBR4 RALGAPB CAPZA1 AGGF1 FRYL ICE1 RFX7 MIER1 NCOR1 RIF1 LATS1 RESF1 BAZ1A MACF1 ARHGAP45 MTDH PCM1 | 1.41e-06 | 1492 | 278 | 37 | M40023 |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | MYH9 HIP1 ERCC5 PDGFRA PDGFRB ZMYM2 DDIT3 FANCD2 BRCA1 KMT2A NSD2 KTN1 CBFA2T3 FCRL4 PCM1 | 2.15e-06 | 323 | 278 | 15 | M9150 |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | SECISBP2L NCOA3 NR2C2 SLK HIVEP1 MYO9A MARK3 HSPH1 RIOK3 CUL7 RSC1A1 DDIT3 PJA2 STX1A DST ZNF394 CLCN6 CLU PKD1 RALGAPB ARFGEF2 RESF1 ARHGAP12 FAM169A ARHGAP45 | 2.67e-06 | 822 | 278 | 25 | M6782 |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | MYH9 MYH10 SMC1A DST ALMS1 PREX1 ARFGEF1 RFC1 LATS1 PPP4R2 PCM1 | 9.90e-06 | 199 | 278 | 11 | M5893 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | SECISBP2L HIP1 SLK HIVEP1 PHF20 CCDC126 RIOK3 POLR2M TENM2 DST LYPLA1 UMOD CAVIN2 TOR1AIP2 SLC12A6 FNDC3B CHMP1B FRYL CBFA2T3 ECPAS ZFY ARFGEF3 NCOR1 MACF1 USP33 | 1.01e-05 | 888 | 278 | 25 | MM1018 |
| Coexpression | GSE9037_WT_VS_IRAK4_KO_BMDM_UP | RALGAPA1 CAAP1 PDGFRA DMD VDAC1 EHBP1 FAT4 FAM204A RIF1 ELF2 USP33 | 1.04e-05 | 200 | 278 | 11 | M5812 |
| Coexpression | GSE31082_DN_VS_DP_THYMOCYTE_DN | SECISBP2L SLK MARK3 MCAM TAF8 PKD1 PREX1 PPP1R21 FRYL LATS1 ARHGAP45 | 1.04e-05 | 200 | 278 | 11 | M5055 |
| Coexpression | YOSHIMURA_MAPK8_TARGETS_DN | MYH1 MYH2 SLK PDGFRA SMC1A HSPH1 CHGA ITGB7 NEO1 ZEB1 CHAMP1 RPGR MTDH PCM1 SMAD2 | 1.47e-05 | 379 | 278 | 15 | M1885 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | SECISBP2L RALGAPA1 HIP1 HSPH1 ZMYM2 POLR2M ABCB4 ITPR2 CEP350 PJA2 NOD1 CCDC47 MICB SYNE2 KMT2A ICE2 KTN1 CAPZA1 ARFGEF2 DESI2 ECPAS IFT52 BAZ1A ARHGAP12 PAXIP1 SMARCC1 MACF1 MTDH EDRF1 PCM1 | 1.65e-05 | 1215 | 278 | 30 | M41122 |
| Coexpression | PUJANA_ATM_PCC_NETWORK | PRPF31 NR2C2 ERCC5 SMC1A RIOK3 PFAS RSC1A1 ITGB7 ITPK1 SAFB BRCA1 MICB LYPLA1 TARBP1 NSD2 KRT83 CHAF1A RALGAPB CAPZA1 ARFGEF2 AGGF1 ICE1 RFC1 CBFA2T3 RIF1 BAZ1A IGKC PAXIP1 SMN1 MTDH SMAD2 PHACTR1 | 3.55e-05 | 1394 | 278 | 32 | M9585 |
| Coexpression | MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN | HSPH1 PEX1 ZMYM2 PJA2 GABPB2 SEC16A TARBP1 FKBP15 SYNE1 ARFGEF2 FRYL RSPRY1 | 3.73e-05 | 272 | 278 | 12 | M15123 |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE | SECISBP2L RALGAPA1 ZMYM2 POLR2M SYNE2 CAVIN2 PTCD3 ZEB1 ANK3 NDFIP2 MLH3 UTP4 FAM169A SMN1 | 3.75e-05 | 363 | 278 | 14 | M41103 |
| Coexpression | NUYTTEN_NIPP1_TARGETS_DN | SMC1A KIAA0319L MCAM RIOK3 PFAS PJA2 GABPB2 CCDC47 SYNE2 SEC16A LYPLA1 C5 PREX1 SLC12A6 NSD2 PARP8 KTN1 CAPZA1 NDFIP2 RIF1 CLSPN SCIN SLC4A11 | 3.90e-05 | 845 | 278 | 23 | M18090 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | SECISBP2L HIP1 SLK HIVEP1 PHF20 CCDC126 RIOK3 TENM2 DST LYPLA1 UMOD CAVIN2 TOR1AIP2 SLC12A6 FNDC3B CHMP1B FRYL CBFA2T3 ECPAS ARFGEF3 NCOR1 MACF1 USP33 | 4.58e-05 | 854 | 278 | 23 | M1533 |
| Coexpression | ERWIN_COHEN_BLOOD_LIVE_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_UP | RALGAPA1 CAAP1 HSPH1 ZMYM2 POLR2M TASOR2 ATP11C ANK3 ICE2 KTN1 BAG4 ARFGEF2 ICE1 RFX7 PPP4R2 IGKC FAM169A SEC63 MTDH EDRF1 | 5.05e-05 | 687 | 278 | 20 | M41022 |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 5.25e-05 | 20 | 278 | 4 | M1123 | |
| Coexpression | DESCARTES_ORGANOGENESIS_EPENDYMAL_CELL | FRMPD4 STOX1 POTEB2 SLC13A4 RSPH1 POTEB MAP3K19 POTEG POTEC POTEM CFAP61 SPAG17 | 5.28e-05 | 282 | 278 | 12 | MM3642 |
| Coexpression | GSE39820_CTRL_VS_TGFBETA1_IL6_IL23A_CD4_TCELL_UP | C5orf22 HSPH1 PEX1 MDM4 TASOR2 PTCD3 RIF1 LATS1 ERCC6L2 TP53BP1 | 5.64e-05 | 199 | 278 | 10 | M5607 |
| Coexpression | GSE10240_CTRL_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN | MYH1 CUL7 DNAJC6 GTF3C4 ARHGAP21 RFC1 CBFA2T3 SMARCC1 SCIN TP53BP1 | 5.88e-05 | 200 | 278 | 10 | M304 |
| Coexpression | GSE27786_LIN_NEG_VS_BCELL_DN | CACTIN TAF8 CCDC47 SYNE2 KMT2A PPP1R21 NDFIP2 CEP164 IGKC SEC63 | 5.88e-05 | 200 | 278 | 10 | M4768 |
| Coexpression | GSE21379_TFH_VS_NON_TFH_CD4_TCELL_UP | 5.88e-05 | 200 | 278 | 10 | M7500 | |
| Coexpression | GSE5142_HTERT_TRANSDUCED_VS_CTRL_CD8_TCELL_LATE_PASSAGE_CLONE_DN | MYO9A DNAJC6 ZNF394 PIK3C3 PEX5 ATP11C CASC3 CHMP1B NDFIP2 MICALL1 | 5.88e-05 | 200 | 278 | 10 | M6552 |
| Coexpression | GSE17721_LPS_VS_GARDIQUIMOD_24H_BMDC_DN | SOX4 SLC22A25 SMC1A FAM13B ABCB4 ARHGAP21 PPP1R21 SMN1 NUP93 SMAD2 | 5.88e-05 | 200 | 278 | 10 | M4066 |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 6.43e-05 | 21 | 278 | 4 | MM1102 | |
| Coexpression | MURARO_PANCREAS_DELTA_CELL | UNC5B DNAJC6 TENM2 PJA2 APOBEC2 SYNE2 ANK3 CAMK2B AKAP12 ARFGEF3 TENM3 | 8.03e-05 | 250 | 278 | 11 | M39170 |
| Coexpression | GEORGES_TARGETS_OF_MIR192_AND_MIR215 | NCOA3 ATAD5 MCAM MDM4 MELTF DST BRCA1 GABPB2 CCDC47 FNDC3B FKBP15 NSD2 ARFGEF1 NDFIP2 LMNB2 LARP1B ATAD2 ANKRD13A MACF1 SEC63 CLSPN MTDH EDRF1 | 8.82e-05 | 892 | 278 | 23 | M18120 |
| Coexpression | FAN_OVARY_CL11_MURAL_GRANULOSA_CELL | SOX4 MARK3 HSPH1 RIOK3 DST SYNE2 TOR1AIP2 FNDC3B KTN1 RDX FAM204A BAZ1A PPP4R2 MACF1 NEXN | 8.91e-05 | 444 | 278 | 15 | M41713 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | NCOA3 CEP350 DST PIK3C3 MICB FRYL ICE1 RIF1 MLH3 BAZ1A ELF2 EDRF1 | 9.52e-05 | 300 | 278 | 12 | M8702 |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | SOX9 MYH1 MYH6 UNC5B SCYL1 RIOK3 TENM2 FRMD4B NEO1 CLU PKD1 DMD ANK3 KRT81 CAMK2B KRT83 KRT86 FRYL | 1.01e-04 | 610 | 278 | 18 | M3854 |
| Coexpression | NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_DN | SECISBP2L MYH10 NEO1 CLU CCDC47 KMT2A SYNE1 PARP8 RDX ICE1 DESI2 ATAD2 BAZ1A ELF2 | 1.03e-04 | 399 | 278 | 14 | M40939 |
| Coexpression | GSE9601_UNTREATED_VS_NFKB_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN | 1.06e-04 | 174 | 278 | 9 | M6881 | |
| Coexpression | SESTO_RESPONSE_TO_UV_C8 | 1.08e-04 | 71 | 278 | 6 | M2948 | |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | SOX9 MYH1 MYH6 UNC5B SCYL1 RIOK3 TENM2 FRMD4B NEO1 CLU PKD1 DMD ANK3 KRT81 CAMK2B KRT83 KRT86 FRYL | 1.12e-04 | 615 | 278 | 18 | M8673 |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | MARK3 HSPH1 FRMD4B ITPR2 NEK3 PIK3C3 SYNE2 LYPLA1 KDR ARFGEF2 ARFGEF1 RDX NCOR1 MLH3 BAZ1A MACF1 RPGR SEC63 EIF4G3 MTDH PHACTR1 | 1.18e-04 | 790 | 278 | 21 | M12490 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | ATAD5 CHGA FANCD2 STX1A ALMS1 EHBP1 NSD2 CHAF1A RFC1 ATAD2 ARFGEF3 RIF1 MTMR7 TRMT6 PAXIP1 SMARCC1 CLSPN PCM1 TP53BP1 | 1.33e-04 | 680 | 278 | 19 | MM456 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | SECISBP2L FRMPD4 NAP1L2 PEX1 CHGA DNAJC6 TMEM132B TENM2 FRMD4B CGN MICAL3 TARBP1 AKAP6 CACNA1C FKBP15 ANK3 COL6A6 CAMK2B ARFGEF1 LARP1B RFX7 ARFGEF3 FAM169A CTNNA2 SPAG17 SCIN | 1.37e-04 | 1106 | 278 | 26 | M39071 |
| Coexpression | WEI_MIR34A_TARGETS | 1.73e-04 | 146 | 278 | 8 | M8617 | |
| Coexpression | JOHNSTONE_PARVB_TARGETS_3_DN | PRPF31 SLK MYH10 C5orf22 PHF20 MDM4 FAM13B CEP350 FANCD2 MICB TOR1AIP2 DPYD ZNF670 KTN1 BAG4 NDFIP2 DESI2 ECPAS ATAD2 FAM204A RIF1 PPP4R2 | 1.85e-04 | 877 | 278 | 22 | M2241 |
| Coexpression | GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_48H_CD4_TCELL_UP | SECISBP2L SOX4 TMEM132B ARHGAP21 FNDC3B DSC1 PARP8 FAM200B FAM204A | 1.98e-04 | 189 | 278 | 9 | M4199 |
| Coexpression | KRAS.600_UP.V1_UP | SOX9 CDHR2 NAP1L2 PLEKHS1 CHGA DEFA5 STX1A ZEB1 ANK3 CD80 CTNNA2 | 2.10e-04 | 279 | 278 | 11 | M2882 |
| Coexpression | LINDGREN_BLADDER_CANCER_CLUSTER_1_DN | HIP1 PDGFRB MCAM ITGB7 BRCA1 CGN RELL1 PREX1 VDAC1 NSD2 ATAD2 AKAP12 CD80 | 2.20e-04 | 378 | 278 | 13 | M17788 |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | SOX9 MYH1 MYH6 UNC5B SCYL1 RIOK3 TENM2 FRMD4B NEO1 CLU PKD1 DMD ANK3 KRT81 CAMK2B KRT83 KRT86 FRYL | 2.22e-04 | 650 | 278 | 18 | MM1042 |
| Coexpression | HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN | 2.30e-04 | 282 | 278 | 11 | M7623 | |
| Coexpression | GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_UP | 2.41e-04 | 194 | 278 | 9 | M7467 | |
| Coexpression | GSE11818_WT_VS_DICER_KO_TREG_DN | 2.49e-04 | 154 | 278 | 8 | M411 | |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | SOX9 MYH1 MYH6 UNC5B SCYL1 RIOK3 TENM2 FRMD4B NEO1 CLU PKD1 DMD ANK3 KRT81 CAMK2B KRT83 KRT86 FRYL | 2.62e-04 | 659 | 278 | 18 | MM1040 |
| Coexpression | GSE42021_TCONV_PLN_VS_TREG_PRECURSORS_THYMUS_UP | 2.80e-04 | 198 | 278 | 9 | M9571 | |
| Coexpression | GABRIELY_MIR21_TARGETS | MYO9A SMC1A ZMYM2 SYNE2 DMD ARHGAP21 ARFGEF1 RFX7 RSPRY1 LATS1 SEC63 | 2.84e-04 | 289 | 278 | 11 | M2196 |
| Coexpression | GSE15139_GMCSF_TREATED_VS_UNTREATED_NEUTROPHILS_DN | RALGAPA1 CAAP1 FANCD2 ARHGAP21 GEMIN5 FAM204A LATS1 SEC63 EIF4G3 | 2.90e-04 | 199 | 278 | 9 | M7099 |
| Coexpression | GSE27786_CD8_TCELL_VS_MONO_MAC_UP | 2.90e-04 | 199 | 278 | 9 | M4848 | |
| Coexpression | GSE40666_UNTREATED_VS_IFNA_STIM_STAT4_KO_EFFECTOR_CD8_TCELL_90MIN_DN | 2.90e-04 | 199 | 278 | 9 | M9236 | |
| Coexpression | GSE7460_TREG_VS_TCONV_ACT_WITH_TGFB_UP | 2.90e-04 | 199 | 278 | 9 | M5692 | |
| Coexpression | GSE11961_UNSTIM_VS_ANTI_IGM_AND_CD40_STIM_6H_FOLLICULAR_BCELL_DN | 3.01e-04 | 200 | 278 | 9 | M9335 | |
| Coexpression | GSE12001_MIR223_KO_VS_WT_NEUTROPHIL_DN | 3.01e-04 | 200 | 278 | 9 | M391 | |
| Coexpression | GSE15330_WT_VS_IKAROS_KO_HSC_UP | GRIPAP1 PDGFRA KIAA0319L STX1A PKD1 SEC16A PARP8 CAPZA1 NCOR1 | 3.01e-04 | 200 | 278 | 9 | M7040 |
| Coexpression | GSE27786_LSK_VS_CD4_TCELL_DN | 3.01e-04 | 200 | 278 | 9 | M4747 | |
| Coexpression | GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP | 3.01e-04 | 200 | 278 | 9 | M3446 | |
| Coexpression | GSE18281_CORTICAL_THYMOCYTE_VS_WHOLE_CORTEX_THYMUS_DN | 3.01e-04 | 200 | 278 | 9 | M7240 | |
| Coexpression | GSE42724_NAIVE_VS_B1_BCELL_UP | 3.01e-04 | 200 | 278 | 9 | M9790 | |
| Coexpression | GSE23568_CTRL_VS_ID3_TRANSDUCED_CD8_TCELL_UP | 3.01e-04 | 200 | 278 | 9 | M8514 | |
| Coexpression | GSE19888_ADENOSINE_A3R_INH_VS_INH_PRETREAT_AND_ACT_WITH_TCELL_MEMBRANES_MAST_CELL_UP | 3.01e-04 | 200 | 278 | 9 | M7342 | |
| Coexpression | GSE20198_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_UP | 3.01e-04 | 200 | 278 | 9 | M7365 | |
| Coexpression | HALLMARK_MYOGENESIS | 3.01e-04 | 200 | 278 | 9 | M5909 | |
| Coexpression | GSE24210_RESTING_TREG_VS_TCONV_UP | 3.01e-04 | 200 | 278 | 9 | M7839 | |
| Coexpression | GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_4MONTH_POST_DX_UP | 3.01e-04 | 200 | 278 | 9 | M5779 | |
| Coexpression | GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_TREATED_CD4_TCELL_UP | 3.01e-04 | 200 | 278 | 9 | M5623 | |
| Coexpression | LAKE_ADULT_KIDNEY_C28_INTERSTITIUM | 3.12e-04 | 86 | 278 | 6 | M39247 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | FAM13B NEO1 BRCA1 RELL1 VDAC1 CHMP1B RFC1 ATAD2 CEP164 RIF1 TRMT6 ERCC6L2 MTDH TP53BP1 | 3.37e-04 | 448 | 278 | 14 | MM1044 |
| Coexpression | MENON_FETAL_KIDNEY_4_PODOCYTES | 3.74e-04 | 206 | 278 | 9 | M39254 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | SECISBP2L HIVEP1 PJA2 RELL1 SLC12A6 ZEB1 CAPZA1 FRYL RFC1 ATAD2 MIER1 RIF1 PPP4R2 FAM169A SMN1 EIF4G3 EDRF1 PHACTR1 | 3.80e-04 | 680 | 278 | 18 | M41089 |
| Coexpression | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP | NCOA3 MYH9 MYH10 ZMYM2 FRMD4B PJA2 DST CLU ZEB1 ANK3 CAPZA1 ARFGEF1 DESI2 IGKC MTDH USP33 | 4.09e-04 | 568 | 278 | 16 | M4023 |
| Coexpression | DARWICHE_PAPILLOMA_PROGRESSION_RISK | 4.48e-04 | 92 | 278 | 6 | MM503 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | ATAD5 SMC1A ZMYM2 SAFB ALMS1 BRCA1 SYNE2 LYPLA1 ARHGAP21 MAP3K19 ICE2 ARFGEF2 NCOR1 RIF1 LATS1 BAZ1A RPGR CLSPN PCM1 | 2.85e-08 | 311 | 276 | 19 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | ATAD5 SMC1A HSPH1 SAFB ALMS1 BRCA1 SYNE2 LYPLA1 MAP3K19 KTN1 ARFGEF2 RIF1 BAZ1A CLSPN PCM1 | 3.47e-08 | 192 | 276 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | SOX9 CAAP1 MYH10 ERCC5 PHF20 ATAD5 MARK3 SMC1A HSPH1 ZMYM2 CEP350 FANCD2 ALMS1 BRCA1 SYNE2 ATP11C DMD ARHGAP21 PLEKHA8 ZEB1 NSD2 ICE2 KTN1 ARFGEF2 RDX RFC1 ATAD2 RIF1 TRMT6 BAZ1A PAXIP1 FAM169A SMARCC1 MACF1 RPGR SEC63 CLSPN MTDH PCM1 TP53BP1 | 1.45e-07 | 1257 | 276 | 40 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | SLK MYH10 ATAD5 SMC1A HSPH1 ZMYM2 POLR2M STX1B SYNE2 LYPLA1 DMD MAP3K19 CASC3 ZEB1 ICE2 KTN1 ARFGEF2 ECPAS RIF1 BAZ1A FAM169A MACF1 CLSPN PCM1 | 2.75e-06 | 629 | 276 | 24 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | SOX9 CAAP1 MYH10 ERCC5 PHF20 ATAD5 MARK3 SMC1A HSPH1 ZMYM2 CEP350 FANCD2 ALMS1 BRCA1 SYNE2 ATP11C DMD ARHGAP21 PLEKHA8 ZEB1 NSD2 ICE2 KTN1 ARFGEF2 RDX RFC1 ATAD2 RIF1 TRMT6 BAZ1A PAXIP1 FAM169A SMARCC1 MACF1 RPGR SEC63 CLSPN MTDH PCM1 TP53BP1 | 6.06e-06 | 1459 | 276 | 40 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | HIP1 ATAD5 HSPH1 SAFB ALMS1 BRCA1 LYPLA1 ATP11C MICAL3 PLEKHA8 KTN1 RFX7 ECPAS ATAD2 RIF1 BAZ1A PPP4R2 PAXIP1 FAM169A SMARCC1 CLSPN | 7.04e-06 | 532 | 276 | 21 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4 | SLK ATAD5 SMC1A HSPH1 SYNE2 ICE2 ARFGEF2 ARFGEF1 ICE1 ECPAS MACF1 RPGR | 1.49e-05 | 203 | 276 | 12 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | SLK MYH10 ATAD5 SMC1A ZMYM2 LYPLA1 MAP3K19 ICE2 SYNE1 IBSP ARFGEF2 ARFGEF1 ECPAS RIF1 BAZ1A MACF1 CLSPN PCM1 | 1.58e-05 | 432 | 276 | 18 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | SYNRG NR2C2 GRIPAP1 ATAD5 HSPH1 STX1B CEP350 SAFB DST ALMS1 BRCA1 SYNE2 NHS DMD DPYD FAT4 KTN1 RIF1 LATS1 BAZ1A FAM169A CLSPN PHACTR1 | 1.66e-05 | 654 | 276 | 23 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_1000 | RALGAPA1 PEX1 UMOD ATP11C QARS1 ANK3 ARFGEF2 ATAD2 RIF1 ERCC6L2 | 2.19e-05 | 146 | 276 | 10 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | SOX9 PHF20 ATAD5 SMC1A HSPH1 ZMYM2 DNAJC6 FRMD4B STX1B FANCD2 SLIT2 ALMS1 BRCA1 CLCN6 SYNE2 ATP11C DMD PLEKHA8 ZEB1 NSD2 ICE2 RIF1 BAZ1A FAM169A SMARCC1 MACF1 RPGR CLSPN PCM1 TP53BP1 PHACTR1 | 2.21e-05 | 1060 | 276 | 31 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | SOX4 MYH10 PHF20 PDGFRA ATAD5 SMC1A HSPH1 ZMYM2 ITPR2 ALMS1 BRCA1 NHS ATP11C PLEKHA8 ANAPC4 CACNA1C ZEB1 ANK3 ICE2 ARFGEF2 RDX ATAD2 RIF1 RESF1 BAZ1A FAM169A SMARCC1 MACF1 RPGR SEC63 CLSPN NEXN ZNF654 PCM1 | 3.29e-05 | 1241 | 276 | 34 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | CAAP1 ATAD5 SMC1A HSPH1 ZMYM2 TENM2 SLIT2 SAFB ALMS1 BRCA1 SYNE2 LYPLA1 MICAL3 DMD ARHGAP21 MAP3K19 ICE2 KTN1 ARFGEF2 FRYL NCOR1 RIF1 TRMT6 LATS1 BAZ1A FAM169A RPGR CLSPN PCM1 | 3.94e-05 | 989 | 276 | 29 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | SLK HIVEP1 ATAD5 MARK3 SMC1A HSPH1 POLR2M ITPR2 ZEB1 ICE2 ARFGEF2 ARFGEF1 ICE1 ECPAS THADA PPP4R2 MACF1 RPGR MTDH PCM1 | 5.33e-05 | 564 | 276 | 20 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | MYO9A STX1B TASOR2 SPICE1 FANCD2 NEK3 ALMS1 BRCA1 ATP11C ICE2 ARFGEF2 LARP1B ATAD2 RIF1 MTMR7 BAZ1A UTP4 FAM169A ERCC6L2 RPGR NUP93 CFAP61 CLSPN HCFC1 EDRF1 | 7.46e-05 | 820 | 276 | 25 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | NCOA3 NR2C2 MYH8 MYO9A FRMD4B TASOR2 SLIT2 ALMS1 BRCA1 GABPB2 SYNE2 ATP11C KDF1 ICE2 GEMIN5 LARP1B ECPAS RSPRY1 FAM204A RIF1 RESF1 FAM169A SMARCC1 RPGR | 8.37e-05 | 776 | 276 | 24 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | SOX9 PHF20 ATAD5 SMC1A HSPH1 ZMYM2 UNC13D DNAJC6 FRMD4B STX1B FANCD2 SLIT2 ALMS1 BRCA1 CLCN6 SYNE2 CGN ATP11C DMD PLEKHA8 KRT78 ZEB1 NSD2 ICE2 BCAS1 RIF1 BAZ1A FAM169A SMARCC1 MACF1 RPGR CFAP61 CLSPN PCM1 TP53BP1 PHACTR1 | 8.62e-05 | 1414 | 276 | 36 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | RALGAPA1 CAAP1 MYO9A ATAD5 SMC1A HSPH1 ZMYM2 SAFB ALMS1 BRCA1 SYNE2 MICAL3 DMD ARHGAP21 MAP3K19 PPP1R21 KTN1 CEP164 NCOR1 RIF1 LATS1 BAZ1A ERCC6L2 CLSPN PCM1 | 9.20e-05 | 831 | 276 | 25 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | SLK MYH10 ATAD5 SMC1A HSPH1 ZMYM2 CLCN6 SYNE2 LYPLA1 MAP3K19 CASC3 ICE2 SYNE1 IBSP KTN1 ARFGEF2 ARFGEF1 ECPAS RIF1 TRMT6 BAZ1A FAM169A MACF1 RPGR CLSPN SCIN PCM1 SMAD2 | 9.82e-05 | 989 | 276 | 28 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | CAAP1 ATAD5 SMC1A HSPH1 SAFB ALMS1 BRCA1 SYNE2 LYPLA1 MAP3K19 KTN1 ARFGEF2 FRYL RIF1 BAZ1A FAM169A CLSPN PCM1 | 9.94e-05 | 498 | 276 | 18 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | PHF20 ATAD5 SMC1A HSPH1 POLR2M DST ALMS1 LYPLA1 PREX1 PLEKHA8 RFX7 ECPAS RIF1 BAZ1A FAM169A SMARCC1 CLSPN | 1.50e-04 | 469 | 276 | 17 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | RALGAPA1 MYH9 C5orf22 PHF20 CEP350 STX1A ANK3 RFC1 CEP164 RIF1 RESF1 BAZ1A ERCC6L2 SMARCC1 | 1.53e-04 | 339 | 276 | 14 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 1.68e-04 | 186 | 276 | 10 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#4_top-relative-expression-ranked_1000 | RALGAPA1 MYH9 C5orf22 CEP350 STX1A UMOD QARS1 ANK3 ARFGEF2 ECPAS CEP164 ERCC6L2 | 1.69e-04 | 261 | 276 | 12 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k4 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | SOX9 MYH10 ATAD5 SMC1A HSPH1 ZMYM2 SLIT2 TAF8 ALMS1 SYNE2 LYPLA1 NHS ATP11C PREX1 ZEB1 COL6A6 ICE2 BCAS1 RFC1 ATAD2 RIF1 TRMT6 RESF1 BAZ1A FAM169A SMARCC1 RPGR CFAP61 CLSPN NEXN ZNF654 PCM1 | 2.04e-04 | 1252 | 276 | 32 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | SOX4 MYH10 PHF20 PDGFRA ATAD5 SMC1A HSPH1 ZMYM2 UNC13D ITPR2 ALMS1 BRCA1 NHS ATP11C PLEKHA8 ANAPC4 CACNA1C ZEB1 ANK3 ICE2 ARFGEF2 RDX ATAD2 RIF1 RESF1 BAZ1A FAM169A SMARCC1 MACF1 RPGR SEC63 CLSPN NEXN ZNF654 PCM1 | 3.78e-04 | 1468 | 276 | 35 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | ATAD5 HSPH1 STX1B CEP350 SAFB ALMS1 BRCA1 SYNE2 DMD DPYD KTN1 LATS1 PHACTR1 | 3.87e-04 | 328 | 276 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | SOX4 SOX9 NCOA3 NR2C2 CAAP1 UNC5B HSPH1 NAP1L2 FRMD4B SLIT2 PJA2 GABPB2 SYNE2 LYPLA1 NSD2 RDX RSPRY1 FAM204A RIF1 RESF1 SMARCC1 SMN1 RPGR | 4.36e-04 | 815 | 276 | 23 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_1000 | PHF20 HSPH1 SPICE1 FANCD2 NEK3 BRCA1 GEMIN5 ATAD2 RIF1 THADA MTMR7 NUP93 CLSPN | 4.47e-04 | 333 | 276 | 13 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k1_1000 |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SOX4 CEP350 KMT2A KTN1 CBFA2T3 MIER1 AKAP12 NCOR1 SMARCC1 MACF1 EIF4G3 PCM1 | 2.34e-09 | 184 | 281 | 12 | 1154a5ad7b8512272b7476f949ddac350910bfb7 |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SLK CHGA CEP350 LYPLA1 NSD2 SYNE1 KTN1 UBR4 CAPZA1 RIF1 MACF1 ARHGAP45 | 3.79e-09 | 192 | 281 | 12 | 1ccc47792edf9ee23501c8e2165d11271636b66a |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CHGA DST SEC16A KMT2A COL6A6 ARFGEF1 FRYL NCOR1 RIF1 MACF1 PCM1 PHACTR1 | 4.52e-09 | 195 | 281 | 12 | 7796ea9247f4c63762f0de8490fed08b9717fa23 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CHGA DST SEC16A KMT2A COL6A6 ARFGEF1 FRYL NCOR1 RIF1 MACF1 PCM1 PHACTR1 | 4.52e-09 | 195 | 281 | 12 | 3e519cffa6144a62b06124642a14c9ff39b76554 |
| ToppCell | LV-03._Atrial_Cardiomyocyte|LV / Chamber and Cluster_Paper | MYH6 CCDC168 ITGB7 DMD AKAP6 CACNA1C ANK3 POTEI NEXN PHACTR1 | 4.88e-09 | 120 | 281 | 10 | 3b77bd0e3630cdd45001cecf5e47660a90ebc92e |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | MYH10 PDGFRA PDGFRB SLIT2 DST COL6A6 PCDHGB5 SYNE1 AKAP12 TENM3 MACF1 NEXN | 5.68e-09 | 199 | 281 | 12 | e1849505b92820a219c5a2c35492bdd55579fb48 |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | SOX4 NCOA3 PHF20 PDGFRB HSPH1 ZMYM2 FNDC1 NOD1 ZSCAN2 RALGAPB ARFGEF2 | 3.37e-08 | 188 | 281 | 11 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | MYH6 TENM2 DST MICAL3 DMD AKAP6 CACNA1C ANK3 CAMK2B NEXN PHACTR1 | 3.76e-08 | 190 | 281 | 11 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | MYH6 TENM2 DST MICAL3 DMD AKAP6 CACNA1C ANK3 CFAP61 NEXN PHACTR1 | 4.90e-08 | 195 | 281 | 11 | 75fc81bddb246dca3b437fb60827b1d4fe416405 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | MYH10 SLIT2 DST NHS COL6A6 PCDHGB5 SYNE1 AKAP12 TENM3 MACF1 NEXN | 5.44e-08 | 197 | 281 | 11 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | MYH10 PDGFRA PDGFRB SLIT2 DST COL6A6 PCDHGB5 SYNE1 TENM3 MACF1 NEXN | 6.03e-08 | 199 | 281 | 11 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | MYH10 PDGFRA PDGFRB SLIT2 DST COL6A6 PCDHGB5 SYNE1 AKAP12 MACF1 NEXN | 6.34e-08 | 200 | 281 | 11 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.34e-08 | 200 | 281 | 11 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | MYH10 PDGFRB MCAM FNDC1 NHS MICAL3 DMD AKAP6 CACNA1C AKAP12 NEXN | 6.34e-08 | 200 | 281 | 11 | a66449b22b39dd6987fc2c3ed160d24564234ced |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.78e-07 | 175 | 281 | 10 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | MYH10 FRMPD4 SLIT2 BRCA1 CHAF1A RFC1 AKAP12 MACF1 CLSPN NEXN | 1.88e-07 | 176 | 281 | 10 | cb8fd56a4f935cdda19d7ab43382cdda7c307667 |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | NCOA3 HIP1 PHF20 PDGFRB HSPH1 FNDC1 KDR RALGAPB ARFGEF2 SEC63 | 2.08e-07 | 178 | 281 | 10 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.19e-07 | 179 | 281 | 10 | ff678e2f33c914e3dd0f338ada25f506c3e3c980 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 3.29e-07 | 187 | 281 | 10 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | MYO9A ZMYM2 KMT2A CACNA1C ANK3 PCDHGB5 AGGF1 LATS1 PAXIP1 ERCC6L2 | 3.46e-07 | 188 | 281 | 10 | 6468fa95ad0395395301115286f2d8c0df5d3882 |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | MYO9A ZMYM2 KMT2A CACNA1C ANK3 PCDHGB5 AGGF1 LATS1 PAXIP1 ERCC6L2 | 3.46e-07 | 188 | 281 | 10 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | MYO9A ZMYM2 KMT2A CACNA1C ANK3 PCDHGB5 AGGF1 LATS1 PAXIP1 ERCC6L2 | 3.46e-07 | 188 | 281 | 10 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | MYH9 TENM2 MICAL3 DMD AKAP6 CACNA1C ANK3 CFAP61 NEXN PHACTR1 | 3.63e-07 | 189 | 281 | 10 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.00e-07 | 191 | 281 | 10 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | MYH6 TENM2 MICAL3 DMD AKAP6 CACNA1C ANK3 CAMK2B NEXN PHACTR1 | 4.00e-07 | 191 | 281 | 10 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.19e-07 | 192 | 281 | 10 | d0649410cf5eacdb0c1dce70e37c7473ef5fddfa | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | MYH6 TENM2 MICAL3 DMD AKAP6 CACNA1C ANK3 CFAP61 NEXN PHACTR1 | 4.40e-07 | 193 | 281 | 10 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | RALGAPA1 SYNRG SMC1A GTF3C4 TASOR2 CEP350 FRYL ARFGEF3 LATS1 SMARCC1 | 4.40e-07 | 193 | 281 | 10 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | MYH10 FRMPD4 TMEM132B TENM2 PKD1 TARBP1 CACNA1C CAMK2B SYNE1 PHACTR1 | 5.07e-07 | 196 | 281 | 10 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 5.07e-07 | 196 | 281 | 10 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 5.07e-07 | 196 | 281 | 10 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-monocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.31e-07 | 197 | 281 | 10 | b2f4d7c301c0b24003374923b31d6d058e40b213 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.31e-07 | 197 | 281 | 10 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.31e-07 | 197 | 281 | 10 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.31e-07 | 197 | 281 | 10 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 5.31e-07 | 197 | 281 | 10 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.56e-07 | 198 | 281 | 10 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.56e-07 | 198 | 281 | 10 | 1f956e369e00d37835095a001db4b62a79014532 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.56e-07 | 198 | 281 | 10 | dc6fbad0ecdd057189f71afcdb6aca25207314a3 | |
| ToppCell | Mild-Epithelial-Epithelial-|Mild / Condition, Lineage, Cell class and cell subclass | IL20RA PLEKHS1 STOX1 RSPH1 CLU CGN MAP3K19 ARFGEF3 RP1 SPAG17 | 5.82e-07 | 199 | 281 | 10 | 81115bbd2c10bfdd38376d2075f03a59c31870d2 |
| ToppCell | BAL-Mild-Epithelial|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | PLEKHS1 STOX1 RSPH1 CLU CGN MAP3K19 BCAS1 ARFGEF3 RP1 SPAG17 | 5.82e-07 | 199 | 281 | 10 | 74087b4b5e567310fc4ac58fb267ff651a180680 |
| ToppCell | Mild-Epithelial|Mild / Condition, Lineage, Cell class and cell subclass | IL20RA PLEKHS1 STOX1 RSPH1 CLU CGN MAP3K19 ARFGEF3 RP1 SPAG17 | 5.82e-07 | 199 | 281 | 10 | ec5fff80e2a8a94fbaf1fdcc6d45c8d7c6252e18 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | MYH10 PDGFRB SLIT2 DST COL6A6 PCDHGB5 SYNE1 AKAP12 MACF1 NEXN | 5.82e-07 | 199 | 281 | 10 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 |
| ToppCell | BAL-Mild-Epithelial-Epithelial|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | PLEKHS1 STOX1 RSPH1 CLU CGN MAP3K19 BCAS1 ARFGEF3 RP1 SPAG17 | 5.82e-07 | 199 | 281 | 10 | 1ee4010d8557564e25e8ee00b914c2dfd9037838 |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | RALGAPA1 MDM4 SYNE2 ANK3 SYNE1 PARP8 ARFGEF1 FRYL MACF1 PCM1 | 5.82e-07 | 199 | 281 | 10 | f0b0097df0026496470a80d8cc9375ffd8389b00 |
| ToppCell | Mild-Epithelial-Epithelial|Mild / Condition, Lineage, Cell class and cell subclass | IL20RA PLEKHS1 STOX1 RSPH1 CLU CGN MAP3K19 ARFGEF3 RP1 SPAG17 | 5.82e-07 | 199 | 281 | 10 | 91308b255783ad4029e5575028c18d7550832c51 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | MYH10 PDGFRA PDGFRB SLIT2 DST COL6A6 SYNE1 AKAP12 MACF1 NEXN | 6.10e-07 | 200 | 281 | 10 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | MYH10 PDGFRA PDGFRB SLIT2 DST COL6A6 SYNE1 AKAP12 MACF1 NEXN | 6.10e-07 | 200 | 281 | 10 | 50ca6550998e461ef26dd670351060bd940765a8 |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | MYH10 PDGFRA PDGFRB SLIT2 DST CACNA1C FAT4 COL6A6 MACF1 NEXN | 6.10e-07 | 200 | 281 | 10 | aa1a35dcca3b799241eef4237f6eb94660e019f0 |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | MYH10 PDGFRA PDGFRB SLIT2 DST CACNA1C FAT4 COL6A6 MACF1 NEXN | 6.10e-07 | 200 | 281 | 10 | a510deaada669e690329183e18df02870bd204b3 |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | MYH10 PDGFRA PDGFRB SLIT2 DST COL6A6 PCDHGB5 AKAP12 MACF1 NEXN | 6.10e-07 | 200 | 281 | 10 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | MYH10 PDGFRB SLIT2 DST COL6A6 PCDHGB5 SYNE1 AKAP12 MACF1 NEXN | 6.10e-07 | 200 | 281 | 10 | 44a68bacdb3d5bf563bd35952176995850933a81 |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | PDGFRA PDGFRB PGR SLIT2 CACNA1C FAT4 ZEB1 COL6A6 SYNE1 AKAP12 | 6.10e-07 | 200 | 281 | 10 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | MYH10 PDGFRB SLIT2 DST COL6A6 PCDHGB5 SYNE1 AKAP12 MACF1 NEXN | 6.10e-07 | 200 | 281 | 10 | dc61016c61729f69649cfb21f6264e685ce83dea |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | MYH10 PDGFRB SLIT2 DST COL6A6 PCDHGB5 SYNE1 AKAP12 MACF1 NEXN | 6.10e-07 | 200 | 281 | 10 | bd8cf33502adea320e91ca2af14e1911d88ad374 |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | MYH10 PDGFRA PDGFRB SLIT2 DST CACNA1C FAT4 COL6A6 MACF1 NEXN | 6.10e-07 | 200 | 281 | 10 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-06 | 176 | 281 | 9 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.14e-06 | 179 | 281 | 9 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 2.24e-06 | 180 | 281 | 9 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | wk_20-22-Mesenchymal-Chondrocyte-intermediate_chondrocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.56e-06 | 183 | 281 | 9 | 1464b5c4425e8776c4aeb4d2b560481d4bf13931 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.58e-06 | 62 | 281 | 6 | a20620a8869721ea62984c2022ee1b484b455824 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.58e-06 | 62 | 281 | 6 | ee694c06bcd924b4ddf744178ba3a99e04eed51b | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 2.80e-06 | 185 | 281 | 9 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Glioblastoma-Primary_GBM-11|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.84e-06 | 63 | 281 | 6 | d7dc1356a60cb527fe668328d5375f352239d911 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.93e-06 | 186 | 281 | 9 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 3.06e-06 | 187 | 281 | 9 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 3.06e-06 | 187 | 281 | 9 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.06e-06 | 187 | 281 | 9 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 3.20e-06 | 188 | 281 | 9 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam_____kidney_distal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-06 | 188 | 281 | 9 | ab6fa1beff91584d9303c2a33735de89aae8d5cd | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.20e-06 | 188 | 281 | 9 | de6f4889e0c5f39fbbaefd85526f645c6afa09d5 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-kidney_distal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-06 | 188 | 281 | 9 | d2d2b6c49448da24f457cedcd213f68841834a99 | |
| ToppCell | COPD-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 3.20e-06 | 188 | 281 | 9 | 186fe1ea328c942910190a4240262c0d8642ea3b | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.34e-06 | 189 | 281 | 9 | 975e7aa3b862a8b07c2ab8426a14f5cc54998aca | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Grp_(Neuron.Slc17a6.Grp)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.41e-06 | 65 | 281 | 6 | b7bc23af54d6d2f7afd584f4df42c24d7c49e344 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Grp_(Neuron.Slc17a6.Grp)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.41e-06 | 65 | 281 | 6 | 3b3630253f5713c4a688c74c4ea0f98c1fe42594 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 3.49e-06 | 190 | 281 | 9 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.49e-06 | 190 | 281 | 9 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 3.64e-06 | 191 | 281 | 9 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.80e-06 | 192 | 281 | 9 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-06 | 194 | 281 | 9 | 8ef0b71fef5b84cfd04973f891215333e7035d1d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.13e-06 | 194 | 281 | 9 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 4.13e-06 | 194 | 281 | 9 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 4.13e-06 | 194 | 281 | 9 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.31e-06 | 195 | 281 | 9 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.49e-06 | 196 | 281 | 9 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 4.49e-06 | 196 | 281 | 9 | 2ce8a787f2731faa913d20342d73041d59468f27 | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 4.49e-06 | 196 | 281 | 9 | 54f4cf778f95a9ff662e5c7520916a25e605bf95 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.68e-06 | 197 | 281 | 9 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.68e-06 | 197 | 281 | 9 | 63b63c6b2f842adb87bc83222ff86796bd9b58f6 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteoblast_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.68e-06 | 197 | 281 | 9 | 2f72fd9a5b6d62c24a95ed2246194ea7458c0f12 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.68e-06 | 197 | 281 | 9 | fb50903b87498b400c8e16e6a561b6d9458e5d97 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.88e-06 | 198 | 281 | 9 | bd42c03e384e64f61b02618cf1a5440033bb04b2 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.88e-06 | 198 | 281 | 9 | 9d61483b0decac2fe90045b3474843360b2c49b3 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.88e-06 | 198 | 281 | 9 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.88e-06 | 198 | 281 | 9 | bc9c9f2c87282b5ef8514773e065d2a6b5dde338 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.08e-06 | 199 | 281 | 9 | 1df69c0cb5f759f6a2152521842506a75bb95cae | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.08e-06 | 199 | 281 | 9 | b1753474152b82a0b811b9878c890a359e14919a | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.08e-06 | 199 | 281 | 9 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 5.08e-06 | 199 | 281 | 9 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | SLK ATAD5 SMC1A TASOR2 CEP350 DST SYNE2 KMT2A ATAD2 RIF1 MACF1 PCM1 | 1.57e-11 | 50 | 174 | 12 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.25e-05 | 49 | 174 | 7 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Neighborhood of BUB3 | PRPF31 SMC1A MRPS27 SAFB LYPLA1 HAX1 VDAC1 NSD2 CHAF1A CAPZA1 ICE1 LMNB2 MTDH HCFC1 | 1.61e-04 | 277 | 174 | 14 | MORF_BUB3 |
| Drug | formycin triphosphate | 9.98e-09 | 51 | 277 | 9 | CID000122274 | |
| Drug | purealin | 3.24e-08 | 58 | 277 | 9 | CID006419303 | |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | SECISBP2L SOX4 SOX9 NCOA3 MYH10 ZMYM2 CEP350 SLIT2 KMT2A ZEB1 AGGF1 DESI2 FAM169A SMARCC1 | 8.17e-08 | 188 | 277 | 14 | 6735_DN |
| Drug | geldanamycin | NR2C2 C5orf22 SMC1A MCAM PGR DST KMT2A ATP11C DMD EHBP1 ICE2 FRYL LARP1B RFX7 MIER1 RESF1 ERCC6L2 PCM1 TP53BP1 | 1.65e-07 | 371 | 277 | 19 | ctd:C001277 |
| Drug | pazopanib | 1.90e-07 | 12 | 277 | 5 | ctd:C516667 | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | SECISBP2L SOX4 SOX9 NCOA3 MYH10 SLIT2 KMT2A EHBP1 FNDC3B ZEB1 ANK3 DESI2 SMARCC1 | 3.19e-07 | 179 | 277 | 13 | 4585_DN |
| Drug | fast white | 6.86e-07 | 42 | 277 | 7 | CID000024008 | |
| Drug | plakin | 6.92e-07 | 82 | 277 | 9 | CID000018752 | |
| Drug | clenbuterol | 1.38e-06 | 142 | 277 | 11 | CID000002783 | |
| Drug | blebbistatin | 1.59e-06 | 116 | 277 | 10 | CID003476986 | |
| Drug | B0683 | 1.72e-06 | 117 | 277 | 10 | CID006398969 | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | SOX4 SOX9 MYH10 PHF20 CEP350 KMT2A FNDC3B CHAF1A KTN1 DESI2 BAZ1A MTDH | 1.89e-06 | 177 | 277 | 12 | 985_DN |
| Drug | AC1N9ZZC | 2.22e-06 | 149 | 277 | 11 | CID004369374 | |
| Drug | S-(-)-Etomoxir | 3.71e-06 | 100 | 277 | 9 | CID000060765 | |
| Drug | AC1LADJ6 | 4.46e-06 | 130 | 277 | 10 | CID000486032 | |
| Drug | AC1NRBPQ | 7.13e-06 | 137 | 277 | 10 | CID005288569 | |
| Drug | SM-2 | 1.10e-05 | 87 | 277 | 8 | CID000486033 | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | SECISBP2L SOX4 MYH10 CEP350 SLIT2 KMT2A EHBP1 AGGF1 DESI2 BAZ1A SMARCC1 | 1.23e-05 | 178 | 277 | 11 | 3998_DN |
| Drug | oxovanadium | 1.65e-05 | 120 | 277 | 9 | CID000024411 | |
| Drug | torcetrapib | NCOA3 SMC1A HSPH1 ITPR2 DST KMT2A EHBP1 CACNA1C MYOT ANK3 RIF1 SMARCC1 EDRF1 PCM1 TP53BP1 | 2.14e-05 | 342 | 277 | 15 | ctd:C483909 |
| Drug | Dichlorodiphenyl Dichloroethylene | PDGFRA PDGFRB UNC5B CHGA DDIT3 PGR BRCA1 CLU DMP1 CACNA1C DPYD CAMK2B ARFGEF2 RDX | 2.20e-05 | 302 | 277 | 14 | ctd:D003633 |
| Drug | nocodazole | MYH1 MYH2 SYNRG MYH4 MYH6 MYH8 MYH9 MYH10 MYH13 EVPL CEP350 NEK3 ARFGEF2 ARFGEF1 LMNB2 AKAP12 LATS1 PCM1 | 2.47e-05 | 477 | 277 | 18 | CID000004122 |
| Drug | Fluorocurarine chloride [22273-09-2]; Up 200; 11.6uM; MCF7; HT_HG-U133A | SECISBP2L SMC1A PLEKHS1 ITPR2 NEK3 CAMK2B ARFGEF2 DESI2 AKAP12 MICALL1 RPGR | 3.15e-05 | 197 | 277 | 11 | 6219_UP |
| Drug | Quipazine dimaleate salt [4774-24-7]; Down 200; 9uM; MCF7; HT_HG-U133A | RALGAPA1 HIP1 PHF20 SLIT2 CACTIN CLCN6 KMT2A ZSCAN2 HCFC1 EDRF1 PCM1 | 3.15e-05 | 197 | 277 | 11 | 2782_DN |
| Drug | Tetracycline hydrochloride [64-75-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A | KIAA0319L SLIT2 STX1A NOD1 ZNF394 DNAJC28 PEX5 KMT2A KCNS1 ECPAS CD80 | 3.46e-05 | 199 | 277 | 11 | 2243_DN |
| Drug | 1,3-bis(diphenylphosphino)propane | 3.47e-05 | 6 | 277 | 3 | CID000081219 | |
| Drug | sulfur monochloride | 3.47e-05 | 6 | 277 | 3 | CID000024807 | |
| Drug | AC1LA6KT | 3.49e-05 | 51 | 277 | 6 | CID000508110 | |
| Drug | phenethyl isothiocyanate | ERCC5 ATAD5 UNC5B HSPH1 DDIT3 FANCD2 SAFB DST CLU SEC16A ANAPC4 PARP8 KTN1 NCOR1 CLSPN PCM1 | 3.61e-05 | 401 | 277 | 16 | ctd:C058305 |
| Drug | Perhexiline maleate [6724-53-4]; Up 200; 10.2uM; MCF7; HT_HG-U133A | SOX9 HIVEP1 PHF20 FRMD4B DDIT3 SPTBN5 CLCN6 IBSP HCFC1 EDRF1 | 4.64e-05 | 170 | 277 | 10 | 5501_UP |
| Drug | NSC339663 | MYH1 MYH2 MYH4 MYH6 MYH8 MYH9 MYH10 MYH13 MYO9A EVPL SYNE2 SYNE1 | 6.08e-05 | 250 | 277 | 12 | CID000003892 |
| Drug | K-Cl | ERVK-6 MYH1 MYH2 MYH4 MYH6 MYH8 MYH9 MYH10 MYH13 MYO9A MARK3 PGR SAFB CGN VDAC1 SLC12A6 CACNA1C ZEB1 CAMK2B | 7.31e-05 | 567 | 277 | 19 | CID000004873 |
| Drug | candesartan cilexetil | 7.36e-05 | 145 | 277 | 9 | CID000002540 | |
| Drug | Sunitinib | 9.54e-05 | 8 | 277 | 3 | DB01268 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | SECISBP2L SOX9 PRPF31 HSPH1 ZMYM2 KMT2A EHBP1 FNDC3B RDX SMARCC1 | 1.03e-04 | 187 | 277 | 10 | 4302_DN |
| Drug | 4-aminoquinoline | 1.09e-04 | 21 | 277 | 4 | CID000068476 | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.13e-04 | 189 | 277 | 10 | 1045_DN | |
| Drug | Spermine | 1.17e-04 | 63 | 277 | 6 | ctd:D013096 | |
| Drug | Deltaline [6836-11-9]; Down 200; 7.8uM; PC3; HT_HG-U133A | SECISBP2L RALGAPA1 MYH10 ATAD5 ZMYM2 ALMS1 EHBP1 MICALL1 SMARCC1 PCM1 | 1.18e-04 | 190 | 277 | 10 | 4306_DN |
| Drug | Oxyphenbutazone [129-20-4]; Up 200; 12.4uM; MCF7; HT_HG-U133A | SOX9 HSPH1 NAP1L2 DDIT3 CLU ZSCAN2 TRAPPC9 ZEB1 RIF1 ARHGAP45 | 1.18e-04 | 190 | 277 | 10 | 6844_UP |
| Drug | procymidone | 1.23e-04 | 155 | 277 | 9 | ctd:C035988 | |
| Drug | Pempidine tartrate [546-48-5]; Down 200; 13uM; MCF7; HT_HG-U133A | CDHR2 ZMYM2 MDM4 FRMD4B DNAJC28 KMT2A EHBP1 AGGF1 SMARCC1 PCM1 | 1.23e-04 | 191 | 277 | 10 | 3926_DN |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A | 1.23e-04 | 191 | 277 | 10 | 4168_DN | |
| Drug | Astemizole [68844-77-9]; Down 200; 8.8uM; HL60; HG-U133A | C5orf22 ATAD5 SAFB PEX5 KMT2A KCNS1 TRAPPC9 CBFA2T3 SMARCC1 ZNF654 | 1.28e-04 | 192 | 277 | 10 | 1365_DN |
| Drug | Pronethalol hydrochloride [51-02-5]; Down 200; 15uM; MCF7; HT_HG-U133A | CUL7 KMT2A KCNS1 EHBP1 FKBP15 AGGF1 RFX7 MICALL1 SMARCC1 PCM1 | 1.28e-04 | 192 | 277 | 10 | 4104_DN |
| Drug | 2bq7 | 1.34e-04 | 123 | 277 | 8 | CID006540267 | |
| Drug | creatine | 1.34e-04 | 193 | 277 | 10 | CID000000586 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A | HIVEP1 KIAA0319L PFAS CACTIN DSPP LMNB2 ECPAS MICALL1 MLH3 BAZ1A | 1.40e-04 | 194 | 277 | 10 | 2523_DN |
| Drug | Gabexate mesilate [56974-61-9]; Down 200; 9.6uM; PC3; HT_HG-U133A | 1.46e-04 | 195 | 277 | 10 | 4220_DN | |
| Drug | Chelidonine monohydrate (+) [476-32-4]; Up 200; 10.8uM; PC3; HT_HG-U133A | CDHR2 ATAD5 SMC1A KIAA0319L CUL7 FRMD4B CLU FAM204A TENM3 EIF4G3 | 1.46e-04 | 195 | 277 | 10 | 5760_UP |
| Drug | Amodiaquin dihydrochloride dihydrate [6398-98-7]; Up 200; 8.6uM; MCF7; HT_HG-U133A | ZMYM2 STX1A APOBEC2 CAMK2B ARFGEF2 RIF1 FAM169A RPGR EDRF1 PCM1 | 1.46e-04 | 195 | 277 | 10 | 6224_UP |
| Drug | Bambuterol hydrochloride [81732-46-9]; Up 200; 10uM; PC3; HT_HG-U133A | RALGAPA1 CDHR2 DDIT3 PGR SPTBN5 CACTIN CLCN6 IBSP DESI2 SCIN | 1.46e-04 | 195 | 277 | 10 | 5885_UP |
| Drug | Chlorambucil [305-03-3]; Down 200; 13.2uM; MCF7; HT_HG-U133A | RALGAPA1 PHF20 KIAA0319L PLEKHS1 CACTIN ALMS1 KMT2A SLC12A6 FKBP15 CAMK2B | 1.46e-04 | 195 | 277 | 10 | 4345_DN |
| Drug | Tolmetin sodium salt dihydrate [64490-92-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A | HIP1 MYH10 SMC1A KIAA0319L MDM4 NOD1 KRT83 DESI2 LATS1 FAM169A | 1.46e-04 | 195 | 277 | 10 | 4167_DN |
| Drug | melicopicine | 1.47e-04 | 2 | 277 | 2 | CID000101253 | |
| Drug | 5,7-Dmpq | 1.47e-04 | 2 | 277 | 2 | CID000003139 | |
| Drug | 3-pyridyl)urea | 1.47e-04 | 2 | 277 | 2 | CID000202697 | |
| Drug | bis(hydroxymethyl)nitramine | 1.47e-04 | 2 | 277 | 2 | CID009543151 | |
| Drug | isocurcumenol | 1.47e-04 | 2 | 277 | 2 | CID005255901 | |
| Drug | tebuquine | 1.47e-04 | 2 | 277 | 2 | CID000071991 | |
| Drug | diethyl acetylenedicarboxylate | 1.47e-04 | 2 | 277 | 2 | CID000069803 | |
| Drug | 3,5-di-O-galloylquinic acid | 1.47e-04 | 2 | 277 | 2 | CID000460896 | |
| Drug | 4-nitrophenylurea | 1.47e-04 | 2 | 277 | 2 | CID000313520 | |
| Drug | Josamycin [16846-24-5]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 1.52e-04 | 196 | 277 | 10 | 5692_UP | |
| Drug | Proscillaridin A [466-06-8]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 1.56e-04 | 160 | 277 | 9 | 4404_UP | |
| Drug | Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Down 200; 6.4uM; MCF7; HT_HG-U133A | SECISBP2L RALGAPA1 MDM4 ITPR2 CEP350 STX1A FKBP15 CILP SIRT2 CD80 | 1.58e-04 | 197 | 277 | 10 | 2259_DN |
| Drug | Betulin [473-98-3]; Up 200; 9uM; MCF7; HT_HG-U133A | 1.58e-04 | 197 | 277 | 10 | 3513_UP | |
| Drug | carvedilol | 1.64e-04 | 161 | 277 | 9 | CID000002585 | |
| Drug | Methyldopa (L,-) [555-30-6]; Down 200; 19uM; HL60; HG-U133A | SOX4 PRPF31 ATAD5 GTF3C4 ZEB1 ARFGEF2 ARFGEF1 NCOR1 RESF1 SMARCC1 | 1.65e-04 | 198 | 277 | 10 | 1619_DN |
| Drug | Epivincamine [6835-99-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.65e-04 | 198 | 277 | 10 | 6838_DN | |
| Drug | Ketorolac tromethamine [74103-07-4]; Down 200; 10.6uM; MCF7; HT_HG-U133A | UNC5B SAFB DNAJC28 BRCA1 KCNS1 C5 TRAPPC9 MICALL1 MLH3 TENM3 | 1.65e-04 | 198 | 277 | 10 | 6489_DN |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.65e-04 | 198 | 277 | 10 | 4348_DN | |
| Drug | Flunixin meglumine [42461-84-7]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 1.65e-04 | 198 | 277 | 10 | 4735_DN | |
| Drug | Flucytosine [2022-85-7]; Up 200; 31uM; HL60; HT_HG-U133A | 1.72e-04 | 199 | 277 | 10 | 3073_UP | |
| Drug | Pyrilamine maleate [59-33-6]; Down 200; 10uM; HL60; HG-U133A | PRPF31 HIP1 DDIT3 CEP350 CACTIN KMT2A PTGES2 NCOR1 MLH3 SMARCC1 | 1.72e-04 | 199 | 277 | 10 | 1568_DN |
| Drug | Graveoline [485-61-0]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 1.79e-04 | 200 | 277 | 10 | 6034_DN | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 9.88e-11 | 10 | 264 | 6 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 9.88e-11 | 10 | 264 | 6 | DOID:0111596 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 9.88e-11 | 10 | 264 | 6 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 9.88e-11 | 10 | 264 | 6 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 9.88e-11 | 10 | 264 | 6 | DOID:0111605 (implicated_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 9.88e-11 | 10 | 264 | 6 | DOID:0111269 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 9.88e-11 | 10 | 264 | 6 | DOID:0110454 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 9.88e-11 | 10 | 264 | 6 | DOID:0080326 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 4.28e-10 | 12 | 264 | 6 | DOID:2106 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 4.28e-10 | 12 | 264 | 6 | DOID:11720 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 7.89e-10 | 13 | 264 | 6 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 2.27e-09 | 15 | 264 | 6 | DOID:0050646 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | NCOA3 MYH1 MYH9 MDM4 DDIT3 PGR BRCA1 SYNE2 NHS KDR DMD PLEKHA8 AKAP6 EHBP1 FNDC3B DPYD ZEB1 NSD2 SYNE1 IBSP KTN1 UBR4 ARFGEF2 AKAP12 MICALL1 NCOR1 RIF1 SLC6A5 MACF1 CLSPN MTDH TP53BP1 | 2.94e-09 | 1074 | 264 | 32 | C0006142 |
| Disease | Colorectal Carcinoma | DDIT3 ABCB4 CABYR ATP11C KDR DMD KDF1 ANAPC4 AKAP6 DPYD MYOT SYNE1 PARP8 ARFGEF1 LMNB2 CBFA2T3 AKAP12 MLH3 DCHS1 SPAG17 MTDH EDRF1 SMAD2 | 1.06e-07 | 702 | 264 | 23 | C0009402 |
| Disease | myopathy (implicated_via_orthology) | 2.28e-07 | 48 | 264 | 7 | DOID:423 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 6.14e-07 | 80 | 264 | 8 | DOID:12930 (implicated_via_orthology) | |
| Disease | monilethrix (is_implicated_in) | 7.08e-07 | 3 | 264 | 3 | DOID:0050472 (is_implicated_in) | |
| Disease | Heterotopia, Periventricular, Autosomal Recessive | 7.08e-07 | 3 | 264 | 3 | C1842563 | |
| Disease | MONILETHRIX | 7.08e-07 | 3 | 264 | 3 | 158000 | |
| Disease | Beaded hair | 7.08e-07 | 3 | 264 | 3 | cv:C0546966 | |
| Disease | breast carcinoma (is_marker_for) | 2.10e-06 | 66 | 264 | 7 | DOID:3459 (is_marker_for) | |
| Disease | Monilethrix | 2.81e-06 | 4 | 264 | 3 | C0546966 | |
| Disease | Intellectual Disability | SOX4 RALGAPA1 SOX9 FRMPD4 PDGFRB ZMYM2 BRCA1 CCDC47 AKAP6 NSD2 CAMK2B SYNE1 CHAMP1 MACF1 CTNNA2 PHACTR1 | 3.21e-06 | 447 | 264 | 16 | C3714756 |
| Disease | vital capacity | NCOA3 MYH2 ATAD5 UNC5B RIOK3 UNC13D MDM4 TENM2 STX1B MELTF DST GABPB2 KDR MICAL3 HAX1 ANAPC4 PPP1R21 EHBP1 DSPP CAMK2B SYNE1 ARFGEF2 PCDHA13 POM121L2 CHAMP1 NCOR1 CTNNA2 | 1.95e-05 | 1236 | 264 | 27 | EFO_0004312 |
| Disease | Mammary Carcinoma, Human | NCOA3 MYH9 MDM4 DDIT3 PGR BRCA1 KDR DPYD ZEB1 NSD2 SYNE1 IBSP AKAP12 NCOR1 MTDH TP53BP1 | 2.36e-05 | 525 | 264 | 16 | C4704874 |
| Disease | Mammary Neoplasms, Human | NCOA3 MYH9 MDM4 DDIT3 PGR BRCA1 KDR DPYD ZEB1 NSD2 SYNE1 IBSP AKAP12 NCOR1 MTDH TP53BP1 | 2.36e-05 | 525 | 264 | 16 | C1257931 |
| Disease | Mammary Neoplasms | NCOA3 MYH9 MDM4 DDIT3 PGR BRCA1 KDR DPYD ZEB1 NSD2 SYNE1 IBSP AKAP12 NCOR1 MTDH TP53BP1 | 2.47e-05 | 527 | 264 | 16 | C1458155 |
| Disease | Breast Carcinoma | NCOA3 MYH9 MDM4 DDIT3 PGR BRCA1 KDR DPYD ZEB1 NSD2 SYNE1 IBSP AKAP12 NCOR1 MTDH TP53BP1 | 3.16e-05 | 538 | 264 | 16 | C0678222 |
| Disease | forced expiratory volume | ATAD5 CCDC126 RIOK3 MDM4 STX1B ITPK1 DST KDR MICAL3 PCDH10 PREX1 ANAPC4 SYNE1 ARFGEF2 POM121L2 ANKRD13A NCOR1 ARHGAP12 ERCC6L2 NEXN | 3.26e-05 | 789 | 264 | 20 | EFO_0004314 |
| Disease | cardiomyopathy (implicated_via_orthology) | 4.27e-05 | 71 | 264 | 6 | DOID:0050700 (implicated_via_orthology) | |
| Disease | mean corpuscular hemoglobin concentration | MYH2 SLK MARK3 PFAS FRMD4B ITPR2 NEO1 CLCN6 SEC16A HAX1 PREX1 ARHGAP21 PPP1R21 FNDC3B POTEF ARFGEF2 RFC1 RIF1 BAZ1A MACF1 CLSPN EIF4G3 MTDH ZNF654 | 6.30e-05 | 1105 | 264 | 24 | EFO_0004528 |
| Disease | cortical thickness | MARK3 POLR2M STOX1 TENM2 FRMD4B SLIT2 NEO1 PKD1 KMT2A MICAL3 ARHGAP21 AKAP6 EHBP1 CHAF1A CAPZA1 ARFGEF2 RAB44 MICALL1 THADA BAZ1A UTP4 ARHGAP12 MACF1 EIF4G3 | 7.04e-05 | 1113 | 264 | 24 | EFO_0004840 |
| Disease | coronary artery disease | CAAP1 SLK MARK3 UNC13D ITPK1 FNDC1 MICB C5 KDF1 PREX1 ARHGAP21 EHBP1 FNDC3B DPYD FAT4 ZEB1 PARP8 ARFGEF2 LMNB2 AKAP12 THADA RP1 SEC63 SMAD2 PHACTR1 | 7.90e-05 | 1194 | 264 | 25 | EFO_0001645 |
| Disease | Van Maldergem Wetzburger Verloes syndrome | 7.97e-05 | 2 | 264 | 2 | C1832390 | |
| Disease | Van Maldergem syndrome | 7.97e-05 | 2 | 264 | 2 | cv:C1832390 | |
| Disease | Growth Deficiency and Mental Retardation with Facial Dysmorphism | 7.97e-05 | 2 | 264 | 2 | C1854630 | |
| Disease | Periventricular gray matter heterotopia | 7.97e-05 | 2 | 264 | 2 | C1849173 | |
| Disease | hair disease (is_implicated_in) | 7.97e-05 | 2 | 264 | 2 | DOID:421 (is_implicated_in) | |
| Disease | periodontal disease (implicated_via_orthology) | 7.97e-05 | 2 | 264 | 2 | DOID:3388 (implicated_via_orthology) | |
| Disease | mean reticulocyte volume | MYH9 MARK3 ABCB4 CEP350 SAFB NOD1 CLCN6 PREX1 ARHGAP21 TRAPPC9 CHAF1A BCAS1 RFC1 CBFA2T3 THADA IFT52 RESF1 HELZ2 PCM1 | 1.19e-04 | 799 | 264 | 19 | EFO_0010701 |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 1.47e-04 | 12 | 264 | 3 | DOID:11726 (implicated_via_orthology) | |
| Disease | chromogranin-A measurement | 2.38e-04 | 3 | 264 | 2 | EFO_0022021 | |
| Disease | prostate adenocarcinoma (biomarker_via_orthology) | 2.38e-04 | 3 | 264 | 2 | DOID:2526 (biomarker_via_orthology) | |
| Disease | cholestasis (is_implicated_in) | 2.38e-04 | 3 | 264 | 2 | DOID:13580 (is_implicated_in) | |
| Disease | Growth delay | 2.38e-04 | 3 | 264 | 2 | C0456070 | |
| Disease | cleft lip | IL20RA CCDC168 DST BRCA1 AKAP6 EHBP1 SYNE1 ICE1 THADA ERCC6L2 | 2.61e-04 | 284 | 264 | 10 | EFO_0003959 |
| Disease | arthrogryposis multiplex congenita (is_implicated_in) | 4.73e-04 | 4 | 264 | 2 | DOID:0080954 (is_implicated_in) | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 4.73e-04 | 4 | 264 | 2 | cv:CN293514 | |
| Disease | Adenocarcinoma | 6.32e-04 | 116 | 264 | 6 | C0001418 | |
| Disease | Carcinoma, Granular Cell | 6.32e-04 | 116 | 264 | 6 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 6.32e-04 | 116 | 264 | 6 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 6.32e-04 | 116 | 264 | 6 | C0205642 | |
| Disease | Carcinoma, Cribriform | 6.32e-04 | 116 | 264 | 6 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 6.32e-04 | 116 | 264 | 6 | C0205641 | |
| Disease | Cerebellar Ataxia | 7.83e-04 | 5 | 264 | 2 | C0007758 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 7.83e-04 | 5 | 264 | 2 | C0410190 | |
| Disease | oligohydramnios (biomarker_via_orthology) | 7.83e-04 | 5 | 264 | 2 | DOID:12215 (biomarker_via_orthology) | |
| Disease | PEROXISOME BIOGENESIS DISORDER 3B | 7.83e-04 | 5 | 264 | 2 | C3550693 | |
| Disease | Fuchs Endothelial Dystrophy | 7.83e-04 | 5 | 264 | 2 | C0016781 | |
| Disease | Corneal dystrophy | 7.83e-04 | 5 | 264 | 2 | cv:C0010036 | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 7.83e-04 | 5 | 264 | 2 | C1450051 | |
| Disease | neurilemmoma (is_marker_for) | 7.83e-04 | 5 | 264 | 2 | DOID:3192 (is_marker_for) | |
| Disease | hormone measurement, progesterone measurement | 7.83e-04 | 5 | 264 | 2 | EFO_0004730, EFO_0007004 | |
| Disease | PEROXISOME BIOGENESIS DISORDER 2B | 7.83e-04 | 5 | 264 | 2 | C3550234 | |
| Disease | Polycystic Kidney - body part | 7.83e-04 | 5 | 264 | 2 | C1567435 | |
| Disease | Corneal endothelial dystrophy | 7.83e-04 | 5 | 264 | 2 | cv:C5441823 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 9.19e-04 | 222 | 264 | 8 | EFO_0008317, EFO_0020943 | |
| Disease | blood pressure | 9.61e-04 | 22 | 264 | 3 | EFO_0004325 | |
| Disease | age at menarche | HIP1 DNAJC6 TENM2 DST ALMS1 BRCA1 GABPB2 ANAPC4 FNDC3B DPYD ECPAS CFAP61 EIF4G3 SMAD2 | 1.01e-03 | 594 | 264 | 14 | EFO_0004703 |
| Disease | Schizophrenia | PDGFRB CHGA STX1A BRCA1 CLU PIK3C3 MICB KMT2A KDR CACNA1C DPYD MCHR1 ANK3 CAMK2B ERVK-8 SLC6A5 CTNNA2 PCM1 | 1.08e-03 | 883 | 264 | 18 | C0036341 |
| Disease | Emery-Dreifuss muscular dystrophy | 1.17e-03 | 6 | 264 | 2 | cv:C0410189 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 1.17e-03 | 6 | 264 | 2 | C0410189 | |
| Disease | inclusion body myositis (is_implicated_in) | 1.17e-03 | 6 | 264 | 2 | DOID:3429 (is_implicated_in) | |
| Disease | Polycystic Kidney Diseases | 1.17e-03 | 6 | 264 | 2 | C0022680 | |
| Disease | Pathologic Neovascularization | 1.17e-03 | 6 | 264 | 2 | C0027686 | |
| Disease | Lissencephaly | 1.17e-03 | 6 | 264 | 2 | C0266463 | |
| Disease | Fuchs' endothelial dystrophy (is_implicated_in) | 1.17e-03 | 6 | 264 | 2 | DOID:11555 (is_implicated_in) | |
| Disease | plasminogen activator inhibitor 1 measurement | 1.39e-03 | 54 | 264 | 4 | EFO_0004792 | |
| Disease | blood rubidium measurement | 1.58e-03 | 26 | 264 | 3 | EFO_0021529 | |
| Disease | unipolar depression, depressive symptom measurement | 1.58e-03 | 26 | 264 | 3 | EFO_0003761, EFO_0007006 | |
| Disease | Acute monocytic leukemia | 1.58e-03 | 26 | 264 | 3 | C0023465 | |
| Disease | Dengue Hemorrhagic Fever | 1.63e-03 | 7 | 264 | 2 | EFO_0004227 | |
| Disease | arabitol measurement | 1.63e-03 | 7 | 264 | 2 | EFO_0800148 | |
| Disease | polycystic liver disease (implicated_via_orthology) | 1.63e-03 | 7 | 264 | 2 | DOID:0050770 (implicated_via_orthology) | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 1.63e-03 | 7 | 264 | 2 | C0751337 | |
| Disease | prostatic hypertrophy (biomarker_via_orthology) | 1.63e-03 | 7 | 264 | 2 | DOID:11132 (biomarker_via_orthology) | |
| Disease | melanoma | 1.85e-03 | 248 | 264 | 8 | C0025202 | |
| Disease | sciatic neuropathy (biomarker_via_orthology) | 1.99e-03 | 99 | 264 | 5 | DOID:11446 (biomarker_via_orthology) | |
| Disease | atrial fibrillation | MYH6 POLR2M CHGA FAM13B FRMD4B ITPR2 SYNE2 ARHGAP21 AKAP6 PCM1 | 2.00e-03 | 371 | 264 | 10 | EFO_0000275 |
| Disease | peroxisomal biogenesis disorder (implicated_via_orthology) | 2.15e-03 | 8 | 264 | 2 | DOID:0080377 (implicated_via_orthology) | |
| Disease | Leydig cell tumor (is_marker_for) | 2.15e-03 | 8 | 264 | 2 | DOID:2696 (is_marker_for) | |
| Disease | Cornelia De Lange Syndrome | 2.15e-03 | 8 | 264 | 2 | C0270972 | |
| Disease | cervical cancer (is_implicated_in) | 2.40e-03 | 30 | 264 | 3 | DOID:4362 (is_implicated_in) | |
| Disease | Mental deterioration | 2.75e-03 | 9 | 264 | 2 | C0234985 | |
| Disease | Mild cognitive disorder | 2.75e-03 | 9 | 264 | 2 | C1270972 | |
| Disease | gallbladder neoplasm | 2.75e-03 | 9 | 264 | 2 | EFO_0004606 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 40 | 2.75e-03 | 9 | 264 | 2 | C4225275 | |
| Disease | uveal melanoma (is_marker_for) | 2.75e-03 | 9 | 264 | 2 | DOID:6039 (is_marker_for) | |
| Disease | unipolar depression, bipolar disorder | 2.88e-03 | 156 | 264 | 6 | EFO_0003761, MONDO_0004985 | |
| Disease | Mental Retardation, X-Linked 1 | 2.90e-03 | 32 | 264 | 3 | C2931498 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NTDNTLGTEITVEDQ | 76 | P21796 | |
| TVNNDDSDLLDSQVQ | 326 | O95429 | |
| TETIRGIDSDDVQDN | 606 | Q96QE3 | |
| GIDSDDVQDNSQLKA | 611 | Q96QE3 | |
| ESGIVNSDNIEKNTD | 26 | P0CF97 | |
| SEEALTAVQSGNVSE | 326 | Q8NHU2 | |
| LRSQAEDGETVTNVN | 206 | Q4G0S4 | |
| LSESEAENQQAGAAA | 776 | Q9UJX5 | |
| QLSTINGVAEQDELS | 61 | Q02952 | |
| AENEQTEADQATAAE | 291 | Q9Y6D6 | |
| DVQDSLTVSNEAQTA | 211 | P52907 | |
| GQLTTANVIDREEQS | 846 | Q6V0I7 | |
| FNVTDADDGINSQLT | 1966 | Q6V0I7 | |
| ETTVTINIVDSNDNA | 2966 | Q6V0I7 | |
| IQTTQLGEEEEANTS | 466 | Q96PJ5 | |
| VDENSQTNGIADDRQ | 331 | Q9Y6D5 | |
| EQGNNEETISSVDEL | 316 | Q8TCU4 | |
| NENADASVQVLITGD | 3356 | Q8TCU4 | |
| VTELSDQQDQAIETS | 121 | Q8N302 | |
| DVVGLANTTVESVND | 481 | Q12882 | |
| VAGSNNSTDNEDEII | 186 | Q9NZW4 | |
| IVSDNTGQEESGENS | 426 | O75952 | |
| DIQRTDEETTDNQEG | 226 | Q6PL18 | |
| GNTGESSVEENEKQQ | 1216 | Q6PL18 | |
| ENTVQSEAGQIDDLE | 281 | Q9H8G2 | |
| ADQQELGEEISTAIS | 96 | P59074 | |
| AQNATGQAEDLAEVS | 321 | Q8IYM0 | |
| LSAEDTLQAQGEISN | 356 | P11532 | |
| GQSTVIIDLTEDSNE | 111 | Q13111 | |
| LENGEELNAINTTVS | 176 | P33681 | |
| DEATLENSGLNLQED | 21 | Q9H8W3 | |
| QSSVSQELQDELEEA | 156 | Q9BSY9 | |
| TEAASQNGEDLENLD | 11 | Q9Y235 | |
| EDEQRNSTADISIGE | 691 | Q9NRL2 | |
| QQAEQLAAETEGISE | 11 | Q8N1F7 | |
| NLSESLNNGDTSEIQ | 286 | P49116 | |
| NRKELSESSQEEAGN | 6 | Q9ULW6 | |
| GQDLSSEQSEQSVEA | 686 | Q7Z6P3 | |
| SNEGDSEQNEIRSLQ | 2636 | Q14571 | |
| RAEQIEDINNTGTES | 146 | Q0ZGT2 | |
| KQLSEEQNTGISQDE | 441 | H3BUK9 | |
| ENNAEASAELSNEGV | 491 | P35241 | |
| ESVSQNVEGTQADSA | 436 | Q8IZ07 | |
| VGTSVASAEQDELSQ | 176 | Q7LBR1 | |
| VENEEQDSQNEGSTD | 201 | Q6ZW49 | |
| SSDVEIRNEENNSGL | 66 | P16234 | |
| SDQGEVESTQGDSVN | 1451 | P51610 | |
| EQNIDVSSQDLSGQT | 326 | A5A3E0 | |
| SATVSVALQDVNDNE | 561 | Q96JQ0 | |
| QTGQSEALEEENDET | 211 | Q96EY7 | |
| KENGEESRQNSTVEE | 111 | Q8N3A8 | |
| EEEEESSEAGNQRLQ | 1011 | Q7RTP6 | |
| TDVILEADQNDSQSL | 61 | Q13572 | |
| TREDNDLDSQVSQEG | 181 | O00165 | |
| EQQQSEASLEVASGS | 1056 | Q92619 | |
| ESADQAVAELNGTQV | 306 | P18615 | |
| GEQLDNLSEQRTDTE | 411 | O15151 | |
| SDEDDQNTGSEIKNR | 1111 | O95835 | |
| QGDEDSALILTQDNL | 596 | Q9Y216 | |
| SVGNDVDVVSDSENI | 116 | Q3B7T1 | |
| DGVQLENANSSVATV | 641 | Q8IZA0 | |
| GVNETENEDNTNRDS | 2201 | Q03001 | |
| LETDVDGQVGTTQEN | 3831 | Q03001 | |
| QQASASGSVSIEEID | 466 | Q03252 | |
| LEAAVAQSEQQGEAA | 346 | O43790 | |
| AVQVQSSLENSESDV | 806 | Q9NYF5 | |
| DTDKNVQQDNSEAGT | 526 | Q92598 | |
| ETTVELEGQDENQEG | 66 | Q96A33 | |
| DQEELIQSATETIGS | 786 | Q5VYK3 | |
| QLQVQSEADSLADAE | 891 | P13535 | |
| VDVQTSLQANTEATE | 1816 | Q15154 | |
| EVEESNGVTTNLSLQ | 771 | Q9UHC1 | |
| LGQEQSSEQLDLEEI | 6 | A8MYZ0 | |
| VSQGEISVASIDDQE | 316 | Q9UKX2 | |
| GTTQAENEQELLAIS | 376 | P50542 | |
| LDLEQALSSEGTQEN | 636 | Q14999 | |
| LLSQEQSVNQLEDDG | 276 | Q92817 | |
| NEDLEVGDQQTSLIS | 2386 | O94915 | |
| DSAADVSQSEENGQK | 146 | O96028 | |
| TDQAAAEQLSLVQAE | 786 | Q5T1M5 | |
| VIEQTNASQSKGEEE | 106 | Q9NX36 | |
| QSSTVDSQDEQNGDV | 876 | P63132 | |
| TQNELNDEVAESLAE | 876 | Q9Y239 | |
| GTIDAEQLSDTDSVQ | 451 | O94854 | |
| EEELGQLQTQASDTS | 251 | Q8N1N4 | |
| EIQNGNLHESDSESV | 66 | Q86UP2 | |
| AVAQSEQQGEAALSD | 181 | A6NCN2 | |
| SQDSRQVENGGTEEV | 396 | Q8N3F8 | |
| RETSQEGQSADLESQ | 501 | Q96KK3 | |
| ADSVAELGEQIDNLQ | 1201 | P12882 | |
| DSTDLSDQIAELQAQ | 1056 | P35579 | |
| QEGATAAETEEQEIS | 196 | P59047 | |
| DGELFLSQNLETQES | 136 | Q29980 | |
| SEENTDDNITVQGEI | 256 | Q96JA3 | |
| VLQVSATDQDEGINS | 261 | Q9Y5G0 | |
| SVTDRDSEENGQVQC | 381 | Q9P2E7 | |
| AQENAAVSNTAGQDE | 616 | Q6ZMI0 | |
| ADEATTQKQSGEDNQ | 26 | Q01523 | |
| SKENLSQEESQNVDG | 321 | Q13316 | |
| DALTVINQQEDSSES | 541 | O75081 | |
| QSSTVDSQDEQNGDV | 876 | Q9BXR3 | |
| EQELSLQEEVSTQGT | 416 | Q9UHF4 | |
| ALGNEASTVQEEEQD | 301 | P51956 | |
| SSTINNQAVETDEGI | 571 | Q8IWW6 | |
| SAVGELSEDSSNVVQ | 366 | P26010 | |
| QTSGSQIQSEEFELN | 631 | P21439 | |
| TVSAQDADAQENALV | 476 | Q9Y5I0 | |
| ISNEEDSLENGQSLS | 171 | Q9C0D0 | |
| EQNVDVSSQDLSGQT | 326 | A0JP26 | |
| SEEQNTGISQDEILT | 481 | A0JP26 | |
| EQNIDVSSQDLSGQT | 326 | Q6S8J3 | |
| DEKTQDQQSLSDVEG | 71 | P06401 | |
| DSLSDQEGSFQELLQ | 346 | Q4G163 | |
| QVLLNEEDNSESSAI | 106 | Q9NV92 | |
| SSINEIGSSDENIQA | 1056 | P38398 | |
| TDGNQLEDNLESSEQ | 1006 | Q9Y2L6 | |
| EEEGNVSVTIQAHDN | 596 | Q9BYE9 | |
| SQIGNDSFQLQVTED | 406 | P51797 | |
| IIDEESSGNNAQALT | 151 | Q9Y366 | |
| GERDDTTQNITEVAA | 906 | Q9Y2F5 | |
| IGENLNASASSVENE | 51 | Q659A1 | |
| DSSTSGLEQDVAQLN | 456 | O15234 | |
| TESVNTENVAGGDIE | 471 | Q13936 | |
| QTEDDQLIAGQSARA | 656 | P26232 | |
| AEENKNTVDVENGAS | 61 | Q96EE4 | |
| TEETEVELGQQGQSL | 86 | Q8IZ16 | |
| IKGQESSSDQEQVDV | 646 | Q96JM3 | |
| VSEEQQTSDNSGVAI | 881 | Q14CM0 | |
| EEATFQISGLQTNTD | 1106 | Q53EP0 | |
| TTSKADVEQNTEDNG | 456 | Q4ZHG4 | |
| LQEQSASSEDGIESV | 1426 | Q5TH69 | |
| NAQTIDVNQETSDLD | 391 | P01031 | |
| NQECQTAASTGEILE | 226 | Q49AR2 | |
| AALVNQESEQSDDEL | 446 | O75061 | |
| DSFTGNVQNSLLDEE | 1186 | Q5VT06 | |
| QSGDTTVETNLERNV | 3661 | Q12955 | |
| TILELSSNGVENQEE | 11 | Q15723 | |
| SSNGVENQEESEKVS | 16 | Q15723 | |
| KASGDENDNIEIDTN | 901 | Q8NDI1 | |
| GQKNQSEEQSEASSE | 606 | Q9Y6X4 | |
| ALQSGNSQESVTEQD | 46 | P01834 | |
| EGSSRNVSAEQKDEN | 636 | P27448 | |
| DSQEDESGIKQAAEN | 81 | O75608 | |
| KQGEDNSTAQDTEEL | 451 | Q86UE4 | |
| GQLRAVSNAQTADEE | 401 | Q99705 | |
| NTGTITISLEDENDN | 336 | Q08554 | |
| AEAEQQDTASVEQSS | 3586 | Q03164 | |
| QLQVTGDASESAEDI | 591 | Q8WUQ7 | |
| SQSSLAQEEEEEDQG | 86 | P35638 | |
| ESEELECNTGSNITN | 816 | Q8NDH2 | |
| QEIDSGKNSQASEDT | 1376 | Q5T890 | |
| VSTDEGNENSKANLE | 2481 | Q9BYK8 | |
| IADQGEQQSEENAST | 201 | P0CAP2 | |
| SADAQEQVEGLLAEN | 321 | Q4V328 | |
| TEQATVDTNSLQNGD | 526 | O75363 | |
| GNTEEAIRDNSQVNA | 41 | O95810 | |
| LLAGEEDALNQTSEQ | 496 | Q92681 | |
| SIQDVENEGVNSLAA | 526 | Q6T423 | |
| QDVIEDLSQNSITGE | 86 | Q9UHW9 | |
| AEDEQLVAGNSNTEE | 161 | Q9UKG4 | |
| EADGQTEEILDSQNL | 476 | O43432 | |
| NTVGITESNENESEI | 221 | O43933 | |
| EESTGDRDISNNQIL | 816 | Q56UN5 | |
| DGETTDLQDQIAELQ | 1061 | P35580 | |
| DGQSQDEVAQAAEAL | 1111 | A6NMZ7 | |
| DALTVNEETSEENNQ | 331 | Q9NY27 | |
| GEEIKSQNSQESTAD | 1396 | Q9BXW9 | |
| GENVSEDEAQSSNQR | 56 | Q659C4 | |
| LEAAVAQSEQQGEAA | 351 | P78385 | |
| ENIKDSSGQEDETQS | 116 | Q8N108 | |
| LGNSSEEESQLETNV | 466 | P09619 | |
| SASDEDLIQQVLAEG | 3466 | P98161 | |
| EQNVDVSSQDLSGQT | 326 | B2RU33 | |
| SEEQNTGISQDEILT | 481 | B2RU33 | |
| EDGSSEFQINEQVLA | 81 | Q9BVI0 | |
| ENATVDTDIIQGTQD | 426 | P56715 | |
| TREAEEETTNDNGVL | 291 | P43121 | |
| EQNVDVSSQDLSGQT | 326 | Q86YR6 | |
| SEEQNTGISQDEILT | 481 | Q86YR6 | |
| QQTIGELTQDTALTE | 526 | Q92834 | |
| ANTEEIIEGNSVDSS | 246 | Q8TAK5 | |
| SQNDEDNQGSEKLVE | 301 | Q92552 | |
| DVVENGETADQTLSL | 206 | P47897 | |
| EDSGAEKENTSVLQQ | 261 | Q7Z7C8 | |
| TTEQLIEAVNNGDFE | 541 | Q13554 | |
| NADVQSIAVADQEDS | 236 | Q969X6 | |
| NDENTDGAIDVQKTI | 381 | Q8NBS3 | |
| NNAENTEALLAGESS | 6 | Q06945 | |
| EEEVSQAENSLLQAA | 901 | Q6YHU6 | |
| QAQETTIIASNAEEA | 26 | Q8NFQ8 | |
| GTDDSVDTQQQQAEN | 51 | Q96DX4 | |
| TEDQETVDINSVSEG | 436 | Q9H2G2 | |
| QAEQVDAVTLSGEDI | 411 | P08582 | |
| LTEVSSENEAQKQGD | 1191 | Q8NF91 | |
| AVQEEIDNGSTQTSA | 336 | Q14DG7 | |
| QVENLQSLQDEAESS | 5316 | Q8WXH0 | |
| AENTSDQNLSIEESG | 261 | Q9UMZ2 | |
| SLEQEAESVLAQQDD | 651 | Q96KG9 | |
| TVATQEDEQGDENKA | 176 | Q9Y345 | |
| NSKAEETQGNVDEAS | 1391 | Q6T4R5 | |
| QNTDESGLNDEAIAK | 191 | P35251 | |
| VEVDVDANSLNSNDV | 526 | Q9Y6U3 | |
| AQTEISEQTAAGELD | 1986 | Q5UIP0 | |
| SSVDGVQTLAQTNEE | 356 | Q9HCM1 | |
| KQLSEEQNTGISQDE | 441 | A0A0A6YYL3 | |
| VENESNVLQDGSLID | 281 | Q8N2H9 | |
| ETQVNDSISAETAEQ | 781 | O75376 | |
| VSENVSNSGINSAEI | 426 | Q8NEB9 | |
| ETIQEQQTTESAGQD | 616 | P28715 | |
| SDRQLDEAGESDVNN | 166 | O00291 | |
| IADNGNETIEAQAEL | 321 | Q92859 | |
| NDDDVQKADVSSTGQ | 91 | Q9Y6Q9 | |
| QNVADSVEKGLTEEN | 81 | Q8TCU6 | |
| EAEVDENEQGINGTS | 166 | P21815 | |
| ETQAGKVQEAQDSDS | 11 | Q8IXJ6 | |
| TLNGSEEDNVEQSGE | 1036 | Q93073 | |
| TDNDVTELIDNNGNS | 1621 | Q9NT68 | |
| AQENENESQVSTDES | 156 | Q16637 | |
| ADSVAELGEQIDSLQ | 1201 | Q9Y623 | |
| LVAQEGESSQQLNDS | 151 | Q9H7Z7 | |
| EQNIDVSSQDLSGQT | 326 | P0CG38 | |
| GGSDELSDDITQQQL | 156 | O00267 | |
| DEGNINSEEEETRQS | 291 | Q8WYR4 | |
| SVKNGQAEAEEATEQ | 181 | P48436 | |
| SGLSQDELTVQISQE | 341 | Q8NAX2 | |
| NLQEEISDLTEQLGE | 1506 | P13533 | |
| QSRSVDLGEDNVTEQ | 431 | Q92922 | |
| ELQVSNNAGEDTTEV | 356 | Q96KW2 | |
| DGQEDVETSLENLQD | 111 | Q15424 | |
| EQLEGALQSSETGQD | 1436 | Q9NRC6 | |
| TVNSQSGESENENEL | 176 | Q8N0Z3 | |
| SGESENENELDNSLN | 181 | Q8N0Z3 | |
| NEDANETAVQDTSDL | 1941 | Q6Q759 | |
| ALEQNGTEENASISN | 2021 | Q13023 | |
| TQADEDQIRAEQEAS | 681 | Q9UPV0 | |
| QLEEALNASQEEEGS | 776 | Q9P2M7 | |
| EDELSEVLENQSSQA | 101 | P10645 | |
| TAAQTDLNFINDEGD | 636 | O75339 | |
| EQTTGAENEVETNAL | 366 | Q9HAW4 | |
| ESGQVLGDQTVSDNE | 16 | P10909 | |
| DVSLGISSNEQDQGS | 601 | Q9H9A5 | |
| EEINEGALVNTSDLN | 386 | Q8NB49 | |
| NAVSGLNITADNEAD | 466 | O14730 | |
| EIDQNSSVEVGISSQ | 66 | Q5SXH7 | |
| IEGEDSKNNELQNSA | 276 | Q53GI3 | |
| TLQDSDFEIQSENGE | 131 | Q7Z7L9 | |
| DQERQETQSSIVVSG | 1316 | Q9BX84 | |
| ASEEATEQNIRAGTQ | 511 | Q6GYQ0 | |
| RDSTIQVVENGESSQ | 531 | P07911 | |
| FQGGETENEENLSSE | 376 | O15027 | |
| QESESLSEELQNAGL | 446 | Q8NE28 | |
| ISEDGETSDQQLNQS | 226 | Q15796 | |
| QDAETTSLENEQLSN | 701 | Q6ZVD7 | |
| IEQSIEQEEGLNRSS | 96 | Q16623 | |
| EQSIEQEEGLNRSSA | 96 | P61266 | |
| LNDSVNENSDTVGQI | 106 | Q8IUW5 | |
| ASSVQVQGDNTSDLD | 466 | O15067 | |
| ANLDEEAQAGTSSLQ | 126 | O95073 | |
| QEETSEEAEITNGNA | 216 | Q8TEQ6 | |
| QSSTVDSQDEQNGDV | 876 | P63133 | |
| ASTTQGQQLSEEELE | 171 | Q8WWY3 | |
| SLEDVTEVSEQSNQA | 166 | Q9Y5U2 | |
| DSLVQNGNERSDDTV | 936 | Q8IZM8 | |
| LEQQTDDLEGSLEQE | 1031 | Q9UKX3 | |
| ADSVAELGEQIDNLQ | 1201 | Q9UKX3 | |
| EESQSQGRDLTLEEN | 356 | Q14683 | |
| SQVLDDEDSNNITVG | 451 | Q9UGP8 | |
| FTQENNTIDSGELDI | 376 | Q9P273 | |
| GTLNAEQSEAVATEA | 176 | A0A0J9YWL9 | |
| QTNITLQIATDEDSG | 1181 | O94813 | |
| SGQLQNIDEEVISSA | 111 | Q2KHR2 | |
| GVLELSQSQDVEENT | 171 | Q12888 | |
| NADDEQQEEGTSSKQ | 616 | Q9UKN8 | |
| EALQQDDGDLNSLAS | 911 | Q8IZJ1 | |
| DGEGSQQEVISSEDI | 1226 | Q86X10 | |
| NQDERQDTSSEGVSN | 866 | P37275 | |
| QDTSSEGVSNVEDQN | 871 | P37275 | |
| EESNGTLEEKQASEQ | 286 | Q9UJA5 | |
| ETGVSSVNDGQLENT | 191 | Q9UBW7 | |
| ADEGDQISSNDNLIF | 31 | B2RUY7 | |
| QENLLQDLSDDGISV | 801 | Q96Q05 | |
| QDKELNDVSGEATAQ | 2131 | Q5VWN6 | |
| GNLENQTTSIGESIE | 671 | P35968 | |
| GSSAQDDEVSTVLQN | 706 | Q13395 | |
| IEVQTNDEGSESLET | 371 | Q9ULD5 | |
| ISTQTLVEGENDEQS | 211 | Q5T4S7 | |
| LVEGENDEQSSTDQA | 216 | Q5T4S7 | |
| QESSNLNEEDTGVTN | 1036 | Q5T5U3 | |
| EQNIDVSSQDLSGQT | 326 | Q6S5H5 | |
| EQNIDVSSQDLSGQT | 326 | A6NI47 | |
| QTLRIEADATDNGDQ | 186 | Q6BDS2 | |
| ENQELSLQEGEQTSL | 481 | O43164 | |
| QQQAETTSEELGAVT | 901 | Q70J99 | |
| SVGDDEELQQNESGT | 1036 | P15822 | |
| DSISETVDLNNQETV | 386 | Q8TEY7 | |
| ASVGNKSEDQNIQDD | 41 | Q9BS34 | |
| VIDASGISVDQQDND | 186 | P08048 | |
| DISNDAVNISNEAAV | 151 | Q8N402 | |
| LEAAVAQSEQQGEAA | 346 | Q14533 | |
| ERAQSQSGVDLQEDV | 1236 | B2RTY4 | |
| STSRGDVNDQDAIQE | 231 | Q9UBF9 |